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ABSTRACT
The formation of insoluble aggregates due to protein misfolding is a phenomenon
associated with in vivo inclusion body formation, in vitro aggregation, and various human
diseases. Analysis of the polymerization mechanism of the aggregation reaction requires
study of the polypeptide chain association pathway and characterization of the multimeric
intermediates.
The model system that was chosen for these folding and aggregation studies was
the phage P22 tailspike protein, which has been investigated previously both in vivo and in
vitro. Nondenaturing polyacrylamide gel electrophoresis (PAGE) was used to isolate early
intermediates in the in vitro pathway to the aggregated state for the tailspike protein. A
sequential ladder of multimers of a partially folded species was present in the initial stages
of the aggregation reaction. Discrete species formed during the polymerization process
involving the noncovalent association of monomeric folding intermediates. The
aggregation intermediates were nonnative multimers that were sensitive to SDS and
protease unlike the thermostable native trimer. Using a nondenaturing Western blot
protocol, reactivity with monoclonal antibodies against native and nonnative tailspike was
screened. Aggregation intermediates displayed nonnative epitopes in common with
productive folding intermediates. The nonnative epitopes on the intermediates were located
on the partially folded N-terminus in a region nonessential to folding, and this had
structural implications as to the mechanism of folding and aggregation.
Quantitative modeling of the aggregation reaction and two-dimensional PAGE
data indicated that tailspike aggregation occurred by multimeric cluster-cluster
polymerization, in which two multimers of any size could associate to form a larger
aggregate. The specificity of aggregation was tested for a mixture of proteins refolding in
vitro, and the results indicated that folding intermediates of different proteins did not
aggregate heterogeneously with each other but only self-associated.
This methodology of isolating early multimers along the aggregation pathway has
been shown to be applicable to other proteins, such as the P22 coat protein and carbonic
anhydrase II, and may potentially be used to monitor the extent of aggregation in the
production of therapeutic proteins, identify inclusion body intermediates, or isolate early
multimeric intermediates in amyloid fibril formation.
Thesis supervisors: Dr. Daniel I.C. Wang, Institute Professor
Dr. Jonathan King, Professor of Biology
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CHAPTER 1: INTRODUCTION
The study of protein folding and aggregation has its historical roots in food science
technology. The food and biotechnology industry arose from the practice of fermentation
to produce beer and wine as early as 7000BC (Bailey & Ollis, 1986). With the
development of microbiology, food science has expanded to include the production of
cheese, yogurt, soy, and whipped cream, which involve protein denaturation and
aggregation of egg, milk, and soy proteins (Ferry, 1948). Rheology and texture are the
issues in protein aggregation during food preparation rather than enzymatic activity, as in
biotechnology. The principles of protein denaturation by heat treatment, shear stress, or
acidic conditions are utilized in food processing. Gel formation depends on the
denaturation conditions of pH, salt, and protein concentration (Mulvihill & Kinsella,
1988). Biochemical studies have been performed on the aggregation of many food
proteins, including lysozyme (Li-Chan & Nakai, 1991), ovalbumin (Painter & Koenig,
1976), Pf-lactoglobulin (Clark & Lee-Tuffnell, 1986; Langton & Hermansson, 1991), ic-
casein (Haque & Kinsella, 1988), whey (Hermansson, 1986), soy glycinin (Badley et al.,
1975), myosin (Kaminer & Bell, 1966), and peanut arachin (Kumar et al., 1980).
Experienced cooks know in making an egg and lemon sauce to add the hot chicken
broth to the egg and lemon sauce in that order and not the reverse (Mitraki, personal
cooking lesson). Aggregation in cooking can be avoided by ensuring proper heat transfer
and dilution of the acid-denatured egg protein. If the order of addition is reversed or the
transfer is not done in stages with continuous mixing, the resulting concoction will
resemble egg drop soup. Whether frying an egg, whipping cream, or making an egg and
lemon sauce, years of experience in the kitchen have utilized the principles of denaturation
and aggregation of egg and milk proteins and heat and mass transfer principles.
With the advent of biotechnology, protein folding became a recognized scientific
problem (Marston, 1986). Before the 1980's, therapeutic proteins such as insulin and
growth hormone were isolated from their natural source (Schein, 1989). The disadvantage
of this practice is the large amount of material that must be processed to extract enough of
the desired protein, the lack of availability of a reliable source, and the possibility of
spreading infectious agents to human recipients. Recombinant DNA technology offered the
possibility of producing heterologous protein in a bacterial host (Cohen et al., 1973). This
technique promised a continuous supply of any protein that could be cloned, expressed,
and purified. However, it became evident that the proteins overexpressed in bacteria
formed insoluble aggregates, or inclusion bodies (Prouty & Goldberg, 1972; Prouty et al.,
1975). In the aggregated state, the protein did not have any enzymatic activity or
therapeutic value. Therefore, the biotechnology industry has catalyzed an intense effort in
solving the protein folding problem.
Seminal work in in vitro protein refolding was performed on RNase A by Anfinsen
(Anfinsen, 1961). This research was the first documentation that a polypeptide chain could
regain its enzymatic activity by refolding. The primary sequence of the protein was
sufficient to direct the refolding into the native conformation without the addition of
exogenous cofactors. In vivo, Prouty discovered that abnormal E. coli proteins aggregated
in cells to form inclusion bodies (Prouty & Goldberg, 1972). Two decades later, the
biotechnology industry is utilizing knowledge of in vivo and in vitro folding and
aggregation to refold recombinant proteins from the aggregated inclusion body state
(Marston, 1986; Cleland, 1993; Schein, 1989). Table 1.1 shows that most therapeutic
proteins important in the biotechnology industry are recovered from the aggregated
inclusion body state.
Protein misfolding also plays a role in human diseases (Benson & Wallace, 1989;
Thomas et al., 1995). Table 1.2 lists some examples of diseases caused by protein
Table 1.1: Folding and aggregation of therapeutic proteins.
Protein Expression Conformation Reference
System State
Antibody OKT3 Hybridoma Native Cleland, 1993
al-Antitrypsin E. coli Nativet Courtney et al., 1984
rh DNase CHO Native Cleland, 1993
rh Erythropoietin CHO Native Lin et al., 1985
Factor VIII hamster kidney Native Wood et al., 1984
cells
Factor IX CHO Native Kaufman et al., 1986
basic-FGF / E. coli Native Squires et al., 1988
FMDV (foot&mouth E. coli Inclusion body Builder&Ogez, 1985;
disease viral coat) Olsen&Pai, 1985
h Fibroblast Interferon E. coli Inclusion bodyt Builder&Ogez, 1985;
Olsen&Pai, 1985
G-CSF E. coli Inclusion body Cleland, 1993
GM-CSF E. coli Inclusion body Cleland, 1993
hGH V E. coli Inclusion bodyt Builder&Ogez, 1985;
Olsen&Pai, 1985
IGF-1 /  E. coli Inclusion body Chang&Swartz, 1993
IL-2 / E. coli Inclusion bodyt Koths et al., 1985
h Insulin E. coli Inclusion body Marston, 1986
a-IFN E. coli Inclusion bodyt Schein & Notebornm,
1988
1-IFN E. coli Inclusion body Konrad et al, 1984;
Hershenson, 1990
rh y-IFN E. coli Inclusion bodyt Schein & Noteborn,
1988
h TNF E. coli Native Pennica et al., 1984
rh tPA CHO Native Lubiniecki et al., 1988
tIndicates that the fraction of polypeptide chains in the aggregated inclusion body state was
highly dependent on growth conditions
Table 1.2: Human diseases caused by protein misfolding, aggregation, and improper
trafficking.
Protein or peptide Human disease Reference
al-Antitrypsin al-Antitrypsin deficiency Lomas et al., 1995
Apolipoprotein A-1 peptide Familial amyloid Benson & Wallace, 1989
polyneuropathy Ill
Amyloid-f3 peptide Alzheimer's disease Glenner & Wong, 1984
CFTR Cystic fibrosis Cheng et al., 1990
Collagen Scurvy Eyre, 1980
Crystallins Cataracts Benedeck, 1971
Fibrillin Marfan syndrome Wu et al., 1995
j~-Hexosaminidase Tay-Sachs Lau & Neufeld, 1989
Immunoglobulin light chains Primary systemic Benson & Wallace, 1989
amyloidosis
Insulin receptor Leprechaunism Thomas et al., 1995
Islet amyloid polypeptide Type II diabetes H6ppener et al., 1994
a-Ketoacid dehydrogenase Maple syrup urine disease Thomas et al., 1995
p53 Cancer Vogelstein & Kinzler, 1992
Prion protein Spongiform encephalopathy Pruisner, 1982
Procollagen pro a (type I) Osteogenesis imperfecta Thomas et al., 1995
Hemoglobin Sickle cell anemia Ingram, 1957
LDL receptor Hypercholesterolemia Hobbs et al., 1990
Rhodopsin Retinitis pigmentosa Thomas et al., 1995
Serum amyloid A Secondary systemic Benson & Wallace, 1989
amyloidosis
Superoxide dismutase Amyotrophic lateral Deng et al., 1993;
sclerosis Borchelt et al., 1995
Transthyretin Familial amyloid Colon & Kelly, 1992
polyneuropathy I;
Senile systemic amyloidosis
misfolding, aggregation, and improper trafficking. Amyloidosis is the most recognized
disease involving protein aggregation (Kelly & Lansbury, 1994). The formation of
insoluble fibrils either systemically or in certain organs, such as the brain, can cause
polyneuropathy and neurodegenerative disorders. Examples of amyloidogenic proteins
include 3-amyloid (Glenner & Wong, 1984), transthyretin (Colon & Kelly, 1992), prions
(Pruisner, 1982), immunoglobulin light chains (Myatt et al., 1994; Hurle et al., 1994), and
islet amyloid polypeptide protein (Hbppener et al., 1994). Other proteins that cause disease
via aggregation include sickle cell hemoglobin (Ingram, 1957), crystallin proteins in
cataract formation (Benedek, 1971), and superoxide dismutase associated with
amyotrophic lateral sclerosis, or Lou Gehrig's disease (Deng et al., 1993; Borchelt et al.,
1995). The molecular mechanism of these diseases may involve the absence of the active
folded native protein, the improper trafficking of protein within the cell, or the presence of
toxic aggregates (Thomas et al., 1995).
Despite of the link between protein aggregation and human diseases, protein
aggregation is a natural process regulated by the body. For example, the aggregation of
lysophospholipase is an essential step in blood clotting. Von Willebrand factor, or factor
VIII, is required to mediate platelet aggregation in blood clotting, the absence of which
causes hemophilia (Wood et al., 1984).
Due to the need of the the biotechnology industry, biochemical engineers have been
recruited to deal with the protein folding problem. The chemical engineering of protein
folding and aggregation includes thermodynamics, kinetics, and engineering principles in
conjunction with biochemistry and molecular biology. Thermodynamic data and molecular
models originally designed for the petroleum industry are now applied to protein folding
and aggregation (Chen et al., 1995). Group contribution theory can be employed to
estimate the AG of transferring amino acid side chains from a solvated state of the unfolded
polypeptide chain to the protein core of the native species. In modeling the kinetics of
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aggregation, principles of polymerization chemistry and irreversible reactions are
incorporated into the kinetic analysis (Sonntag & Strenge, 1987). Fundamental reactor
engineering principles are also used in the design of novel refolding strategies. One such
design involves immobilizing unfolded polypeptide chains onto a column matrix and
passing the refolding buffer through the matrix (Sinna & Light, 1975). Other refolding
strategies attempt to keep the concentration of folding intermediates below the critical
aggregation concentration by performing a series of step-wise dilutions of the denatured
protein (Rudolph & Fischer, 1987).
To address the protein folding problem, this thesis research focuses on the
competition between productive folding and aggregation. The point at which one can
control the folding reaction is the critical folding intermediates at the junction between the
productive folding pathway and the off-pathway aggregation reaction (Mitraki & King,
1989). An understanding of the folding pathway as well as the polymerization mechanism
of aggregation is required to address the protein folding problem. Aggregation occurs by
the association of folding intermediates via a defined polymerization mechanism. The
resulting off-pathway intermediates are multimeric precursors to the aggregated inclusion
body state (Speed et al., 1995). The objectives of this thesis research are: 1) identify the
multimeric aggregation intermediates of P22 tailspike polypeptide chains, 2) characterize
the biophysical properties of the aggregation intermediates, 3) characterize the structural
basis of aggregation, 4) determine the polymerization mechanism of aggregation, 5)
determine the specificity of aggregation, and, 6) extend the methodologies to other protein
systems.
CHAPTER 2: LITERATURE REVIEW
A major problem in biotechnology is the incorrect folding of newly synthesized polypeptide
chains and formation of insoluble aggregates which are biologically inactive (Marston,
1986; Mitraki and King, 1989; DeBernardez-Clark and Georgiou, 1991; Wetzel, 1994). In
vivo, this folding problem frequently arises with heterologous proteins overexpressed in E.
coli, which form inclusion bodies, or amorphous aggregates within the cell. The
analogous aggregation problem occurs in vitro via a similar association mechanism
(Zettlmeissl et al., 1979; Colon & Kelly, 1992; Mitraki et al., 1991). In the cases where
the competition between the refolding and aggregation reactions has been directly studied,
the precursor to aggregation is a defined intermediate in the refolding pathway (Brems,
1988; Mitraki et al., 1993). For numerous proteins, this class of folding intermediates is
the species that is recognized by the GroE chaperonin, which assists in protein folding by
binding to folding intermediates and preventing improper association of the polypeptide
chains (Goloubinoff et al., 1989). Non-native multimerization subsequently leads
irreversibly to the formation of large aggregates or inclusion bodies. Therefore, further
study of the aggregation reaction is essential in designing effective refolding strategies.
A. In vitro refolding and aggregation
In the early 1960's, Anfinsen performed the first experiments in protein refolding in which
he successfully renatured bovine pancreatic ribonuclease in vitro without additional
cofactors (Anfinsen et al., 1961). The blueprint for folding was located in the primary
amino acid sequence and was not dependent upon external templates (Anfinsen, 1973).
Over the course of three decades of research in protein folding with significant advances,
the protein folding problem has not been solved. However, there is now a greater
understanding of the structural changes, thermodynamic forces, and kinetic competition
associated with protein folding and aggregation.
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In the simplest model for protein folding, the unfolded polypeptide chain is in
equilibrium with the native state. For most proteins, the folding pathway is more
complicated and involves either a two-step folding process with a single intermediate or a
complicated multistage mechanism with several intermediates. Most globular proteins are
hypothesized to refold through a molten globule intermediate, in which the folding
intermediate has an exposed hydrophobic surface that can lead to aggregation. Examples of
proteins that have molten globule folding intermediates include carbonic anhydrase B, a-
lactalbumin, p-lactamase, bovine growth hormone, phosphoglycerate kinase, and P-
lactoglobulin (Ptitsyn et al., 1990).
The forces that are important in protein folding and aggregation are electrostatics,
hydrogen bonding, van der Waals interactions, and hydrophobic interactions (Dill, 1990;
Creighton, 1993). Electrostatics are long-range interactions with a strong dependence on
ionic strength and pH. High salt concentrations can shield charges and reduce the
electrostatic effect. The pH determines the global charge of a protein, and aggregation is
more likely to occur when the solution pH equals the isoelectric point of the protein due to
the lack of charge repulsion for neutral species. Although each ion pair in the native protein
can provide 1-3 kcal/mol stabilization (Fersht, 1972), ion pairing generally is not the
dominant force in protein folding, as determined by a weak dependence on ionic strength
near the isoelectric point (Hermans & Sheraga, 1961) and lack of conservation of ion
pairing in structural evolution (Barlow & Thorton, 1983). Hydrogen bonds and van der
Waals interactions, which provide 2-10 kcal/mol stabilization (Pauling, 1960), are critical
in the formation of secondary structure, such as helix-coil transitions (Schellman, 1958)
and P-sheet formation (Mattice & Scheraga, 1984). The main driving force of folding is
generally hydrophobicity, or the "transfer of nonpolar solutes into an aqueous solution,
characterized by the ordering of water molecules around nonpolar solutes" (Dill, 1990).
The dominant force opposing protein folding is the loss in degrees of freedom of the
polypeptide chain in folding into the native conformation. There is an unfavorable loss in
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entropy upon ordering water molecules around the protein, an excluded volume effect, and
steric constraints. Generally, the overall change in free energy associated with protein
folding is 5-20 kcal/mol (Pace, 1975; Privalov, 1979).
Seminal work in identifying and characterizing intermediates on the folding
pathway was first done on bovine growth hormone (bGH) by Brems and colleagues
(Brems et al., 1986; Brems, 1988; Lehrman et al., 1991). Equilibrium experiments of
bGH in various concentrations of guanidine hydrochloride (GuHC1) were performed using
size-exclusion HPLC to measure the hydrodynamic radius or compactness, far-ultraviolet
circular dichroism at 222nm (far-UV CD) to measure secondary structure, and ultraviolet
absorbance at 290nm to measure exposure to solvent or extent of packing of the aromatic
residues (Brems & Havel, 1989). The data indicate that the unfolding transition measured
by the above three techniques did not occur at the same GuHC1 concentrations. This
noncoincidence of signals indicated that the unfolding process was a multistate transition
and not a simple two-step mechanism. The initial sign of denaturation was the disruption
of the packed aromatic residues (tyrosine and tryptophan residues), followed by a loss in
compactness and secondary structure at higher GuHCI concentrations. Tryptophan
fluorescence quenching experiments were performed on bGH over a range of denaturant
concentrations with various chemical quenchers (iodide, acrylamide, and trichloroethanol),
measuring fluorescence at 350nm. The data indicated that the quenching was greater for
the intermediate than native bGH but less than fully denatured protein, which suggested
that the tertiary structure was disrupted during the unfolding process. From the other data
comparing the properties of native, intermediate, and unfolded species, the intermediate
was determined to be a compact globule that retained much of its a-helical structure (far-
UV CD data) but had disrupted packing of the aromatic side chains (UV absorption data).
The problem with aggregation arises when the monomeric folding intermediates
associate to form off-pathway multimeric species. Brems used a two-step dilution method
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to investigate the folding intermediates and aggregation process during refolding of bovine
growth hormone (Brems, 1988). In the first step, certain bovine growth hormone
conformers were populated by adjusting GuHCl and protein concentrations or by taking
samples during kinetic refolding experiments. The second step was to dilute the sample to
solvent conditions (low GuHCl concentration) to cause precipitation of only associated
intermediates. To determine the amount of aggregate, the turbidity was measured at 450nm
using a spectrophotometer. During refolding, the initial unfolding conditions affected the
extent of aggregation and partially unfolded bGH led to aggregation. In addition, the
mechanism was temperature dependent, with more aggregation occurring at higher
temperatures.
Previous work by Brems (1986) suggested that aggregation was reduced by adding
peptide fragments of bGH (residues 96-133) to prevent association of intermediates. This
peptide fragment was thought to be an amphipathic helix, and perhaps it interacted with the
hydrophobic surface of the intermediate and blocked self-aggregation. Experiments were
performed to see the effects of adding various concentrations of peptide 96-133 in refolding
assays (Brems, 1988). The peptide fragment effectively inhibited precipitation and
demonstrated half of its inhibition potential at a peptide concentration in excess of three fold
over the bGH concentration. Further studies showed that peptide fragment 109-133 was
just as effective in preventing precipitation as fragment 96-133, but peptide 96-112 was
not. Therefore, the C-terminal section of fragment 96-133 plays an important role in
intermolecular self-association that leads to precipitation of folding intermediates. The
aggregation mechanism appears to involve a specific hydrophobic patch or helix docking
site on the surface of the protein folding intermediate. The free energy of the helix-helix
docking reaction during dimer formation can be calculated by group contribution theory
(Chen et al., 1995).
Another globular protein that has been extensively studied is carbonic anhydrase B
(CAB), which is an esterase that regulates the ratio of carbon dioxide to bicarbonate
concentration in blood. Using quasi-elastic light scattering (QLS) and size exclusion
chromatography (HPLC) to monitor the refolding and aggregation process, the folding
pathway and association of folding intermediates were characterized (Cleland & Wang,
1991). The refolding pathway involved two folding intermediates and an aggregation
pathway that is caused by association of the first folding intermediate. The conditions
under which micron-sized aggregates immediately formed defined the aggregation regime,
and the multimer formation-regime was characterized by observable dimer and trimer
species that formed before micron-sized aggregation. The lower limit for refolding was the
regime which allowed the formation of multimers that did not develop into micron-sized
aggregates. Measuring the formation of multimeric species by QLS, the aggregation
regime and lower limit of refolding was mapped with respect to protein and denaturant
concentration. The protein refolded into the native structure or a stable intermediate that did
not aggregate at denaturant concentrations between the lower refolding limit and 1M
GuHC1. The association of the early monomeric intermediate II to form a dimer was a
slow reaction at equilibrium with a Keq of 1.3mM- 1 and association rate of 5.16x10-3min-1.
After dimerization, trimerization proceeded rapidly (Keq of 0.42M- 1 and association rate of
0.133min-1), which directly led to irreversible aggregation (Cleland & Wang, 1991).
In kinetic and equilibrium experiments, aggregation occurs by the association of
folding intermediates with exposed hydrophobic patches. Certain cosolvents can inhibit
aggregation by interacting with folding intermediates to block self-association. These small
organic and inorganic substances include an assortment of cofactors, metal ions, specific
ligands, surfactants, sugars, and other solvent additives (Schein, 1990). The simplest
possible mechanism by which cosolvents act involves the solvent molecule (e.g. low
concentration of PEG) binding directly to the protein to stabilize that conformer and prevent
self association. If the formation of the binding site is the rate limiting step of protein
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folding, then specific binding of the cosolvent to stabilize the folding intermediate enhances
the rate of refolding. An alternative mechanism is that the cosolvent alters the solution
properties by preferential hydration or exclusion (Arakawa & Timasheff, 1985).
Preferential hydration occurs when cosolvents, such as sugars, increase the surface tension
of an aqueous solution and have a higher affinity for water than the hydrophobic protein
does. The resulting hydration shell surrounding the protein is conducive for the burial of
the hydrophobic core during refolding. The hydration leads to less free surface area and a
lower free energy for the protein, which is the driving force for forming a compact
structure such as the native species or aggregate. The effectiveness of cosolvent addition in
protein folding or solubility of the native species is dependent on the specific protein,
protein concentration, cosolvent type, and cosolvent molecular weight (Arakawa et al.,
1990).
The cosolvent polyethylene glycol (PEG) of molecular weight 1000 to 8000 Da
inhibited CAB aggregation and increased the refolding yield (Cleland & Wang, 1990a).
The molecular weight of PEG was critical because too low MW PEG (200-600) did not
effectively shield the exposed hydophobic patches on the folding intermediate, whereas
high MW PEG (20,000 Da) actually increased aggregation by the PEG molecule binding to
more than one polypeptide chain (Cleland, Hedgepeth, & Wang, 1992). In addition, the
solvent exclusion effect caused high molecular weight PEG (10-50 wt%) to exclude CAB
sterically from the bulk solution and caused the protein to precipitate because of the higher
effective CAB concentration (Cleland & Wang, 1990a). The mechanism by which PEG
interacted with CAB involved the cosolvent molecule binding to the first folding
intermediate of CAB (Cleland & Randolph, 1992). Because the hydrophobic patches on
the protein surface were the sites for aggregation interactions, PEG binding to the
aggregation sites induced changes in the surface characteristics and prevented dimerization.
Using PEG of MW 3350, stoichiometric analysis indicated that 2 PEG molecules were
bound to the hydrophobic patches of each CAB polypeptide chain (Cleland, Hedgepeth, &
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Wang, 1992). PEG bound to the first folding intermediate and not the second intermediate
and native CAB. The mechanism of PEG-assisted refolding involved preventing the first
intermediate from dimerizing rather than increasing the folding rate to form the second
intermediate (Cleland, Hedgepeth, & Wang, 1992). PEG effectively assisted refolding at a
concentration of 3 to 30g/L to produce an active species without aggregation, and optimal
refolding was observed for PEG concentrations of 0.15-0.20 g/L (MW 3350) at a
[PEG]/[CAB] molar ratio of 2-3 under the refolding conditions of 0.50 mg/mL CAB, 1M
GdnHC1, 50mM Tris, pH 7.5 (Cleland, Hedgepeth, & Wang, 1992). The apparent
refolding rate increased three fold by adding 3g/L PEG of molecular weight 3350Da, as
measured by the recovery of enzymatic activity (Cleland & Wang, 1990a). The ability of a
cosolvent to assist refolding allowed recovery of an enzymatically active protein at
conditions which normally resulted in aggregation. In this respect, the mechanism by
which cosolvents assist refolding is similar to the role of molecular chaperones in in vivo
folding (Cleland, Hedgepeth, & Wang, 1992).
Several amyloidogenic proteins in the human body have a propensity to aggregate
to form insoluble plaques which then lead to neurodegenerative disorders. One such
species is the [3-amyloid peptide, which is associated with Alzheimer's disease (Glenner &
Wong, 1984). The C-terminus of amyloid peptide (Al1-42) is critical in fibril formation
(Halverson et al., 1990), and this sequence is homologous to the region of the
amyloidogenic prion protein 94-111 involved in scrapie (Jarrett & Lansbury, 1992).
Aggregates of the [3-amyloid peptide are found in the brain as plaques with substantial
neurofibrillary tangles. The dimension of the fibrils are >1000A in length and 70-100A in
width (Kelly & Lansbury, 1994). FTIR data indicate that the fibrils contain 13-sheet
secondary structure with the [3-sheet contacts parallel to the axis of the fibril. This motif is
similar to the parallel [3-spiral of the tailspike protein, except the local [3-sheet contacts are
antiparallel for amyloid. The cross D3-fibril structure has specific interstrand alignment
determined by solid state NMR (Sun et al., 1995). There is also extreme sheet pleating
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with the side chains packed together tightly without the presence of water molecules.
Examination of the bond angles shows an unusual Gly-Gly structure in a cis conformation.
Fragment Ar334-42, which is extremely insoluble, may initiate fibril formation by the
hydrophobic cluster stabilizing the cis isomer. The kinetics of fibril polymerization follow
nucleation growth kinetics, which will be discussed in a later section (Jarrett & Lansbury,
1992). Seeding of the aggregation reaction with a preformed fibril bypasses the slow
nucleation step, characteristic of nucleation-growth reactions (Jarrett et al., 1993).
Prion diseases are neurodegenerative disorders related to 03-amyloid fibril
formation. Types of prion diseases or scrapie include bovine spongiform encephalopathy,
Creutzfeldt-Jakob disease, Gerstmann-Straussler-Schienker syndrome, fatal familial
insomnia. The term "prion" was coined by Pruisner to describe a PROteinaceous
INfectious agent which did not require nucleic acids to pass along its genetic code
(Pruisner, 1982). Infectious scrapie prion protein was resistant to nucleic acid modifying
agents but susceptible to protein modifiers (Prusiner, 1982; Prusiner, 1992). Caughey,
Lansbury, and colleagues developed an in vitro cell-free conversion of PrPC to PrPSc to
prove that prion protein is the infectious agent for scrapie (Kocisko et al., 1994). In
mixing 35S-labeled PrPC and PrPs e, PrPSc was found to convert PrPC to the scrapie
form, and the transition was monitored by the protease-resistance characteristic of PrPse.
The conversion was specific in that other types of amyloid could not seed the scrapie
transition and certain strains of scrapie were not infectious due to slight conformational
differences in the scrapie seed (Kocisko et al., 1995). Similar to 1-amyloid fibril
formation, the conversion of normal cellular prion protein (PrPC) to the scrapie form
(PrPSC) was accompanied by an a-helix to P-sheet conformational transition, as measured
by CD (Pan et al., 1993). In fact, all known inherited scrapie mutations except one,
F198S, have a higher predicted propensity to adopt a n-sheet conformation (Baldwin et al.,
1995). Structural models of the normal cellular prion protein predict a 4-helix bundle motif
in an x-orientation (Baldwin et al., 1995). Evidence suggests that the first helix and
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specifically the hydrophobic peptide 104-122 is involved in converting prion protein to the
scrapie form with 3-sheet structure, as measured by CD and FTIR spectroscopy (Nguyen
et al., 1995). As in other protein aggregation phenomena, scrapie infectivity displayed a
concentration dependence on prion protein, with greater susceptibility to scrapie occurring
at higher prion concentrations.
Transthyretin (TTR) is another amyloidogenic protein that has been extensively
studied. TTR is a plasma protein involved in binding thyroxine and retinol binding protein,
which then binds vitamin A (van Jaarsveld et al., 1973). The native state of TTR is a
tetramer, with each monomer having a 3-sheet sandwich motif (Blake et al., 1974). The
proposed model is that the tetramer dissociates under acidic conditions and the resulting
monomer is the amyloidogenic intermediate, which may form in the acidic environment of
the lysosomes (Colon & Kelly, 1992). Near UV CD spectroscopy data indicated that the
tetramer was still intact at pH 5.1, although tertiary structure was disrupted. At pH 3, TTR
was monomeric and in the acid denatured A-state. However, at an intermediate pH of 4,
the plateau in fluorescence indicated an accumulation of a monomeric intermediate. This
intermediate was a structured monomer and not analogous to a hydrophobic folding
intermediate, as determined by the lack of ANS binding. The familial mutations of TTR
destabilized the tetramer and caused the transition to the amyloidogenic monomer to occur
at a higher pH (McCutchen et al., 1993). Proteolysis experiments using endoproteinase
Glu-C (commonly known as protease V-8) indicated that a loop between 2 P-sheet strands
(C-D loop) rearranged in fibril formation and was critical in the polymerization reaction.
Since the H-strand of the 3-sheet has a reduced affinity for self-association causing the
TTR tetramer to dissociate under acidic conditions, the amyloidogenic monomers assemble
in a head-to-tail orientation.
B. In vivo folding and inclusion body formation
The cellular environment in which the protein folds in vivo and interactions with molecular
chaperonins that aid in folding are generally unique aspects of in vivo folding that are
difficult to fully replicate in vitro. Although the in vivo and in vitro folding pathways
consist of similar thermolabile intermediates, folding in a cellular environment differs from
in vitro folding. The progressive exposure of a nascent polypeptide chain to the cellular
environment is not identical to in vitro initiation of refolding by dilution of denaturant. At a
standard translation rate of 40-50 nucleosides/s/ribosome (Spirin, 1986), it takes 40-50 sec
for the complete tailspike polypeptide chain to be synthesized, and the N-terminus is
exposed to the folding conditions within the cell while the incomplete chain is still tethered
to the ribosome. Within the cell, the presence of ions, cofactors, chaperones, isomerases,
proteases, and other cellular components which interact with nascent polypeptide chains
can influence the folding process. The concentration of polypeptide chains is also relatively
high in the cell (approximately 150 mg/mL), whereas standard protein concentrations for in
vitro refolding are much more dilute (3-4 orders of magnitude lower, King et al., 1996).
Generally, the cell is better equipped to fold polypeptide chains correctly than in vitro
systems.
Although the amino acid sequence contains the information to determine the native
tertiary structure, certain cofactors and auxiliary proteins are often required to ensure proper
folding. Molecular chaperones are one type of auxiliary protein that aid in the folding
process by associating with partially folded proteins to prevent incorrect interactions (Ellis,
1994). Chaperones help stabilize the folding intermediates of nascent polypeptide chains,
translocating proteins, and proteins destabilized under stress. Chaperones recognize certain
protein structural characteristics that are only exposed to the solvent in partially folded or
stress-destabilized proteins. Like an enzyme, the molecular chaperone is not associated
with the final folded protein substrate. It does not determine the final steric conformation
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but only prevents inappropriate interactions. Most of the moleular chaperone proteins in E.
coli are constitutively expressed, and their rate of synthesis is dramatically increased when
the cell is exposed to stressful growing conditions, such as heat shock.
GroE proteins are heat-shock molecular chaperones found in prokaryotic cytoplasm
and eukaryotic organelles. GroEL, or chaperonin 60, is an 812kD complex of fourteen
58kD subunits in the form of 2 heptameric rings. GroEL was originally discovered for its
role in assembling T4 phage tails and bacteriophage lambda heads. Further studies with the
photosynthetic enzyme ribulose bisphosphate carboxylase, known as Rubisco (Viitanen,
1990; Gatenby et al., 1990; Goloubinoff, 1989), bacteriophage P22 coat protein (Gordon
et al., 1994), and numerous other proteins revealed that GroEL and other related molecular
chaperones are important in protein folding and assembly of oligomeric proteins. Closely
associated with GroEL is chaperonin 10 or the GroES protein, a ring of seven 10kD
subunits. ATP hydrolysis and K+ cations are required to catalyze the release of the
polypeptide chains. Through a series of binding and release reactions, the nascent
polypeptide chain folds within the GroEL-ES complex, which shields the chains from self-
association.
Other heat shock proteins (hsp) play an essential role in protein folding within the
cell. DnaK, a member of the hsp70 family in E. coli, binds to nascent polypeptide chains,
keeping them in the unfolded state. Subsequent binding of the chaperone DnaJ to the
DnaK-polypeptide complex stabilizes the partially folded intermediate. ATP hydrolysis and
the addition of chaperonin GrpE catalyzes the release of DnaK and DnaJ, and the folding
intermediate then binds to GroEL. SecB is another cytoplasmic chaperone in E. coli that
binds to folding intermediates and maintains the chains in a nonnative conformation to
enable export into the periplasmic space (Diamond et al., 1995). The homologue of hsp70
in eukaryotes is the heavy chain binding protein BiP which aids the folding of polypeptide
chains in the endoplasmic reticulum. Heat shock cognate hsc70 is another related
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chaperonin which is synthesized constitutively in eukaryotic cytoplasm. In addition, other
heat shock proteins display proteolytic activity, such as ion and clpP proteases in E coli,
and aid in the degradation of misfolded polypeptide chains. The analogous protein in
eukaryotes is ubiquitin, which binds to polypeptide chains and presents the chains to
proteolytic enzymes.
Frequently when overexpressing heterologous protein in bacteria, the polypeptide
chains are found in the aggregated inclusion body state. Locally, the concentration of
nascent polypeptide chains may be relatively high, resulting in aggregation. The
predominant factor in inclusion body formation is growth temperature rather than
production rate or protein concentration, although the rate of protein synthesis is important
for secreted proteins (Schein & Notebom, 1988). The host chaperonins and foldases may
not recognize the foreign protein or may be present in insufficient amounts to aid the
overexpressed polypeptide chains. Constitutive expression of human erythropoeitin,
human granulocyte colony stimulating factor, and S. pombe acid phosphatase in yeast
depleted the amount of free protein disulphide isomerase (PDI) and the chaperone BiP
(Robinson & Wittrup, 1995). Cotranslation and overexpression of heterologous
chaperonins or amplification of native chaperonins can improve the yield of recombinant
proteins. In yeast, overexpression of PDI improved the secretion of S. pombe acid
phosphatase by 4-fold and human platelet derived growth factor B by 10-fold (Robinson et
al., 1994). Bacteria lack certain cellular machinery to produce certain native eukaryotic
proteins. Since the bacterial cytosol is a reducing environment, disulfide bonds that may be
required in the native recombinant protein are not generally formed. This problem can be
circumvented by expression as a fusion peptide with a signal sequence to direct the protein
to the periplasmic space. Bacteria also lack certain cellular compartments, the endoplasmic
reticulum and Golgi apparatus, which are required for the secretion of glycosylated
mammalian proteins. Without the presence of various foldases, such as PDI, PPI, and
thioredoxin, the recombinant polypeptide chains often accumulate folding intermediates that
are susceptible to aggregating to form inclusion bodies.
Scanning electron microscopy has been used to determine the morphology of
inclusion bodies, also known as refractile bodies. Electron micrographs of cells show that
inclusion bodies are large amorphous or spherical particles that occupy a substantial
fraction of the cell volume (Fig. 2.1). Generally, the size of inclusion bodies in E. coli are
approximately 1 pm in diameter. In a statistical analysis of particle size, y-interferon and
prochymosin inclusion bodies were 0.81pm (std deviation 0.17) and 1.28 pm (std
deviation 0.46), respectively (Taylor et al., 1986). Sedimentation studies by centrifugation
determined the apparent density of the y-interferon and prochymosin inclusion bodies to be
approximately 1.37 and 1.20 g/mL with a 70% and 80% voidage, respectively (Taylor et
al., 1986). Theoretical correlations between the measured density and the particle size
suggested that the y-interferon inclusion bodies were more ordered than the prochymosin
aggregates. Although most inclusion bodies in E. coli are cytosolic, aggregated inclusion
bodies can form in the periplasmic space by having a signal peptide sequence directing the
polypeptide chain across the inner membrane. Since the periplasmic environment differs
from the cytosol in terms of redox potential and cofactors, the inclusion bodies that form in
the perisplasmic space have different biophysical characteristics, including the possibility of
disulfide bond formation. 1-lactamase inclusion bodies located in E. coli cytoplasm were
amorphous and spherical, whereas periplasmic inclusion bodies were more regular and
cylindrical (Bowden et al., 1991).
Besides folding and aggregation, various other posttranslational modifications are
in kinetic competition acting upon the nascent polypeptide chains. Proline bond
isomerization to the cis isoform may be a rate-limiting step of folding, and this reaction is
catalyzed by peptidyl-prolyl isomerase (PPI). Sequence analysis has correlated empirically
high proline content of proteins to the propensity to aggregate (Schein, 1989; Wood et al.,
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1995). Other reactions are associated with proteins secreted into cellular compartments,
such as the periplasmic space of Gram-negative bacteria or the eukaryotic endoplasmic
reticulum, which has a redox potential, pH, and posttranslational enzymes different from
the cytoplasm. Oxidation of cysteines and correct pairing in disulfide bond formation are
reactions that often require export into the periplasmic space because disulfide bonds
generally do not form in the reducing environment of the cytoplasm with glutathione
present (DeBernardez & Georgiou, 1991). In eukaryotic cells, disulfide bond
rearrangement is catalyzed by protein disulfide isomerase (PDI) which shuffles the bonding
of cysteines to the correct pairing. Also, glycosylation of eukaryotic proteins in the
endoplasmic reticulum can increase protein solubility and refolding yield (Schein, 1990).
Other chemical modifications, such as acylation, can occur for secreted proteins. Proteins
must undergo all of the above posttranslational modifications correctly to produce the active
native molecule. If a certain mammalian protein requires posttranslational modifications
that the bacterial cell is not equipt to perform, then mammalian cell culture-must be used.
C. Bacteriophage P22 tailspike protein
The folding and aggregation of P22 tailspike protein has been studied both in vitro and in
vivo. The tailspike protein has a number of temperature-sensitive mutations that can be
used to elucidate further information about the kinetics of the individual steps of the folding
reaction and assembly of the native trimer species. At restrictive temperatures, the
refolding tailspike protein does not reach the protrimer conformation, and so temperature-
sensitive mutants indicate which amino acids are critical for the folding process. Further
investigation of the folding mechanism will identify the thermolabile folding intermediates
and further characterize the species along the folding pathway of an oligomeric protein.
The tailspike endorhamnosidase is the organelle by which phage P22 attaches to the
Salmonella cell. Infectious phage contain six tailspikes forming a small neck for cell
attachment. The individual tailspike is a trimer consisting of identical 72kD subunits
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Figure 2.1: Electron micrographs of inclusion bodies in E. coli. a) EM of cytosolic
inclusion bodies of signal sequence deletion mutant of P-lactamase expressed in E.
coli. Transmission electron micrographs of platinum replicas of purified inclusion
bodies of: b) OmpA-p-lactamase (periplasmic), c) wild type f-lactamase
(periplasmic), and d) the signal sequence deletion mutant (cytosolic). Reprinted with
permission of GA Bowden, AM Paredes, and G Georgiou (1991).
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containing 666 residues encoded by phage gene 9. The function of the tailspike protein is
to recognize phage by binding to the O-antigen receptor of Salmonella typhimurium. This
attachment process involves the tailspike endorhamnosidase hydrolyzing the
rhamnosylgalactose linkage in the Salmonella O-antigen.
The structure of the tailspike has been solved by x-ray crystallography (Steinbacher
et al., 1994). Figure 2.2 is a ribbon diagram depicting the structure of the tailspike
monomer and native trimer. The central region of each 72kD subunit of the native trimer
has a right-handed parallel 5-helix conformation similar to pectate lyase, a monomeric
protein (Yoder et al., 1993). Recently, a left-handed helix motif was discovered in solving
the structure of acetylglucosamine, an enzyme required in the lipid A synthesis (Raetz &
Roderick,1995). Similar to the tailspike protein, acetylglucosamine acetyltransferase
(LpxA) is a trimer with each of the subunits in the 3-helix conformation. Unlike the
tailspike protein and pectate lyase, LpxA has a hexapeptide repeat sequence in which
alaphatic amino acid (isoleucine, leucine, or valine) is found every sixth residue, followed
by a small amino acid (usually glycine). Two residues before the conserved aliphatic
residue is a hydrophobic amino acid. The cross section of the three 3-sheets of the LpxA
(-spiral resemble equilateral triangles, whereas the tailspike polypeptide chain has a
dimpled configuration with two (-sheets forming a (-sandwich and a third sheet at a 900
angle. In (-spirals, the intrachain (-sheet contacts occur between each successive rung in
the (3-spiral and not between the monomeric subunits.
For the tailspike protein, the main body of the polypeptide chain is in the (-helix
conformation with 13 (-strands. The C-terminal regions interdigitate and form further (-
sheet structures. For most of the tailspike molecule, the central cavity contains hydrophilic
residues and several water molecules stabilizing the trimer. The conformation of the
partially folded intermediates is not known, but is likely to have substantial (3-sheet content.
Figure 2.2: a) Polypeptide backbone of the native tailspike trimer (residues 108-
666). The main body of the polypeptide chain (residues 143-540) is in an
intrasubunit [3-helix conformation, and then the three polypeptide chains intertwine
to form an intermolecular [3-sheet at the C-terminus. b) Cross-sectional view of the
native trimer. A ribbon diagram of residues 150-400 is shown looking down the
axis of the [-helix from the N-terminus (Steinbacher et al., 1994; Goldenberg &
Creighton, 1994).
a)
b)
The monomer depicted in Fig. 2.2 is the monomeric polypeptide chain within the native
trimer and does not represent a proposed structure of the folding intermediate.
Structural data indicate that the 3-spiral motif of the tailspike protein may be similar
to the local structure within amyloid fibrils composed of 1-amyloid peptide, prion protein,
transthyretin, and immunoglobulin light chains. FTIR and solid state NMR data indicate
the fibrils have a cross-3-structure, which is a repeating pattern of anti-parallel 1-sheets.
Although the 1-spiral structure of the tailspike contains parallel 1-sheets, the structure has
the similar property of the 1-strands being perpendicular to the fibril axis. The fibrils have
a characteristic green birefringence upon binding the hydrophobic dye, Congo red (Jarrett
& Lansbury, 1992). This phenomenon occurs when the Congo red molecules bound to the
1-sheets are aligned in a regular fashion.
Inclusion bodies, which form by the association of partially folded intermediates,
may contain secondary structure that resembles the native state, including significant
amounts of 0-sheet content. The aggregates may contain incorrect cross-3-sheet structures
(either intermolecular or intramolecular) or associated hydrophobic sites involving 1-sheet
interactions. These structural issues will be discussed further in Chapter 7, including an
analysis of the structural data on the aggregation intermediates found in Chapter 4.
In order to obtain soluble tailspike protein instead of tailspike attached to the virus,
a mutation in phage gene 5 blocks viral shell assembly by interfering with synthesis of the
coat protein. This allows DNA to remain unpackaged and levels of tailspike protein to
increase ten times the wild type concentrations. The final step in viral assembly is the
tailspike binding to the heads to create infectious phage. Since this process occurs readily
in vitro, the ability to produce infectious phage is a convenient assay to test tailspike
activity.
The native tailspike is thermally stable with a melting temperature of 880 C. Partially
folded or misfolded tailspikes are not heat resistant and can be distinguished from native
tailspikes by checking activity at high temperatures (-800C). Besides thermal stability, the
tailspike is also resistant to common denaturing conditions. The native tailspike does not
denature in either protease or sodium dodecyl sulfate (SDS). Since partially folded species
or misfolded aggregates are susceptible to protease and SDS, assays testing resistance to
protease, SDS, and heat can distinguish native from non-native tailspikes.
Most in vivo tailspike folding experiments involve bacteriophage P22 infection of
Salmonella host cells, which then synthesize the phage proteins. Recent work by A.S.
Robinson has been in expressing tailspike off a plasmid in E. coli, which is analogous
techniques utilized by the biotechnology industry. In a pulse-chase assay, a transient dose
of radioactively labeled amino acids is added in order to monitor the amount of protein
synthesized within a given time. In using phage-infected cells for these assays, the phage
proteins can be easily recovered when the phage genes cause lysozyme production to break
open the host cell. When expressing tailspike in E. coli, the addition of lysozyme and
EDTA is necessary to lyse the cells.
Although most proteins have transient folding intermediates that cannot be isolated,
the relatively large tailspike with significant secondary structure can be trapped after lysis.
Quickly chilling the lysed solutions of radiolabeled infected cells and running the samples
on an acrylamide gel isolates certain folding intermediates. Since the tailspike protein is
overexpressed in the host cells, the main radiolabeled species is the protein of interest.
The in vivo folding pathway (Figure 2.3) involves an unfolded nascent polypeptide
chain coming off the ribosome forming a partially folded species with significant structure.
This single-chain intermediate (I) can associate to form a protrimer (pt) of partially folded
chains (Goldenberg et al., 1983). Although the protrimer is a transient species, it is
metastable enough to be trapped on an acrylamide gel at low temperatures. The final
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Figure 2.3: In vivo folding and aggregation pathway. Nascent polypeptide chain is
released from the ribosome and forms a partially folded intermediate (I). This critical
folding intermediate is at the junction between productive folding and aggregation. Along
the productive folding pathway, the polypeptide chain folds into a protrimer intermediate
(Ipt), an SDS-sensitive protrimer species (pt), and then the fully stable native trimer (N).
The first off-pathway intermediate (I*) is in equilibrium with the productive folding
intermediate (I). Higher ordered multimeric aggregation intermediates along the
aggregation pathway lead to the formation of large aggregated inclusion bodies.
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folding step is the conversion of the protrimer to the stable native tailspike by a first order
reaction. In terms of kinetics, the complete refolding reaction has a half time of 5 minutes
at 30 0 C (King et al., 1990). When applied to an SDS gel, the native tailspike protein stays
intact and migrates down the gel slower than the denatured SDS protein complex with 1.4g
SDS bound per gram of tailspike (Reynolds & Tanford, 1970). Because partially folded
intermediates are susceptible to detergent, one can differentiate the native tailspike and the
folding intermediates. Since the single-chain folding intermediates are only partially folded
species, there is no species that acts as a native monomer.
Over 30 temperature sensitive folding (tsf) mutations in phage gene 9 have been
isolated and characterized for the P22 tailspike protein. This type of conditional lethal
mutation is described as a tsf mutation because it causes an early folding intermediate to
shift from the productive folding pathway onto the aggregation pathway at restrictive
temperatures of 38-420C (Goldenberg & King, 1981). The significance of these mutants is
that a change in only one amino acid can shift the early folding intermediates from the
productive pathway onto the aggregation pathway at restrictive temperatures (Yu & King,
1984). The existence of single amino acid substitutions which suppress inclusion body
formation suggested that the reaction was specific. The mutants were made by exposing
P22 phage to ultraviolet light and isolating the colonies that form plaques at 280 C but not at
380 C. Sequencing data show that all of the tsf mutations occur in the center of gene 9
between residues 150 and 500 in the J-helix domain (Fig. 2.4 and Appendix A; Villafane
& King, 1988). Most of the mutations occur at glycine or hydrophilic residues that are
involved in stabilizing P-turns. For mutations causing a change in charge, the mutant
tailspikes display a change in electrophoretic mobility and isoelectric point. Since neutral
substitutions do not produce an altered mobility, the change in electrophoretic mobility
associated with charged substitutions is likely to be a result of changes on the protein
surface rather than local conformational disruptions (Yu & King, 1988). Structural

analysis of the native tailspike suggests that tsf mutations involve 13-turn formation in the
monomeric folding intermediates (BeiBinger et al., 1995).
There are also two global suppressor mutations that have been isolated for the
tailspike protein (Val331Ala and Ala334Val). These suppression mutations are single
amino acid substitutions that decrease aggregation in vivo and in vitro (Mitraki et al.,
1991). Like tsf mutants, there is no effect on the native stability and activity of the final
refolded protein. Electrophoretic mobility data indicate that Val 331 is located at the surface
of the native protein and is tolerant to a wide range of amino acid substitutions which are
not critical for folding completion. However, position 334 only allows the substitution of
uncharged residues, which suggests that this residue is located in a hydrophobic region.
The global suppression of aggregation by the two mutations is additive, and the
suppressors may operate independently in interacting with the tailspike chains (Lee et al.,
1991). These two mutations suppress the aggregation reaction of the tailspike
intermediates both in vivo and in vitro (Mitraki et al., 1991).
The protein molecules that have not yet aggregated can often be rescued by chilling
the solution in a "shift-down" experiment and carrying out folding at permissive
temperatures. If the folding reaction is run at permissive temperatures, the tsf mutants can
fold correctly to form fully stable native tailspike. In vivo temperature shift-down
experiments with tsf mutants determined that the protrimer forms by a first order reaction
with k--0.30min- 1 and then transforms to the native conformation by another first order
reaction with k2--0.19min- 1 at 24OC (Goldenberg et al., 1983).
In vivo inclusion body formation has been studied for the P22 tailspike
endorhamnosidase (Haase-Pettingell & King, 1988). Analysis of the folding and
aggregation mechanism of the tailspike protein have shown that aggregation occurs by the
association of a partially folded monomeric intermediate rather than the native species. This
thermolabile intermediate preferentially partitions onto the aggregation pathway as the
temperature increases (Haase-Pettingell & King, 1988). After lysing the cells, a brief pulse
of the microcentrifuge is used to separate the insoluble aggregates from the soluble folding
intermediates and native tailspike. The samples are electrophoresed through an SDS gel to
quantify the amount of native tailspike, soluble intermediates, and insoluble aggregates.
All nonnative tailspike species migrate as monomeric chains on an SDS gel.
The results of the pellet/supernatant studies to characterize in vivo tailspike
aggregation showed that the tsf-mutants aggregated faster than the wild-type tailspike (Fig.
2.5). At restrictive temperatures (-38°C or higher), the tsf mutant tailspike polypeptide
chains did not refold into an enzymatically active native trimer but formed intracellular
aggregates, or inclusion bodies. The measurements of the kinetics of in vivo folding and
aggregation at 38.50C indicated that 25% of the wild-type tailspike polypeptide chains
folded into the native trimer conformation with a half-time of approximately 3 min, whereas
the H304 and U9 mutants formed no native trimer. The kinetics of aggregation was faster
for tsf U9 than for tsf H304; all of the U9 tailspike polypeptide chains were found in the
insoluble pellet within 22 min, whereas 10% of the H304 chains were still soluble (Haase-
Pettingell & King, 1988). The population of soluble species contains both productive
folding intermediates and soluble aggregation intermediates. The drop in yield of native
tailspike at a function of temperature is shown in Figure 2.6. Compared to U9, the tsf
H304 mutant has a steeper drop in yield of native protein which occurs at about 320C.
The in vitro folding pathway of the tailspike protein corresponds to the in vivo
folding reaction, having similar folding intermediates and folding kinetics (Fuchs et al.,
1991; Danner & Seckler, 1993). The mechanism by which the folding intermediates
polymerize is analogous to inclusion body formation in vivo. In vitro studies in the Seckler
laboratory have determined the final stage of refolding to be a unimolecular reaction with a
rate constant of k=l.6xl0-3s-1 at 100C and k=7x10-3s-1 at 250C at a protein concentration of
Figure 2.5: Time course or intracellular aggregation. The cells were infected and pulse-
labeled with 1Ci/mL 14C-amino acids as described (Haase-Pettingell & King, 1988)
with wild type and temperature-sensitive folding mutants, H304 and U9. Samples were
placed in an ice bath at 3.5, 4.5, 7, 10, and 21.5min after labeling. The infected cells
were concentrated 5 fold by low speed centrifugation and lysed by two cycles of freezing
and thawing. The lysed cells were separated into supernatant and pellet fractions, the
pellet washed, and the samples electrophoresed through an SDS-polyacrylamide gel.
Autoradiograms were prepared and analyzed as described. Each value represents the
percent of total 14C-labeled tailspike polypeptide chains present in the sample. Symbols:
A, native tailspike; 0, soluble partially folded species (pfs); 0, pelleted aggregates. This
figure was reprinted with permission from Haase-Pettingell & King, 1988.
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Figure 2.6: In vivo aggregation of tailspike polypeptide increases with temperature of
maturation. The cells were infected and pulse-labeled as described (Haase-Pettingell
& King, 1988) with wild type and temperature-sensitive folding mutants, H304 and
U9. After the chase with cold amino acids at 380C, aliquots were shifted to the
appropriate temperatures (20, 30, 34, 38, 420C), incubated for 1 hr, iced, and lysed by
freezing and thawing two times. A pellet-supernatant separation was performed as
described. Then, samples were applied to an SDS-polyacrylamide gel. The graph
represents each species as a percent of the total tailspike polypeptide chains at the end
of incubation. A, native tailspike, 0, soluble partially folded species; *, pelleted
aggregates. Reprinted with permission from Haase-Pettingell & King, 1988.
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20gg/ml (Fuchs et al., 1991). The conversion of protrimer to trimer has an energy barrier
of AG=165 kcallmol (Danner & Seckler, 1993). Similar to the in vivo inclusion body
formation, the kinetics of in vitro aggregation for the tsf-mutants is faster than wild-type
protein, as monitored by UV spectroscopy (Fig. 2.7).
Certain cosolvents or detergents inhibit aggregation by binding to the folding
intermediate and preventing self-association of protein molecules. Although PEG
effectively inhibits aggregation of carbonic anhydrase B by binding to the surface of the
first folding intermediate (Cleland & Randolph, 1992), it has no effect on the P22 tailspike.
The nonionic surfactant lauryl maltoside has been found to inhibit aggregation of the
tailspike protein, but the mechanism by which it interacts with the refolding tailspike
remains to be determined. Previous work indicate that lauryl maltoside inhibits the
aggregation of rhodanese by interacting with the hydrophobic surface of a folding
intermediate (Horowitz & Criscimagna, 1986). The effect of lauryl maltoside on tailspike
misfolding may be due to the mechanism of interaction (possibly preferential hydration),
which may act on this particularly large protein differently than PEG.
Although the tailspike has 8 cysteines, there are no disulfide bonds in the native
protein. However, a least one of the three C-terminal cysteine residues is essential for
trimerization. The addition of iodoacetamide or iodoacetic acid blocks productive folding
both in vivo and in vitro by binding to one or more cysteines (Sather & King, 1994;
Robinson et al., manuscript in preparation). During tailspike aggregation, disulfide bonds
do not form in the reducing environment naturally occuring in E. coli during in vivo folding
nor in the reducing conditions (10mM 3-mercaptoethanol) of in vitro refolding. Perhaps
the cysteine is involved in a very strong hydrogen bond which is essential for alignment of
the monomeric subunits and native trimerization. Electrostatic forces such as salt bridges
between polypeptide chains can also play a role in the association mechanism. The strength
of these interactions is affected by changes in salt concentration of the buffer. A large
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Figure 2.7: Aggregation of partially folded tailspike chains. Kinetics of aggregation
of tailspike proteins from wild type (0), the temperature-sensitive folding mutant
G244R (0), the suppressor mutant A334V (V), and the double mutant G244R,
A334V (A) observed as increase in turbidity after denaturation at 6M GdmCl and
subsequent dilution to 0.15M GdmC1. a) aggregation kinetics at 120C (filled
symbols) and at 190C (open symbols). b) aggregation kinetics at 140C. The
continuous lines represent the direct data; the symbols have been superimposed to aid
the reader. Reprinted with permission from Mitraki et al. (1993).
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fraction of charged residues are located in the inner core of the native trimer, and several
water molecules are involved in hydrogen bonding to the core residues.
D. Polymerization mechanisms
Since the mechanism of aggregation for the tailspike was previously unknown, it is useful
to look at other analogous crystallization, self-assembly, and polymerization processes that
have been previously studied (Caspar, 1980; Lindsey, 1991). For these processes,
subunits that are in a disordered state interact and form stabilizing contacts with each other
to produce a highly ordered structure. Like protein folding, the assembly mechanism
proceeds without the guidance of an external template. Unlike self-assembly,
crystallization and aggregation are not biologically regulated processes but rather
thermodynamically and kinetically controlled phenomena. Although the aggregate or
crystal is in equilibrium with the monomeric units in solution, the molecules at the surface
of the assembled species have a higher energy because they lack certain stabilizing bonds
with other units within the aggregate. Because of this phenomenon, the initial nucleation
product is unstable, but spontaneous polymerization can occur once the aggregate reaches a
certain critical size. For molecules that form helical assemblies, the critical size is the
number of units necessary to complete one turn of the helix.
The assembly of bacterial flagella is similar to crystallization, but in vitro
association only occurs when the flagellum monomers are seeded with flagella fragments
(Asakura et al., 1964). Although the growth rate of crystals above the critical aggregate
size is proportional to the collision rate, the rate-limiting step in flagella assembly is the
conformational change of the last monomer bound to the filament end (Asakura et al.,
1964). The newly attached monomer must be transformed to have a higher affinity for
additional monomeric units of a growing polymer chain. The assembly process has
Michaelis-Menten kinetics with the flagellum monomer acting as the substrate and the seed
serving as the enzyme. The flagellum acts as an allosteric effector on itself with the
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conformational change of the monomer to an associable form being induced by the actual
binding of the unit to the growing structure.
A well-characterized system of self-assembly is the polymerization of sickle cell
hemoglobin (hemoglobin S). Sickle cell disease arises from a mutation of GTG to GAG in
the sixth codon of the b-chain (Ingram, 1957). This causes glutamate to be replaced by
valine, which creates a hydrophobic patch on the surface of the protein. At high
concentrations comparable to that found in red blood cells (>0.2g/cm3), the deoxygenated
hemoglobin S aggregates to form a viscous gel of helical fibers. The hemoglobin S
molecules form a very ordered polymer fiber of 21nm diameter made of 14 interwound
helical chains (Eaton & Hofrichter, 1990). Slow deoxygenation causes the sickling effect
on the cell shape, but the normal disk shape can be recovered during reoxygenation. The
kinetics of polymerization involve a lag time during which the metastable hemoglobin S
solution slowly undergoes a nucleation event highly dependent on concentration,
temperature, and solution conditions. The length of the delay period is therefore inversely
proportional to hemoglobin S concentration of order n, with n ranging from n=15 for
0.35g/cm 3 (Ferrone et al., 1980) to n=35-50 for 0.25g/cm 3 (Hofrichter et al., 1974).
Nucleation is followed by a faster growth phase characterized by monomeric units attaching
to the ends of the growing polymer. In addition, the surface of the polymer fiber may
serve as a heterogeneous nucleation site for another fiber by providing additional stabilizing
contacts. The autocatalytic behavior of polymerization results in an enormous growth in
fiber formation after nucleation and a characteristic S-shaped curve for aggregation kinetics.
A protein that undergoes a conformational change upon polymerization and has
nucleation-growth kinetics is actin, which transforms from G-actin to F-actin during
assembly. The critical balance between polymerized and monomeric actin is highly
regulated to control cell functions and cytoskeletal interaction with the membrane. The
mechanism of actin polymerization displays the cooperativity of crystal growth in that the
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kinetics follow nucleation-growth behavior. The linear polymerization of actin is
characterized by the formation of an unstable nucleus in rapid equilibrium with the
monomer followed by spontaneous polymerization once the critical aggregate size is
reached. The nucleus for polymerization is the smallest aggregate that has a propensity to
increase in size rather than to dissociate. Since the initial polymerization rate depends on
concentration to the fourth power, the actin nucleus is a tetramer (Tobacman & Korn,
1983).
Similarly, the assembly of bacteriophage P22 coat protein into an icosahedral
procapsid shell is a process with nucleation growth kinetics. The assembly reaction
requires the help of a scaffolding protein to direct the coat monomers to polymerize into the
procapsid structure (Greene & King, 1994). To form an icosohedral structure, the
concentration dependence of initiating the polymerization is fifth order for the coat protein
and second or third order for the scaffolding (Prevelige et al., 1993). Presumably with the
guidance of the scaffolding protein, the monomeric coat protein undergoes a
conformational switch to produce a set of assembly-competent isomers fitting the
icosohedral lattice. The kinetics data suggests that scaffolding dimers or trimers interact
with coat pentamers in the rate-limiting step of polymerization (Prevelige et al., 1993).
Another process that undergoes similar nucleation-growth kinetics is amyloid fibril
formation. The development of amyloid plaques has been associated with Alzheimer's
disease, which is characterized by the formation of insoluble aggregates of 3-amyloid
protein in the brain. Similar to other nucleation-dependent events, the aggregation of 3-
amyloid protein begins with the entropically unfavorable process of nucleation. Further
polymerization is thermodynamically favored because the monomeric units form additional
stabilizing contacts to the growing chain. The resulting kinetic profile shows a lag time
during which a supersaturated solution of protein exists as a metastable solution that is
"kinetically soluble" (Jarrett & Lansbury, 1992). Once aggregation initiates, it continues
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rapidly until an equilibrium concentration of monomer and large polymers is reached. The
concentration of monomeric protein remaining in solution is the critical aggregation
concentration (CAC), and aggregation can be avoided for initial protein concentrations less
than the CAC. Since the nucleation step is rate limiting, seeding the reaction with a
homologous fibril produces immediate aggregation of a supersaturated solution. Using a
closely related peptide as a fibril seed does not initiate nucleation, and this evidence
indicates the specific nature of aggregation (Jarrett et al., 1993).
A more complicated kinetic phenomenon occurs with refolding of collagen. The
native conformational state of collagen is three polypeptide chains intertwined and
supercoiled to form an extended triple helix structure. The pattern of amino acid sequence
has glycine present every third residue and an abundance of imino acids. The residues of
the three polypeptide strands are closely packed together and form interchain hydrogen
bonds. In renaturing collagen, the triple helix must be in register or gelatin will form.
Refolding experiments can be performed by extracting animal collagen, raising the
temperature to 500C to denature the protein (Tm=370C), lowering the temperature 100C
below the Tm ("undercooling," AT), and observing renaturation. A significant discovery is
the observation of two distinct refolding pathways. For low concentrations, the formation
of a collagen-like triple helix is a unimolecular process involving intrachain associations
(not dependent on concentration). At high protein concentrations and low levels of
undercooling, the collagen triple helix forms by interchain association, and this reaction has
a second order dependence on concentration. The association reaction is a nucleation-
growth process which is difficult to initiate near the Tm. For interchain associations, the
propagation of the triple helix is not as physically limited as intrachain structures, and so
interchain helices can undergo increased propagation, remelting, and realignment of the
polypeptide chains at higher temperatures. Operating at higher temperatures favors the
propagation of the triple helix but inhibits the formation of a stable nucleus. The balance of
these temperature dependences accounts for the observed maximum in the initial refolding
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rate vs. temperature plot (Harrington & Karr, 1970) and is consistent with the Flory-
Weaver rate equation, rate=Bexp(-A/RTAT) (Flory & Weaver, 1960).
E. Methods to monitor folding and aggregation
In studying in vitro refolding and unfolding kinetics and equilibrium, there are various
techniques available to measure the properties of the folding intermediates during the
denaturation process. A wide range of traditional biophysical and spectroscopic techniques
can measure the characteristics of protein unfolding and refolding in vitro (Schein, 1991).
Depending on the time required for each measurement and the state of the sample, certain
techniques are applicable to equilibrium measurement rather than kinetic processes.
Thermodynamic analysis of equilibrium curves give the free energy of the folding or
unfolding transition assuming that the native and denatured protein is in equilibrium with
negligible off-pathway aggregation. Study of the kinetic competition between folding and
aggregation requires a different class of methodologies.
Spectroscopic techniques are generally noninvasive and continuous measurements,
which can monitor kinetic changes in polypeptide size and conformation. Turbidity, or
absorbance at 450-500nm, is a simple means of monitoring aggregation (Jarrett &
Lansbury, 1992), but the sensitivity of the measurement is low because the particle size
must be on the order of 500nm for detection. Light scattering at 900 is a more sensitive
measurement than absorbance and can detect particles much smaller than the wavelength.
Classical light scattering ("elastic" or "static") measured at various angles can be used to
determine the molecular weight distribution and radius of gyration of molecules in solution.
Quasi-elastic light scattering ("dynamic") indirectly measures the hydrodynamic radius of
molecules in solution by correlating the time for scattered light to decay to the Brownian
motion and diffusivity of particles in solution (Bloomfield & Lim, 1978; Stock & Ray,
1985; Cleland & Wang, 1990b).
Other spectroscopic techniques can be used to determine the secondary and tertiary
structured of the protein. Ultraviolet absorbance at 290nm measures exposure to solvent or
extent of packing of the aromatic residues (Wetlaufer, 1962). Circular dichroism (CD)
measures the global amount of secondary strucure within a protein or peptide and can
monitor conformational changes. Far-ultraviolet circular dichroism at 222nm determines
a-helical content (Yang et al., 1986), and near-UV CD signal at 340nm indicates the
environment of the aromatic residues, which is indicative of tertiary structure (Strickland,
1974).
Fluorescence is another technique that determines secondary and tertiary structure.
The intrinsic fluorescence of a protein indicates the local environment of the tryptophan
residues as well as tyrosine. Tryptophan fluorescence quenching experiments with various
chemical quenchers (iodide, acrylamide, and trichloroethanol) using a 295nm excitation
wavelength and 350nm emission wavelength can monitor the formation or disruption of
tertiary structure. The strong fluorescence of a hydrophobic probe, such as bis-ANS
(anilino-naphthalene sulfonate), upon binding to hydrophobic patches has been used to
monitor folding intermediates of rhodanese (Horowitz & Criscimagna, 1986), carbonic
anhydrase (Rodionova et al., 1989), and P22 coat protein (Teschke & King, 1993).
Raman spectroscopy, Fourier transform infrared spectroscopy (FTIR), and infrared
attenuated total reflection spectroscopy (IR-ATR) are related techniques to measure the
overall amount of secondary structure in a protein. The vibrational mode of the amide bond
(-CO-NH) depends on the conformation of the protein backbone. The amide I band of the
Raman spectrum is located at 1645-1657 cm-1 for a-helical proteins, 1700 cm- 1 for 0-
sheets, and at 1660 cm- 1 for random coils (Li-Chan & Nakai, 1991). The amide HI band is
at 1238-1245 cmr1 for 1-sheet proteins and at 1250 cm-1 for random coils. This peak is
characteristically low in intensity and broad (1260-1300 crm-l) for a-helical proteins.
Usually the samples must be highly concentrated in an organic solvent or a thin solid state
precipitate.
Electron microscopy and cryo-electron microscopy provide structural data on
protein complexes, viral capsid structures (Prasad et al., 1993), and cell organelles.
Drawbacks to this technique are that the fixing procedures of acid or gluteraldehyde
treatment may be disruptive and a predetermined symmetry is imposed upon the images
during the deconvolution of the data. Detailed three-dimensional structures can be obtained
by x-ray crystallography, which has been used to solve the native structure of 4,000
proteins, and this database is growing rapidly (Brookhaven Protein Data Bank). The
difficulty with this method lies in obtaining high quality crystals, and the technique can
only be performed on stable species rather than kinetic intermediates.
Structural data on kinetic folding intermediates in solution can be obtained by
hydrogen exchange labeling and subsequent mass spectrometry and NMR analysis for
small proteins, including lysozyme, ribonuclease, apomyoglobin, cytochrome c, and
barnase (Udgaonkar & Baldwin, 1988; Roder et al., 1988). Denatured protein in D20
solution is refolded in H20 under conditions where amide hydrogen exchange is slow,
such as at 100C and pH 6 (Englander, 1993). At a given timepoint in the refolding
reaction, the folding intermediates are labeled by shifting to high pH to promote rapid
hydrogen exchange. Domains which are already folded will not be susceptible to hydrogen
exchange and will retain the deuterium. This technique has been utilized to study the
folding intermediates of lysozyme (Miranker et al., 1993), apomyoglobin (Jennings &
Wright, 1993), and ribonuclease A (Mayo & Baldwin, 1993).
Chemical and biophysical methods of studying protein structure include
proteolysis, molecular interactions, and calorimetry. Treatment of a protein with protease
can map the domains that are solvent accessible during folding or aggregation (Kelly, in
press). Similarly, reactivity with other chemical reagents, such as iodoacetamide (Sather &
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King, 1994; Robinson et al., manuscript in preparation), is indicative of conformation.
Binding of ligands or antibodies also determines the conformational state of the protein.
Differential scanning calorimetry measures the conformational transition of thermal
denaturation and determines thermal stability and the enthaly of unfolding (Sturtevant et al.,
1989).
Physical means of separating folding and aggregation species has the advantage in
analyzing distributions of heterogeneous populations. Size-exclusion HPLC measures the
hydrodynamic radius or compactness of protein conformers or multimers, and gel
permeation chromatography has been used to study the folding and aggregation of bovine
carbonic anhydrase (DeFelice et al., 1993). Mass spectrometry is also useful in
conjunction with HPLC to identify species by molecular weight. Analytical
ultracentrifugation can also separate heterogeneous populations of macromolecular species
(Hansen et al., 1994).
A variety of electrophoretic techniques are routine methods for determining the size,
molecular weight, and conformational state of proteins. Folding intermediates can be
trapped by capillary zone electrophoresis (CZE), which utilizes electroosmotic flow to drive
the bulk solution through the capillary in an applied potential field (Wallingford & Ewing,
1989; Strege & Lagu, 1993). SDS gel electrophoresis can separate species of different
molecular weight, and the resolution is sometimes sufficient to distinguish charge changes
or internal disulfide bonds. However, the detergent SDS often denatures proteins and
dissociates multimers held together by noncovalent bonds. Nondenaturing gel
electrophoresis can separate folding intermediates and multimeric aggregation
intermediates, as described in Chapter 3 (Speed et al., 1995; Lomas et al., 1995). The
separation process is on the basis of both size and charge. A related technique of isoelectric
focusing in combination with urea gradient electrophoresis can also isolate aggregation
species (van den Oetelaar et al., 1989).
II II
In vivo folding and aggregation is generally studied by pulse-chase labeling using
radioactive 14C-amino acids or 35S-labeled methionine. For the tailspike protein, the
folding and aggregation kinetics can be subsequently monitored by SDS and nondenaturing
electrophoresis. Pellet/supernatant experiments can quantify the amount of aggregated
polypeptide chains that are found in a pellet after a brief pulse in the microfuge, whereas
soluble species remain in the supernatant (Haase-Pettingell & King, 1988).
Certain problems are associated with the established biophysical techniques of
monitoring folding and aggregation. For spectroscopic techniques, the solution must
contain purified protein in only a few conformational states. If the solution contains a
heterogeneous population of conformers or multimers, it is difficult to deconvolute the
signal without making broad assumptions about geometry (Kratky & Porod, 1949;
Yamakawa & Fuji, 1973). In physical separation of folding and aggregation intermediates,
the resolution in separating closely related conformers is ofen inadequate. In addition,
these techniques were developed to isolate stable native proteins rather than metastable
intermediates prone to self-association.
F. Strategies to address the protein folding problem
Although the understanding of the mechanism of protein folding and aggregation is
somewhat limited, the ability to influence the kinetic competition between productive
folding and aggregation is a requirement for improving the recovery of active protein
expressed in a heterologous host cell. The objectives of folding strategies can be to
increase the yield of soluble native protein in vivo for direct recovery of active product,
enhance inclusion body formation for ease of initial purification from cellular proteins, or
increase the efficiency of in vitro refolding. In the case of human diseases involving
protein misfolding, therapies which are nontoxic to the patient and localized to the affected
area are needed to enhance productive folding in vivo, increase clearance of misfolded
protein, and inhibit deposition of extracellular aggregates or fibrils.
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Currently, most recombinant proteins are expressed in E. coli if they do not require
glycosylation. Hybridoma animal cells or Chinese Hamster Ovary cells are used to
produce therapeutic proteins that have one or more glycosylation site or many disulfide
bonds, including tissue plaminogen activator (Lubiniecki et al., 1988), erythropoietin (Lin
et al., 1985), monoclonal antibody OKT 3 (Cleland, 1993), and human deoxyribonuclease
(Cleland, 1993), and Factor VIII (Wood et al., 1984). The disadvantages of mammalian
cell culture are the shear-sensitivity of'the cells, slow growth rate, low fraction of
recombinant protein synthesized, and nutrient requirements. To reduce the shear stress,
novel bioreactor designs are being used, such as airlift reactors, bubble columns, hollow
fibres, or roller bottles to produce erythropoeitin. Use of serum-free media reduces the
production expense and contaminant concerns, but often cell lines adapt poorly to this
change. Production of recombinant proteins in E. coli is preferrable, even if the proteins
contain disulfide bonds. For example, somatotropin, interferon, interleukin, insulin, and
basic fibroblast growth factor are produced in E. coli (Cleland, 1993). All of these
proteins except y-interferon contain disulfide bonds in the native state. After solubilizing
the inclusion bodies, these disulfide bonds can form during the refolding step in an
oxidizing environment.
The main advantage of expressing protein as inclusion bodies is the ease in
purifying the product from most cellular components by centrifugation. In the
biotechnology industry, examples of proteins which are recovered from the inclusion body
state include tissue plasminogen activator, interferon, interleukin, somatotropin, and insulin
(DeBernardez-Clark & Georgiou, 1991). The protocol for protein purification from the
inclusion body state is a function of the compartmental location of the inclusion bodies and
biophysical properties of the particular protein, including size, charge, stability, oligomeric
state, and covalent bonds (Wingfield, 1995). If the protein of interest is located in the
periplasmic space as either soluble species or inclusion bodies, the outer membrane can be
selectively disrupted by osmotic shock or lysozyme. For cytoplasmic inclusion bodies, the
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cells are lysed by homogenization, French press, or lysozyme and sonication. Low speed
centrifugation at 10,000xg for 30min separates the soluble proteins and membrane vesicles
from the pelleted inclusion bodies, outer membrane, peptidoglycan layer, and remaining
whole cells. To remove the contaminating cell wall material loosely associated
peptidoglycan components, outer membrane, and lipopolysacchharides, the inclusion body
fraction is washed 2-3 times by resuspending the pellet in buffer containing 1-5% Triton X-
100, 2-5mM EDTA, and 1-4M urea or 0.5-1.5M guanidine HC1 and pelleting for 30min at
10,000xg. The inclusion bodies can then be solubilized in 5-10M urea or 4-7M guanidine
HC1 and subsequently refolded by buffer exchange or dilution to optimal in vitro refolding
conditions. The addition of reducing agents (5-100mM dithiothreitol or 0.1-0.3M |3-
mercaptoethanol) and a metal chelator (EDTA) is required to break disulfide bonds within
inclusion bodies or to prevent oxidation that may occur during cell lysis. In a few cases,
the relatively mild treatment of incubating the inclusion bodies in high ionic strength buffer
or ion exchange resin may disrupt the aggregates and generate active native protein, such as
for interleukin-2, SV40 T antigen peptide Th, and retroviral v-myb oncoprotein (Hoess et
al., 1988).
Methods to control in vivo folding and aggregation usually involve recombant DNA
technology. Site-directed mutagenesis to influence the rate of protein folding selectively
without adversely changing the enzymatic activity of the protein has been used, but this
requires extensive knowledge of the native structure, active site, and folding pathway.
Expression as a fusion protein to direct the polypeptide chains to the periplasmic space can
circumvent proteolytic degradation within the cytoplasm and can provide an oxidizing
environment for disulfide bond formation. Overexpression of molecular chaperones,
foldases, or bacterial translocators for secretion can improve the yield of soluble native
protein if the helper protein acts upon the rate limiting step of folding. Expression in
strains that have a reduction in cell envelope proteases (Bisbee, 1995) also improve
recovery of protease sensitive products. The type of promoter or host strain can reduce
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inclusion body formation (Wingfield, 1995). Other external factors of the cell culture can
influence protein folding within the cells. Changing the pH to the medium or adding
nonmetabolizable sugars can inhibit inclusion body formation (Bowden & Georgiou, 1988;
Schein, 1989; Wetzel, 1992). Also, certain detergents or nonpolar solvents may drive
inclusion body formation during cell killing and increase the amount of product in the
inclusion body state (DeBernardez-Clark & Georgiou, 1991).
To improve the yield in in vitro refolding, the refolding conditions must be
optimized, including parameters such as temperature, protein concentration, denaturant
concentration, pH, ionic strength, and salt concentration. For most monomeric globular
proteins, higher yields of native protein are achieved when refolding is done at low
temperature and low protein concentration because aggregation is a higher order reaction
involving hydrophobic forces and bimolecular collisions. Generally, the pH of the
refolding buffer is set away from the isolelectric point of the protein because charge-charge
repulsion can inhibit aggregation. Higher yields can also be achieved with a hydration or
solvent exclusion effect by the addition of cosolvents, sugars, or detergents, such as 100-
2000MW polyethylene glycol, dextrans, levans, sucrose, glucose, fructose, trehalose.
mannitol, sorbitol, glycerol, isopropanol, Tween, Trycol, Durfax, or Pluraface (Schein.
1990; DeBernardez-Clark & Georgiou, 1991). The use of reducing agents or metal
chelators may influence the folding of proteins that lack native disulfide bonds or have a
metal ligand. Disulfide bond formation that occurs by air oxidation after cell lysis can Ne
minimized by adding metal chelators to scavenge trace metal ions, such as Co2+ and Cu:"
which catalyze cysteine oxidation (DeBernardez-Clark & Georgiou, 1991). For protein\
that contain disulfide bonds in their native state, the addition of metal ions or thiol reagent.,
can aid refolding. For example, Cu2+aided the oxidation and refolding of interleukin-2
(Weir & Sparks, 1987), and glutathione addition aided in the refolding of interleukin-4
(van Kimmenade et al., 1988) and serine proteinase (Light et al., 1986).
II II
The method of removal of denaturant to initiate in vitro refolding is a critical factor
that incorporates some basic biochemical engineering principles (Builder & Ogez, 1985;
Olsen, 1985; Olsen & Pai, 1985; Rudolph & Fischer, 1987). Simple dilution to
renaturation conditions is used for refolding on a small scale, but large scale production of
therapeutic proteins or assembly of oligomeric proteins often require alternative strategies.
Dialysis to remove denaturant also has inherent problems in scale-up due to slow
processing times (London et al., 1974). Gel filtration and size exclusion chromatography
effectively remove the denaturant by addition of running buffer yet concentrated the eluent
product. Diafiltration, which is the method of choice for large scale buffer exchange, has
been used in refolding P-interferon (Hershenson et al., 1990) and prorennin (Wetzel,
1986). The development of novel refolding methods to remove the denaturant has also
improved recovery, including a series of step-wise dilutions in a fed-batch reactor
(Rudolph et al., 1987) and immobilization of refolding polypeptide chains onto a solid
support (DeBernardez-Clark & Georgiou, 1991). Although there is a battery of folding
strategies available, currently each individual protein requires unique folding optimization
on a case by case basis.
CHAPTER 3: MULTIMERIC INTERMEDIATES IN THE PATHWAY TO
THE AGGREGATED INCLUSION BODY STATEt
The failure of newly synthesized polypeptide chains to reach the native conformation due to
their accumulation as inclusion bodies is a serious problem in biotechnology (Marston,
1986; Mitraki & King, 1989). Analysis of the aggregation phenomenon has been limited
by the available methodologies to study protein folding intermediates. Most analytical
bioseparation techniques were designed to isolate stable native protein rather than
metastable, hydrophobic species. Early aggregation studies used centrifugation to separate
the aggregates in the pellet from the soluble protein. Due to the limitations in the analytical
techniques, all multimers on the aggregation pathway have been grouped into one category,
namely "aggregates." Understanding the mechanisms underlying the off-pathway
aggregation reaction requires a description of the chain association pathway and multimeric
intermediates.
In the cases where the competition between the refolding and aggregation reactions
has been directly studied, the precursor to aggregation is a defined intermediate in the
refolding pathway (Zettlmeissl et al., 1979; Brems, 1988; Hendrick & Hartl, 1993).
During in vitro refolding experiments with bovine growth hormone, the initial refolding
conditions in a two-step dilution method were found to affect the extent of aggregation and
that only partially folded intermediates led to aggregation (Brems, 1988). For numerous
proteins, this class of folding intermediates is the species that is recognized by the GroE
chaperonin, which assists in protein folding by binding to folding intermediates and
t Copyright © 1995 The Protein Society. Reprinted with the permission of Cambridge
University Press. Speed, MA, Wang, DIC, King, J. 1995. Multimeric Intermediates in the
Pathway to the Aggregated Inclusion Body State for P22 Tailspike Polypeptide Chains.
Protein Science 4:900-908.
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preventing improper association of the polypeptide chains (Goloubinoff et al., 1989).
Cleland and Wang (1991) have used quasi-elastic light scattering to determine the
aggregation mechanism of carbonic anhydrase II (CAB), a monomeric protein. In vitro
refolding studies showed that an early monomeric folding intermediate (II) is in equilibrium
with a dimer aggregation intermediate, which directly leads to irreversible aggregation
(Cleland & Wang, 1991). This early folding intermediate is the substrate to which the
cosolvent PEG binds and inhibits aggregation by a mechanism analogous to molecular
chaperones.
The in vivo and in vitro intermediates in the folding and aggregation reactions have
been characterized for the P22 tailspike endorhamnosidase (Goldenberg & King, 1983;
Haase-Pettingell & King, 1988). As described in Chaper 2, the critical intermediate at the
junction between the productive folding and the inclusion body pathway has been
previously identified for the P22 tailspike endorhamnosidase. This thermolabile
intermediate preferentially partitions onto the aggregation pathway at high temperatures
(Haase-Pettingell & King, 1988; Mitraki et al., 1991; Mitraki et al., 1993).
The in vitro folding pathway of the tailspike protein corresponds to the in vivo
folding reaction, having similar folding intermediates and folding kinetics as described in
Chapter 2. The in vitro refolding and aggregation pathway involves an unfolded tailspike
polypeptide chain forming a partially folded species upon dilution out of denaturant (Fig.
3.1). This monomeric intermediate (I) can associate to form a protrimer (pt) of partially
folded chains (Goldenberg et al., 1983; Haase-Pettingell & King, 1988), which then forms
the fully stable native trimer with a 13-spiral conformation (Steinbacher et al., 1994).
For most small monomeric proteins, hydrophobic collapse occurs on a timescale
less than lmsec, and the transition from a molten globule folding intermediate to the native
state requires times of the order of seconds (Kim & Baldwin, 1990). For the tailspike
protein, the transition of protrimer to native trimer is the rate-limiting step in the folding
Figure 3.1: In vitro refolding and aggregation pathway. Unfolded polypeptide chains
denatured in 5M acid urea (pH 3) or 6M guanidine hydrochloride are rapidly diluted to
refolding and aggregating conditions. The polypeptide chain undergoes a hydrophobic
collapse and forms a partially folded intermediate (I). This critical folding intermediate
is at the junction between productive folding and aggregation. Along the productive
folding pathway, the polypeptide chain folds into a protrimer intermediate (Ipt), an SDS-
sensitive protrimer species (pt), and then the fully stable native trimer (N). The first off-
pathway intermediate (I*) is in equilibrium with the productive folding intermediate (I).
Higher ordered multimeric aggregation intermediates along the aggregation pathway
lead to the formation of large aggregates that are insoluble.
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reaction. The half-times of tailspike refolding for both the in vivo and in vitro reactions are
of the order of minutes rather than seconds (Danner & Seckler, 1993), and metastable
intermediates can be trapped in the cold (Goldenberg & King, 1982). The half-times for
the off pathway aggregation reactions are similar to those for the productive pathway. This
suggested that it might be possible to directly identify the intermediates along the
aggregation pathway.
A. Materials & methods
i. Protein
P22 tailspike protein was produced by infecting Salmonella typhimurium with P22 phage
as described (King & Yu, 1986, Fuchs et al., 1991). The tailspike was then purified to
approximately 95% purity, and its purity was verified by silver-stained SDS gels. The
protein was stored as an ammonium sulfate precipitate and then dialyzed against Tris buffer
when required. All experiments with the P22 tailspike used protein from the same
preparation. The P22 coat protein was produced and purified as described (Teschke &
King, 1993). Carbonic anhydrase II (CAB) from bovine erythrocytes was purchased from
Sigma (product C2522).
ii. In vitro refolding and aggregation
Native P22 tailspike protein was denatured for approximately 45 min in 5M urea at pH 3.
The refolding and aggregation reaction was initiated by rapid dilution (20 fold) with 40mM
sodium phosphate buffer and 0.58M urea (1mM EDTA, 1mM P3-mercaptoethanol, pH
7.6). To ensure rapid mixing for the aggregation kinetics experiment, 342pL of the
dilution buffer was added to a tube containing 18JpL of denatured protein, and the mixture
was pipetted vigorously several times. The aggregation conditions were 100 jgg/mL
protein at 200C and 0.8M urea in 40mM sodium phosphate buffer (pH 7.6). In following
the aggregation kinetics, aliquots of sample were taken at various time points and rapidly
transferred to preincubated tubes containing cold 3x sample buffer (0.015M Tris, 0.12M
glycine, 3mM DTT, 30% glycerol, bromophenol blue) in an ice-water bath. An alternative
treatment of the samples involved freezing the samples instantaneously using liquid
nitrogen immediately after adding the sample to the cold sample buffer. The samples were
kept frozen until just prior to loading the gel in the cold room. No discernable difference in
the distribution of multimers was observed for these two protocols.
iii. Gel electrophoresis
Nondenaturing polyacrylamide gel electrophoresis (PAGE) was performed using a
discontinuous buffer system (Davis, 1964; Omstein, 1964). The resolving gel contained
0.37M Tris buffer (pH 8.9) with 3.8mM TEMED, 3.0mM ammonium persulfate, and a
specified percent acrylamide. A stacking gel was used initially, but omitting the stacking
gel gave the same distribution of species. The upper gel contained 0.07M Tris buffer (pH
6.7) with 4.3% acrylamide, 7.5mM TEMED, 2.5mM ammonium persulfate. The standard
acrylamide concentration was 9-10% acrylamide to isolate multimers and proteolytic
fragments, and the range of acrylamide concentration was 6.5-10% for the Ferguson plots
(Ferguson, 1964). A reducing agent (1mM dithiothreitol) was added to the sample buffer
to ensure that disulfide bonds did not form. An aliquot of 20pL of protein solution in
sample buffer (1.3gtg protein) was loaded onto the gel for each sample. The gels were run
at constant current (10mA/gel) for 3-4 hours at 40C and then silver stained as described by
Sather & King, 1994.
Two-dimensional SDS gel electrophoresis was performed by cutting a lane of
multimers isolated on a nondenaturing gel (9% acrylamide) and soaking the lane in SDS
sample buffer without any reducing agent. The lane was then placed horizontally across
the top of a 1.5mm thick SDS gel (7.5% acrylamide) and run in a second dimension. SDS
gel electrophoresis was done in a discontinuous buffer system with 7.5% acrylamide gels
(Fuchs et al., 1991; Brunschier et al., 1993).
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iv. Proteolysis
Proteolysis experiments were performed using trypsin. Tailspike polypeptide chains and
proteolytic fragments were isolated using both nondenaturing and SDS gel electrophoresis
(10% acrylamide gel). A sample of refolding and aggregating tailspike was taken 0.5 min
and 30 min after dilution (100tg/mL, 0.8M urea, 200C) and was proteolyzed using trypsin
(4 gg/mL) for given incubation times (0, 0.5, 1, 2, 5, 15 min). Samples were taken at
these designated times and combined with bovine pancreatic trypsin inhibitor (200 gg/mL)
for 0.5-1.0 min to quench the proteolysis reaction. Aliquots of the proteolytic fragments
were then combined with 3x sample buffer on ice for both SDS and nondenaturing gel
electrophoresis. The nondenaturing gel was run at constant current (10mA) and the SDS
gel at constant voltage (150V) until the dye front reached the end of the gel.
B. Results
The in vitro partitioning of refolding intermediates between the productive and aggregation
pathways had been initially established for denatured polypeptide chains diluted from
concentrated solutions of guanidinium hydrochloride (Mitraki et al., 1993). To avoid
problems associated with the presence of a charged denaturant, acid-urea (5M urea, pH 3)
was used as the initial denaturant as described by Seckler et al. (1989). Denatured protein
was diluted into buffer at pH 7.6 to a final concentration of 100gtg/mL. Under these
conditions approximately 10% of the chains refolded to the native trimer which is SDS-
resistant, and the remainder of the chains associated to form small aggregates as detected by
quasi-elastic light scattering. At the early stages of the multimerization reaction, the extent
of aggregation under these conditions was too low to measure accurately by classical light
scattering at 500nm.
In the original studies of the in vivo folding pathway, nondenaturing gel
electrophoresis in the cold was used to identify the metastable protrimer intermediate
(Goldenberg & King, 1982). It seemed reasonable that nondenaturing gel electrophoresis
in the cold might also be useful in separating putative multimeric intermediates along the
aggregation pathway.
For in vitro refolding studies, native P22 tailspike protein was denatured in 5M urea
at pH 3 for approximately 45 min. The refolding and aggregation reaction was initiated by
rapid dilution (20 fold) with phosphate buffer containing 0.58M urea, 1mM EDTA, 1mM
j3-mercaptoethanol, pH 7.6. The final aggregation conditions were 100 gg/mL protein at
200C and 0.8M urea in sodium phosphate buffer. In following the aggregation kinetics,
samples were taken at various times and rapidly transferred to preincubated tubes
containing cold 3x sample buffer in an ice-water bath. Nondenaturing polyacrylamide gel
electrophoresis (PAGE) was performed using a discontinuous buffer system (Davis, 1964;
Ornstein, 1964). The standard acrylamide concentration was 9-10% acrylamide to isolate
multimers and proteolytic fragments, and the range of acrylamide concentration was 6.5-
10% for the Ferguson plots. The gels were run at constant current (10mA/gel) for 3-4
hours at 40C and then silver stained (Sather & King, 1994).
i. Identification of aggregation intermediates
Figure 3.2 shows the pattern of protein bands as a function of time after initiation of the
reaction. The starting native protein, prior to denaturation, migrated about 115 of the way
down the gel as shown in lane 9. The lanes with samples renatured for various times after
initiation showed multiple bands, representing multimers of tailspike chains. At the early
time points (0.3-1.0 minutes), the distribution centered around species with higher
electrophoretic mobility and presumably lower molecular weight than the native tailspike.
The species with the highest mobility migrated approximately twice the distance as the
native trimer. As the reaction proceeded, the multimer distribution shifted to species of
decreasing mobility, consistent with increasing subunit composition. Polypeptide chains
accumulated at the top of gel as the reaction proceeded, representing aggregates too large to
enter the gel matrix.
The native tailspike that formed in the refolding reaction can be seen on the
nondenaturing gels directly above the second band of multimers. Its time course of
appearance was about 7 min with a final yield of less than 10%. The values for refolding
kinetics reported in the literature (Danner & Seckler, 1993) were based on significantly
different refolding conditions (30gg/mL, 0.1M urea, 250C, 20h reconstitution). The native
trimer is clearly a sharper band than that of the multimers. The fastest migrating band is
presumably a conformer of the monomeric tailspike polypeptide chain. The relatively
broad band may represent several species of folding or aggregation intermediates in
different conformations. Comparison of the data to the native gels of Goldenberg (1982)
suggests a possible candidate for the protrimer. The species migrating slightly slower than
the trimer aggregate appears approximately on the same time scale as native trimer
formation. This species is distinct but not predominant, and further analysis is necessary to
confirm its identity.
Electrophoretic separation required 3-4 hours in the cold. Since discrete species
were observed, these species must have half-lives in the cold of hours rather than minutes.
The isolation of distinct ladder of multimer bands rather than a smear of protein indicated
that aggregation reaction was retarded within the gel matrix during electrophoresis.
The earliest time point (0.3 min) already shows the presence of a distribution of
multimers. One possibility was that the aggregation reaction was not efficiently quenched
by dilution and chilling. To examine this, an in vitro aggregation reaction was done at
standard conditions of 100 l.g/mL protein at 200C and 0.8M urea in sodium phosphate
buffer. The reaction mixture was placed on ice after 0.3 min, and samples from this
mixture were electrophoresed at 1, 15, 30, and 60 min. The samples incubated on ice
showed a distribution of multimers that was indistinguishable from that of the sample
Figure 3.2: In vitro aggregation kinetics of P22 tailspike protein. Denatured
tailspike chains in 5M urea, pH 3 were diluted 20-fold to 100ug/mL protein at
20C and 0.8M urea in 40mM sodium phosphate buffer, pH 7.6. Samples were
placed on ice and then electrophoresed through a 9% acrylamide native gel run for
4hr at 4C. The amount of sample loaded was 1.3ug protein for the aggregation
timepoints and 0.2ug for the native tailspike control. The protein bands were
visualized by silver staining.
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which was electrophoresed immediately (data not shown). Although the aggregation
reaction cannot be stopped completely, these controls suggest that the quenching conditions
were adequate for experiments for which the samples incubate on ice for less than an hour.
In the productive refolding pathway, tryptophan fluorescence was quenched within
milliseconds, even though the overall refolding reaction required much longer times (Fuchs
et al., 1991). The presence of a distribution of multimers at early time points (0.3 min)
suggested that these species formed from a very early kinetic intermediate. The multimers
appeared to be stabilized within the gel matrix and were less susceptible to further
aggregation in the gel than in solution.
In the initial development of this protocol to isolate aggregation intermediates, we
were concerned that the polypeptide chains would aggregate further during the stacking
step. The purpose of the upper gel is to concentrate the macromolecules into a narrow
band, and this process could lead to aggregation which could be occurring within the upper
gel. In preliminary experiments, the upper gel was omitted to avoid any stacking effect.
Comparison of the distribution of multimers obtained in gels with and without the upper gel
indicated that the stacking effect in the upper gel as the dye became concentrated into a
narrow band did not cause further aggregation. Additional controls indicated that the
amount of protein loaded onto the gel and the extent of stacking did not affect the
distribution of multimers.
ii. Chain composition of the aggregation intermediates
Electrophoretic mobility in a nondenaturing gel depends on both size and charge
(Chranbach & Rodbard, 1971). Unlike SDS gel electrophoresis one cannot directly
determine molecular weights from mobilities. In order to determine the number of chains
in the various species, a set of nondenaturing gels was run at different percentages of
Figure 3.3: a) Ferguson plot of P22 tailspike multimers. 0, monomer; n, dimer; X,
native trimer; +, trimer aggregate; v, tetramer; &, pentamer. b) Molecular wieght
analysis of data from Ferguson plot. Linear regression determined to be the following:
-Kr = 0.122 + 0.00110(MW), R=0.994.
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acrylamide (Ferguson, 1964). The mobility of each multimeric species was then analyzed
by the Ferguson method of plotting relative mobility versus the percent acrylamide.
The electrophoretic mobility of each multimer was measured in nondenaturing gels
ranging from 6.5-10% acrylamide (Fig. 3.3a). To determine the molecular weight and size
of multimers on a nondenaturing gel, the slope of the Ferguson plot IKrI (the retardation
coefficient) was calculated. Assigning assumed molecular weights to the series of
multimers and plotting this versus IKrl produced a linear correlation with R=0.994 (Fig.
3.3b). Other nonsequential distributions (e.g. monomer, dimer, tetramer, octamer, etc.)
did not produce a linear correlation with the slopes of the Ferguson plots. The results were
consistent with the model that the ladder of distinct species separated on the nondenaturing
gels was a sequential set of multimers of tailspike polypeptide chains.
iii. Intermolecular bonding
The tailspike polypeptide chains have no disulfide bonds but contain 8 cysteine residues.
To avoid the formation of disulfide bonds, 1mM dithiothreitol (DTT) was added to the
standard nondenaturing sample buffer. To confirm that the species isolated on the
nondenaturing gels were not a ladder of multimers having disulfide bonds, a lane was cut
out of the nondenaturing gel and run in a second dimension on an SDS gel under
nonreducing conditions (Fig. 3.4). If the aggregation intermediates contained disulfide
bonds or any other covalent bonds, the multimers would not dissociate in the second
dimension and would produce a diagonal pattern of dots when electrophoresed in the
second dimension. Without covalent bonds, the multimers would dissociate in the
presence of SDS and electrophorese as monomeric polypeptide chains.
The results show that the aggregation intermediates electrophoresed as monomers
through the SDS gel. A sample of IgG (biotinylated polyclonal antibodies against the P22
coat protein) was used as a control to confirm that a disulfide bonded species broke apart
Figure 3.4: Protocol for electrophoresing aggregation intermediates in a second
dimension through a nonreducing SDS gel.
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Figure 3.5: Two-dimensional gel electrophoresis. Tailspike multimers isolated by
nondenaturing gel electrophoresis and then electrophored in a second dimension
through an SDS gel under nonreducing conditions. IgG + BME, polyclonal IgG
against P22 coat protein + B-mercaptoethanol (BME). Native, native tailspike
protein. monomers, thermally denatured monomeric tailspike. IgG-BME,
polyclonal IgG against P22 coat protein (no BME).
Lane of tailspike multimers
cut from nondenaturing gel
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on an SDS gel in the presence of 3-mercaptoethanol (3ME) but remained intact when no
3ME was present. The multimers dissociated in the presence of SDS and comigrated with
the monomeric tailspike control in the absence of O3ME (Fig. 3.5). This result proved that
no disulfide bonds were present in the tailspike multimers, and the forces holding together
the multimers could be disrupted by a strong detergent.
iv. Conformation of the aggregation intermediates
The native tailspike trimer is resistant to proteolysis, but both the monomeric and protrimer
intermediate are susceptible to proteolysis. If the multimeric species represent associated
intermediates, they should be susceptible to proteolysis. To characterize the conformation
of the multimers, a proteolysis experiment was performed on a solution of aggregating
tailspike polypeptide chains. An in vitro refolding and aggregation study (Fig. 3.6) was
done at the standard conditions of 100pg/mL, 200C, and 0.8M urea in 40mM sodium
phosphate buffer (pH 7.6). Samples were taken at 0.5min and 30min and treated with
trypsin (4gg/mL) for incubation periods of 0, 0.5, 1, 2, 5, and 15min. After partial
proteolysis for the given time interval, the trypsin was deactivated by combining the sample
with bovine pancreatic trypsin inhibitor (200pg/mL) for 0.5-1.0min. Samples were then
transferred to tubes on ice with aliquots of 3x sample buffer for nondenaturing and SDS gel
electrophoresis. Nondenaturing gel electrophoresis was used to isolate tailspike multimers
and the proteolytic fragments; SDS gel electrophoresis was used to determine the
molecular weight distribution of the proteolytic fragments.
Although the multimers dissociated to form monomers in the presence of SDS, the
SDS gel showed the pattern of proteolytic fragments clearer than the nondenaturing gel.
Nondenaturing and SDS gel electrophoresis provided complementary data for the physical
characterization of the multimers. Treatment of the reaction mixture with trypsin resulted in
the appearance of shorter chain fragments under conditions in which native tailspike was
Figure 3.6: Protocol for trypsin digestion of tailspike aggregates. During in vitro refolding
and aggregation (100lg/mL, 200C, 0.8M urea in 40mM sodium phosphate buffer, pH 7.6),
samples were taken at 0.5 min and 30 min and treated with trypsin (41ig/mL) for 0, 0.6, 1.3,
2.1, 5, and 15 min. After partial proteolysis, the trypsin was deactivated by combining each
sample with bovine pancreatic trypsin inhibitor (200g1g/mL) for 0.5-1.0 min. Tailspike
polypeptide chains and proteolytic fragments were isolated by SDS gel electrophoresis and
nondenaturing PAGE.
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Figure 3.7: Trypsin digestion of tailspike aggregates. During in vitro refolding and
aggregation (100ug/mL, 20C, 0.8M urea in 40mM sodium phosphate buffer, pH
7.6), samples were taken at 0.5min and 30min and treated with trypsin (4ug/mL)
for 0, 0.6, 1.3, 2.1, 5, and 15min. After partial proteolysis, the trypsin was
deactivated by combining each sample with bovine pancreatic trypsin inhibitor
(200ug/mL) for 0.5-1.0min. Tailspike polypeptide chains and proteolytic fragments
were isolated by a) SDS gel electrophoresis and b) nondenaturing PAGE. To
conserve space, certain control lanes of MW markers, bovine pancreatic trypsin
inhibitor, and trypsin are not shown.
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not cleaved. All of the multimers were susceptible to trypsin digestion (Fig. 3.7). At high
concentrations of trypsin, native tailspike that had the N-terminal end slightly unfolded
(Chen & King, 1991) could be proteolytically clipped but not fully digested. The
susceptibility of the multimers to protease digestion confirmed that these species had a non-
native conformation. Note that large aggregates that were formed 30 min after the initial
dilution were proteolyzed slower than the early multimeric species present early in the
aggregation reaction.
v. Extension of the methodology to other proteins
To determine if intermediates in other aggregation reactions could be trapped and
fractionated by native gel electrophoresis, we examined the aggregation of carbonic
anhydrase II (Cleland, 1991) and the P22 coat protein (Teschke & King, 1993). Both
proteins are monomeric and can be efficiently refolded in vitro from the fully denatured
state. Off-pathway aggregation reactions compete with productive refolding by the
association of a folding intermediate for both proteins. Native protein was denatured and
refolding initiated by dilution following the protocol described in the Materials and methods
section. Multimers of carbonic anhydrase II and P22 coat protein could be isolated by
running a 10% acrylamide gel (Fig 3.8). Both of these proteins have a native state that is
monomeric, and the gels showed the presence of a strong monomeric band of native
protein as well as a series of distinct multimers. The technique of nondenaturing PAGE to
isolate early multimeric species during the initial stages of aggregation is clearly applicable
to other protein systems.
C. Discussion
Despite the widespread occurrence of aggregation reactions competing effectively with the
folding of pharmaceutically important proteins, there has been very limited analysis of the
mechanisms of these association reactions. Part of the difficulty reflects the limited
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methodologies available to characterize the aggregated state; neither X-ray crystallography
nor 2-D NMR is capable of providing structural information on the aggregation
intermediates. The still soluble but larger aggregates presumed to be intermediates in such
reactions have also been difficult to trap and characterize. However, the initial species in
multimerization are likely to be critical in determining the yield in such pathways and in
controlling the balance between productive folding and aggregation.
Nondenaturing polyacrylamide gel electrophoresis (PAGE) effectively resolved
multimeric species up to hexamers or heptamers of the tailspike partially folded chains.
The results reported above identify discrete metastable polypeptide chain species which
have the characteristics of early intermediates in the aggregation reaction. These species
were not conformers of the native trimeric tailspike nor were they oligomers of the native
state. The protease sensitivity indicates that these species were related to the folding
intermediates along the productive pathway, which are also trypsin sensitive (Haase-
Pettingell & King, 1988). Recently, multimers of wild-type and mutant al-antitrypsin
were resolved using a similar methodology (Lomas et al., 1995).
i. Characterization of aggregation intermediates
Under reducing conditions, in vitro tailspike aggregation occurs without the formation of
intermolecular disulfide bonds. Dissociation of the multimers into monomers in the
presence of SDS without reducing agents is consistent with hydrophobic forces as the
underlying driving force of aggregation, but this does not exclude the importance of
electrostatic interactions.
Proteolysis confirmed that the multimers on the aggregation pathway are non-
native. Unlike small aggregates, the fully folded native tailspike protein is resistant to
protease, SDS, and thermal denaturation (Tm=880 C). The species produced by partial
proteolysis of the aggregates are a distinct distribution of small fragments. It is possible
Figure 3.8: Nondenaturing gel electrophoresis used to isolate multimers
during in vitro aggregation. a) Carbonic anhydrase II (CAB) multimers
formed by refolding at 1.0 mg/mL, 20C, 0.4M urea in 40mM sodium
phosphate buffer, pH 7.6, for 0.3min. Denaturation conditions were 5M urea,
pH 3, for >45min at room temperature. b) P22 coat protein multimers
aggregating at 1 00ug/mL, 30C, 0.4M urea in 40mM sodium phosphate
buffer, pH 7.6, for 0.3min. Denaturation conditions were 6.75M urea, pH 7.6,
for >1 hr at room temperature.
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that the multimers have a defined structure and distinct exposed sites that are susceptible to
proteolysis in a non-random manner. Aggregates may be less susceptible to proteolysis at
later times in the aggregation reaction because large aggregates have a lower fraction of
surface area exposed to the solvent. Protease molecules are prevented from reaching the
inner core of the aggregate, and a significant fraction of the proteolytic cleavage sites may
be buried.
Although aggregates form from folding intermediates and have non-native
properties, there is evidence for various proteins that the folding intermediate involved in
the association reaction has significant native-like secondary structure (Oberg et al., 1994).
Raman spectroscopy data of J-lactamase inclusion bodies (Przybycien et al., 1994) and in
vitro aggregates of P22 tailspike polypeptide chains (Mitraki & Thomas, unpublished
results) show the presence of a significant amount of 3-sheet structure. Therefore, it is
reasonable to hypothesize that the monomeric tailspike folding intermediate may have
secondary structure similar to the subunit within the native trimer. If the folding
intermediate has a 3-spiral motif, the aggregation process may be analogous to the folding
reaction. In tailspike folding, each monomeric subunit forms a 1-spiral structure with
significant hydrophobic interactions and intrasubunit 3-sheet contacts between rungs of the
helix. The complex is stabilized by hydrophilic contacts between the 3 f-spirals. A late
folding step involves intersubunit winding of the C-terminal ends. By analogy, possible
models for chain aggregation include the following: 1. inappropriate intersubunit 1-sheet
formation, 2. misalignment of hydrophilic 1-spiral contacts, and 3. incorrect intersubunit
contacts at the C-terminus. Although all of these models are consistent with the Raman
spectroscopy data, evidence that the folding intermediate responsible for aggregation is
monomeric rules out the third model, which involves association of the protrimer species.
These models will be discussed further in the Chapter 7 with an analysis of additional
aggregate structural data from Chapter 4.
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ii. Determination of the aggregation pathway
In the tailspike aggregation pathway, the critical species is the monomeric folding
intermediate (I) at the junction between productive folding and aggregation. It is unknown
whether the first species along the aggregation pathway is monomeric (I*, in the model of
Haase-Pettingell & King, 1988) or dimeric, similar to carbonic anhydrase II (Cleland &
Wang, 1991). The monomeric species isolated by nondenaturing gel electrophoresis may
be I, I*, or a mixture of both species. Close inspection of the gels reveals that the broad
monomer band contains several distinct monomeric species, which may correspond to I
and I*. Although the gel electrophoresis data provide no evidence for the reversibility of
the aggregation reaction, we cannot rule out the possiblity of an equilibrium existing
between the first two aggregation intermediates or even with higher order multimeric
species.
The presence of the dimer aggregate under nonproductive refolding conditions
provides evidence that aggregation involves the association of a monomeric folding
intermediate to form discrete populations of multimers. During productive folding, no
stable dimer folding intermediate is detectable in the folding pathway between the
monomeric intermediate and the protrimer (Goldenberg & King, 1982). Therefore, the
dimer identified in these experiments is presumably one of the early species along the
aggregation pathway. However, we cannot rule out the possibility that a productive
folding dimer is present and overlaps in electrophoretic mobility with other multimer bands.
iii. The mechanism of polymerization
Within the sensitivity of silver staining, it appears that the aggregation reaction continues
after the monomeric species have been depleted. This makes it unlikely that sequential
addition of monomers is the major association pathway. Aggregation can proceed without
a pool of monomers presumably by the association of multimers of various sizes by the
"cluster-cluster" mechanism (Hemker & Frank, 1990). The polymerization process is not
restricted to a sequential addition of monomeric units to the growing aggregate, or "particle-
cluster" aggregation. These data suggest that multimeric polymerization rather than
sequential polymerization can occur at later stages of aggregation. However, sequential
polymerization is an essential step in the initial phase of multimerization. A sequential
addition of a monomeric subunit is required for the formation of a dimer from two
monomers and the generation of a trimer from a monomer and dimer. Determining the
mechanism of the aggregation reaction will be discussed further in Chapter 5, where
quantification of the aggregation kinetics and computer simulations to model aggregation
are analyzed.
The question of whether aggregation is a reaction under kinetic or thermodynamic
control has been difficult to resolve. Since aggregation occurs by the association of a
folding intermediate, the extent of aggregation is not a function of the thermodynamic
stability of the native state. The kinetic competition between folding and aggregation may
be predicted and controlled by focusing on the critical folding intermediate and the relative
rates of the folding and aggregation reactions at that junction. Although it is evident that the
aggregation process is essentially irreversible once large aggregates have formed, the early
steps of multimerization may be reversible. For example, CAB forms a dimeric species
which is in thermodynamic equilibrium with the monomeric folding intermediate (Cleland
& Wang, 1991). For the tailspike protein, it is possible that early multimers along the
aggregation pathway may be in equilibrium with each other. However, the equilibrium
must be relatively slow because discrete bands are isolated on a nondenaturing gel rather
than a smear. Controlling the early steps of multimerization is essential in pursuit of an
effective strategy to balance the relative rates of folding versus aggregation. Application of
this methodology of nondenaturing gel electrophoresis to study aggregation intermediates is
feasible for other proteins of potential pharmaceutical interest.

CHAPTER 4: STRUCTURAL EPITOPES OF FOLDING AND
AGGREGATION INTERMEDIATES
The formation of inclusion bodies in vivo or insoluble aggregates in vitro occurs by the
polymerization of folding intermediates (Marston, 1986; Mitraki & King, 1989;
DeBernardez-Clark & Georgiou, 1991). At the junction between the productive folding
and aggregation pathways, the folding reaction is in kinetic competition with the
aggregation of the partially folded species. During folding, certain sites on the surface of
the folding intermediates may cause the polypeptide chains to be susceptible to self-
association (Brems et al., 1988; Cleland & Wang, 1992). Probing the conformation of the
folding and aggregation intermediates can lead to a greater understanding of the structural
basis of aggregation and the possibility of controlling the kinetic competition between
productive folding and aggregation.
Due to a lack of structural data on the folding intermediates involved in the
polymerization reaction, often aggregates are presumed to have a heterogeneous,
disordered structure (Zettlmeissl et al., 1979). Techniques to obtain structural data on the
aggregated state have been limited due to the instability of the multimeric intermediates and
insolubility of the aggregated inclusion body state. For soluble 3-amyloid peptides, the
random coil to [-sheet structural transition has been monitored by far-UV circular
dichroism at 222nm (Terzi et al., 1994). For solid phase aggregates, FTIR analysis of
interleukin-10 inclusion bodies indicated nativelike structure (Oberg et al., 1994), whereas
3-lactamase inclusion bodies contained an increased amount of nonnative [-sheet structure
and less (a-helical content (Przybycien et al., 1994). Solid-state NMR has been performed
on 0-amyloid fibrils to determine the local sequence alignment (Sun et al., 1994).
Although not much structural analysis has been performed on soluble aggregation
intermediates, antibodies have been used to probe the structure of productive folding
intermediates formed either in vitro or in vivo. Antibodies directed against specific
domains of native bovine serum albumin were used to determine that refolding occurred
progressively from the C-terminus to N-terminus (Chavez & Benjamin, 1978).
Monoclonal antibodies (MAb's) against native tryptophan synthase were used to identify
nativelike epitopes on early folding intermediates during in vitro refolding (Blond &
Goldberg, 1987). In vivo folding of influenza hemagglutinin within the endoplasmic
reticulum was followed by similar immunoreactivity experiments (Braakman et al., 1991).
Likewise, a set of monoclonal antibodies against native and nonnative tailspike were used
to monitor the folding of tailspike polypeptide chains formed in vitro and in vivo (Friguet et
al., 1994).
In vitro refolding in the presence of MAb's can also affect the refolding and
aggregation reactions. Addition of MAb's against the S-protein of RNase plus the S-
peptide enhanced the refolding yield of RNase A (Carlson & Yarmush, 1992). Likewise,
MAb's against carboxypeptidase A assisted in the refolding of heat-denatured
carboxypeptidase A in a manner analogous to molecular chaperone interactions (Solomon
& Schwartz, 1995). Also, the presence of MAb's against the 13-amyloid peptide effectively
blocked fibril formation (Solomon et al., 1996).
The folding and aggregation pathway of P22 tailspike endorhamnosidase has been
extensively studied both in vivo and in vitro (Goldenberg & et al., 1983; Haase-Pettingell
& King, 1988; Mitraki et al., 1993). As discussed in Chapter 3, the early multimeric
intermediates on the aggregation pathway have also been trapped and characterized using
nondenaturing gel electrophoresis (Speed et al., 1995). These aggregation intermediates
are thermolabile and sensitive to both SDS and protease unlike the native trimer. Further
structural data on the folding and aggregation intermediates can be obtained by screening
reactivity with a set of monoclonal antibodies against native and nonnative tailspike chains.
A. Materials & methods
i. Materials
P22 tailspike protein (full length wildtype) was produced and purified as described in the
Materials & Methods section of Chapter 3 (King & Yu, 1986). The 3 forms of truncated
tailspike protein (residues 108-666; wt, Asp392Asn, and Asp395Asn) and the N-terminal
peptide fragment (residues 1-124 with a 6 His tag on the C-terminus for purification
purposes) were produced and purified by Miller & Seckler (1995). The monoclonal
antibodies against nonnative tailspike chains (anti-I: 70, 92, 105, 124) and native tailspike
(anti-N: 33, 51, 54, 155, 175, 219, 236) were produced and purified as described by
Friguet et al., 1990. The numbers in the parentheses shown above refer to the
identification code used during the original ELISA screening of the monoclonal antibodies.
ii. In vitro refolding
Native P22 tailspike protein was denatured for approximately 45 min in 5M urea at pH 3.
The refolding and aggregation reaction was initiated by rapid dilution (20 fold) with 40mM
sodium phosphate buffer and 0.58M urea (1mM EDTA, 1mM ~-mercaptoethanol, pH
7.6). The final refolding conditions were 100 pgg/mL protein and 0.8M urea in 40mM
sodium phosphate buffer (pH 7.6) at 200C. Aliquots of sample were taken at various time
points and rapidly transferred to preincubated tubes containing cold 3x sample buffer
(0.015M Tris, 0.12M glycine, 3mM DTT, 30% glycerol, bromophenol blue). These
samples were immediately frozen in liquid nitrogen.
iii. Gel electrophoresis
Nondenaturing polyacrylamide gel electrophoresis (PAGE) was performed using a
discontinuous buffer system as described in Chapter 3 (Andrews, 1986; Speed et al.,
1995). SDS gel electrophoresis with a discontinuous buffer system was performed as
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described using 7.5% or 12% acrylamide in the resolving gel (King & Laemmli, 1971).
Bands were visualized by Coomassie staining, silver staining (Sather & King, 1994), or
Western blotting, as described below.
iv. Western blotting
Conformational studies on the folding and aggregation intermediates were performed using
a set of monoclonal antibodies (MAb's) against native and nonnative tailspike polypeptide
chains (Friguet et al., 1990). In vitro aggregation intermediates and purified native
tailspike protein were isolated by nondenaturing gel electrophoresis, and a modified
Western blot procedure was developed to preserve the conformation of the aggregation
intermediates. The PVDF membrane was presoaked in methanol and washed repeatedly
with transfer buffer to remove the solvent. The electrotransfer procedure was done in the
cold (40C) in a nondenaturing buffer (20mM Tris, 150mM glycine) without the standard
0. 1%SDS and 20% methanol. The nondenaturing Western blot was also performed in the
cold to ensure that the polypeptide chains did not change in conformation during the
washes and antibody binding procedures.
To test for reactivity of the MAb's with fully denatured tailspike chains, a Western
blot was run under denaturing conditions with 0.1% SDS in the washing solution and
primary antibody steps. The positive control for this experiment was reactivity of anti-
native tailspike MAb's with the native tailspike band under identical conditions.
v. Refolding in presence of antibodies
In vitro refolding and aggregation studies were performed in the presence of tailspike
MAb's to determine whether these antibodies recognized epitopes on productive folding
intermediates. The initial dilution of denatured protein was performed at 100C with the
antibodies in the dilution buffer in order to allow the antibodies to bind to the tailspike
polypeptide chains under conditions in which folding and aggregation were slow compared
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to antibody binding. The antibody concentration was 0.2mg/mL and tailspike polypeptide
chains at 100gg/mL, making the molar ratio of 1.1:1.0 with antibodies in slight excess.
After a 5min incubation, the mixture was transferred to aggregating conditions at 200C
(100l g tailspike/mL, 0.8M urea, 40mM phosphate buffer, pH 7.6) for 0.5min, and a
sample was taken. The solution was then diluted 5x to productive refolding conditions
(20pg tailspike/mL, 200C, 40mM phosphate buffer, 0.16M urea), and a sample was taken
after 30min of refolding. This refolding step provided a sensitive measurement of the
fraction of tailspike polypeptide chains that were productive folding intermediates.
Each of the samples was taken in duplicate and combined with the appropriate SDS
or nondenaturing sample buffer. Samples were electrophoresed through SDS gel (12%
acrylamide) and nondenaturing gel (9% acrylamide), and bands were visualized by silver
staining. The bands visible on the nondenaturing gel represented the tailspike species that
did not react with the antibodies, whereas missing bands represented the species that were
prevented from being formed or were bound to the antibodies, migrating to the position of
the antibody complex. The results were compared to SDS gels to determine the yield of
native protein and to identify which tailspike species that were not visible on the
nondenaturing gel.
vi. Immunoprecipitation
Immunoprecipitation of tailspike chains after in vitro tailspike refolding in the presence of
MAb's (anti-I and anti-N) was performed to determine whether MAb's bind to productive
folding intermediates. MAb binding was initiated by diluting the denatured tailspike protein
with MAb's in excess (20g.g tailspike/mL, 0.8M urea, 40mM phosphate buffer, pH 7.6, at
100C for 10min), and the solution was transferred to refolding conditions (200C, 30min).
100pL of refolding solution was incubated with 100tLL Protein-G beads at 40C for 1.5hr
while rocking gently. Samples were taken, combined with SDS or nondenaturing sample
buffer, and stored on ice. The remaining solution was centrifuged with a brief
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microcentrifuge pulse. The supernatant was saved, and the pellet was resuspended with
75pL SDS sample buffer. A sample (designated "pellet") was taken after another brief
microcentrifuge pulse to remove the beads. Samples were electrophoresed through SDS
and nondenaturing gels, and bands were visualized by silver staining.
B. Results
As discussed in Chapter 3, aggregation intermediates of P22 tailspike polypeptide chains
were found to be nonnative in their biophysical properties, such as thermolability and
sensitivity to SDS and protease (Speed et al., 1995). These characteristics suggested that
aggregation intermediates were nonnative in their conformation. However, due to the
absence of structural data on the tailspike aggregates, it was unknown whether the
aggregates displayed nativelike structural epitopes.
i. Probing the structure of aggregation intermediates
To characterize the structural epitopes of aggregation intermediates, reactivity of the
aggregates with a set of monoclonal antibodies was screened. These monoclonals were
originally isolated from mice injected with native tailspike. Upon screening the purified
monoclonals by ELISA, a set of 7 antibodies reacted with native tailspike protein and 4
antibodies reacted with thermally denatured tailspike (Friguet et al., 1990).
The 7 anti-native tailspike MAb's (anti-N, designated 33, 51, 54, 155, 175, 219,
236) and 4 anti-nonnative tailspike MAb's (anti-I, 70, 92, 105, 124) were tested for
reactivity with native tailspike and refolding tailspike (100 gtg/mL protein, 200C, 0.8M
urea, 40mM sodium phosphate buffer, pH 7.6, 0.5min after dilution). The refolding
conditions were chosen to generate multimeric aggregation intermediates and a minor
fraction of protrimer and native protein. The samples of purified native protein and
refolding tailspike were loaded in triplicate onto a nondenaturing gel (9% acrylamide) and
electrophoresed for 4hr in the cold.
A nondenaturing Western blot procedure was developed to ensure that the
aggregation intermediates did not undergo a conformational change during the procedure.
The PVDF transfer membrane was pre-wet with methanol in order to enable
macromolecules in the aqueous phase to bind to the hydrophobic surface of the membrane.
The membrane was then rinsed repeatedly with tris-glycine buffer to remove all the
methanol before use. The electrotransfer solution was changed to a 20mM Tris, 150mM
glycine buffer without the standard 20% methanol and 0.1% SDS. In addition, both the
electrotransfer and Western blot incubation steps were performed at 40C to maintain the
conformation of the aggregation intermediates. Bands were visualized by enhanced
chemiluminesence.
The silver stained gel (Fig. 4. la) showed a distribution of folding and aggregation
intermediates. Since the timepoint was taken immediately after dilution, a small fraction of
tailspike had refolded into the native trimer. The majority of polypeptide chains were in the
monomer, dimer, and timer aggregate states, with some higher ordered aggregates seen
faintly at the top of the gel.
Nondenaturing Western blotting of these bands showed reactivity of the antibodies
with the tailspike species. In Fig. 4.lb, anti-native tailspike MAb's (anti-N) reacted only
with the native tailspike and not with the aggregation intermediates. A band representing
the protrimer folding intermediate, migrating with mobility similar to the trimer aggregate,
can be seen in the refolding sample using anti-N MAb's. This result indicated that the
protrimer intermediate displayed the nativelike epitope recognized by the anti-N MAb's. In
addition, a minor fraction of the refolding tailspike chains which reached a nativelike
conformation did react with the anti-N MAb's.
In Fig. 4.1c, the anti-nonnative tailspike MAb's (anti-I) reacted only with the
aggregates and not with the native species. The distribution of multimeric intermediates
was similar to that of the silver stained bands. The higher ordered multimers at the top of
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the gel appeared to display antigenic reactivity similar to the early multimeric intermediate
precursors. Since there was no apparent cross reactivity with the anti-I MAb's with the
native tailspike protein, the multimeric aggregation intermediates displayed epitopes which
were nonnative. This suggests that an early folding intermediate without nativelike
epitopes was susceptible to aggregation rather than a late folding intermediates.
Screening each of the MAb's individually gave consistent results (Fig. 4.2).
Certain MAb's displayed a relatively high binding affinity, including anti-I MAb 92 and
anti-N MAb 51. The blot using 2 anti-N MAb's (33, 54) were omitted because these
antibodies exhibited extremely poor antigenic reactivity. Previous studies reported that
MAb 33 had a low binding affinity (KD=3x10-9M, Friguet et al., 1990), and MAb 54
(IgG2 class) reacted poorly with the secondary Ab (Amersham horseradish peroxidase
labeled goat anti-mouse IgGi).
ii. Characterizing the nonnative epitopes
Under standard Western blot conditions, the incubation of the blots in powdered milk and
TBS solutions at room temperature allows the polypeptide chains to renature and aggregate
on the surface of the membrane. After electrotransfer using the standard denaturing buffer
containing SDS and methanol, renaturation during the initial steps of the Western blot is
generally required for the chains to reacquire the structural epitopes that the antibodies
recognize in the Western blot.
If the nonnative tailspike epitope recognized by the anti-I MAb's is found on
denatured polypeptide chains (Fig. 4.3), then renaturation on the membrane would not be
necessary. Originally the anti-I MAb's were designated "anti-denatured" tailspike MAb's
because they were screened for reactivity against thermally denatured tailspike by ELISA
(Friguet et al., 1990). This screening method may have inadvertently selected for MAb's
against aggregates rather than truly denatured polypeptide chains.
Figure 4.1: Screening of MAb's for reactivity against native tailspike and in vitro
refolding tailspike. Refolding was performed at 100ug/mL, 0.8M urea, in 40mM
phosphate buffer, pH 7.6, at 20C, and aliquots of sample were taken 0.5 min
after dilution. 0.3ug of native tailspike protein and 2ug of refolding and
aggregating tailspike were loaded onto a 9% acrylamide nondenaturing gel and
electrophoresed for 4hr at 4C. Bands were visualized by silver staining (a) and
by Western blotting using MAb's against native tailspike chains (anti-N MAb's,
panel b) and against nonnative tailspike (anti-I MAb's, panel c).
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Figure 4.2: Screening of individual MAb's reactivity with native tailspike (N) and
in vitro aggregates (A). Samples were obtained as described (refolding at
100ug/mL, 0.8M urea, in 40mM phosphate buffer, pH 7.6, at 20C for 0.5min) and
electrophoresed through a nondenaturing gel. Bands were visualized by
Coomassie staining and Western blot using MAb's against nonnative tailspike
chains (anti-I: 70, 92, 105, 124) and native tailspike (anti-N: 33, 51, 54, 155, 175,
219, 236). Numbers refer to identification code used during the original ELISA
screening of the monoclonal antibodies, as described (Friguet et al., 1990).
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Figure 4.3: Model depicting which folding and aggregation intermediates may contain
the nonnative structural epitopes recognized by the anti-I monoclonals. The nonnative
epitope may be found on denatured polypeptide chains, productive folding
intermediates, and/or off-pathway aggregation intermediates.
NONNATIVE EPITOPE
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To determine whether anti-I MAb's recognize denatured polypeptide chains, native
and thermally denatured monomeric tailspike chains were electrophoresed through an SDS
gel, and the protein bands were electrotransferred onto the PVDF membrane using the
standard transfer buffer containing SDS and methanol. Western blots were then performed
under standard and denaturing conditions, with 0.1 %SDS in the blocking and primary
MAb solutions.
The results indicate a difference in MAb recognition of tailspike chains using the
standard and denaturing Western blotting protocols (Fig. 4.4). Under standard Western
blotting conditions without SDS in the blotting solutions, anti-N reacted with the purified
native tailspike protein and the refolded protein. Anti-I MAb's bound to the monomeric
tailspike species but did not recognize the fully folded native trimer. Without the addition
of SDS, the chains in this monomer band had presumably undergone aggregation during
the standard Western blot procedure.
Using the modified denaturing Western blot procedure with 0.1% SDS in the
blotting solutions, the tailspike polypeptide chains were maintained in the monomeric
denatured state. Native tailspike protein, which is SDS resistant, displayed the native
epitopes recognized by the anti-N MAb's (Fig. 4.4). Similar to the results of the standard
procedure, the anti-I MAb's recognized a trimeric tailspike species in the sample of purified
native protein. However, the anti-I monoclonals did not efficiently recognize denatured
polypeptide chains in the monomeric tailspike band. This suggests that the aggregation
intermediates display unique structural epitopes.
iii. Location of the nonnative epitopes
Certain observations indicated that anti-I MAb's bind to the N-terminal region of the
tailspike polypeptide chain. Previous studies showed that 3 anti-I MAb's (92, 105, 124)
disrupted binding of the tailspike to the capsid head of phage 22, which involves the N-
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Figure 4.4: Determining whether anti-I MAb's recognize denatured polypeptide
chains (0.1%SDS) or aggregated tailspike. Native tailspike (N) and thermally
denatured monomeric tailspike (M, boiled for 3 min) electrophoresed through
an SDS gel. Bands were visualized by silver staining and by Western
blotting with MAb's against native tailspike (anti-N) and nonnative tailspike
chains (anti-1) using either the standard Western blotting procedure or modified
protocol with 0.1% SDS in the blocking and MAb solutions.
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terminus of the protein (Friguet et al., 1990). In addition, anti-I MAb's could not
recognize fully folded native tailspike trimer but could bind to tailspike with a partially
folded N-terminus. This species, which forms upon heating, electrophoreses slightly
faster than the folded tailspike trimer on an SDS gel (Chen & King, 1991). Using the anti-
I MAb's, it might be possible to identify an aggregation epitope characteristic of off-
pathway intermediates.
To pinpoint the location of the structural epitopes recognized by the MAb's against
native and nonnative tailspike, certain tailspike fragments and mutants were screened.
Antibody reactivity was screened against full length wild type protein, N-terminal peptide
fragment (residues 1-124 with a 6 His tag on the C-terminus for purification purposes),
and 3 forms of truncated tailspike (residues 108-666; wildtype, Asp392Asn, and
Asp395Asn). The truncated tailspike, whose refolding properties have been characterized
previously (Danner, Fuchs, Miller, & Seckler, 1993), was the species whose structure was
solved by x-ray crystallography (Steinbacher et al., 1994). A fraction of these tailspike
samples was boiled for 3 min to obtain monomeric polypeptide chains. The samples were
electrophoresed through an SDS gel, the protein was electrotransferred to a membrane, and
a standard Western blot was performed using anti-I and anti-N MAb's.
The results show that the anti-tailspike antibodies react with only certain tailspike
species (Fig. 4.5). The anti-N MAb's recognize all of the native tailspike proteins that
contain the main body of the 3-helix (lanes 1, 3, 4, 5). This suggested that the nativelike
epitope was located on the P-helix domain of the protein. However, since the reactivity of
the anti-N MAb's for the truncated tailspike protein (lanes 3, 4, 5) was significantly
reduced, the binding of some of the antibodies was inhibited by structural changes upon
removal of the N-terminus. The N-terminal peptide fragment (residues 1-124), which was
missing the 3-helix, did not react with the anti-N MAb's (lane 2).
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In the last panel of Fig. 4.5, anti-I MAb's were screen for reactivity with the set of
tailspike species. Anti-I MAb's recognized the monomeric (boiled) full length wildtype
tailspike chains (lane 1) and the N-terminal peptide fragment (lane 2). However, these
antibodies did not bind to the truncated tailspike chains missing residues 1-107 on the N-
terminus (lane 3, 4, 5). Therefore, the results indicated that the nonnative epitope
recognized by anti-I MAb's was located in the N-terminus. The structure of this section of
the tailspike protein was not solved by x-ray crystallography, possibly due to fluctuations
in the structure of the N-terminal region (Steinbacher et al., 1994).
iv. Nonnative epitopes on productive folding intermediates
Since the anti-I MAb's did not bind to the native tailspike, the aggregation epitope may be
found on either a productive folding intermediate or off-pathway aggregate. In vitro
folding and aggregation studies were performed in presence and absence of anti-I or anti-N
MAb's. Presumably, if anti-I recognized epitopes of a productive folding intermediate, the
binding of the MAb's to the folding intermediate would interfere with productive folding
(Fig. 4.6). One would expect the folding reaction could be slowed or blocked completely.
The protocol was designed to have 3 incubation periods for each of the 3 reactions
taking place (Fig. 4.7): incubation at 100C for 5 min for binding the MAb's to folding
intermediates, incubation at 200C for 0.5 min to form aggregation intermediates (100
Lg/mL tailspike, 0.8M urea, 40mM sodium phosphate buffer, pH 7.6), and 5x dilution to
productive folding conditions for 30 min (20 Cgg/mL tailspike, 0.16M urea, 40mM sodium
phosphate buffer, pH 7.6). Determining the overall yield of native protein after the
refolding period was a measure of the amount of productive folding intermediates that were
competent for folding. Similar results were obtained using variants of this protocol,
including omission of the MAb binding period at 100C and diluting the denatured protein
directly to productive folding conditions of 20 gg/mL tailspike. The samples were
electrophoresed through both nondenaturing and SDS gels, and bands were visualized by
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Figure 4.5: Identifying the binding site of anti-i MAb's as the N-terminal
domain of tailspike polypeptide chains. Native tailspike (N) and thermally
denatured monomeric tailspike (M, boiled for 3 min) were loaded into the
same lane and electrophoresed through an SDS gel. The samples were full
chain wildtype (wt) tailspike (lane 1), the N-terminal peptide fragment
(residues 1-124; lane 2), truncated tailspike protein (residues 108-666) having
the wt sequence (lane 3), truncated mutant Asp392Asn (lane 4), and
truncated Asp395Asn (lane 5). Bands were visualized by silver staining and
standard Western blotting using MAb's against native tailspike (anti-N) and
nonnative tailspike chains (anti-I).
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Figure 4.6: Model depicting which folding and aggregation intermediates may contain the
nonnative structural epitopes recognized by the anti-I monoclonals. The nonnative epitope
may be found on productive folding intermediates and/or off-pathway aggregation
intermediates. Binding of monoclonal antibodies to folding intermediates could interfere
with productive folding.
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Figure 4.7: Protocol for refolding and aggregating tailspike polypeptide chains in the
presence of monoclonal antibodies to determine whether the nonnative epitope is
located on productive folding intermediates or exclusively on off-pathway aggregates.
MAb binding was initiated by diluting the denatured tailspike protein with MAb's in
excess (100gg tailspike/mL, 0.8M urea, 40mM phosphate buffer, pH 7.6) at 10oC.
After 5 min, the solution was transferred.to aggregating conditions at 200C for 0.5 min,
and sample #1 was taken. The solution was then diluted 5x to productive refolding
conditions (20gtg tailspike/mL, 200C, 40mM phosphate buffer, 0.16M urea), and sample
#2 was taken at 30 min.
Dilute denatured tailspike
sample
#2
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silver staining. A high percentage of acrylamide (12%) was used for the SDS gel to
achieve sufficient separation between the native trimer and the immunoglobulin bands.
The results indicated that under productive folding conditions, the anti-N
monoclonals blocked native trimerization by presumably binding to a monomeric folding
intermediate (Fig. 4.8a). No native trimer was seen on the SDS gel for the sample after the
refolding period with anti-N present (lane 7). This suggests that anti-N MAb's bind to a
productive folding intermediate and block folding. The folding intermediate is probably
late in the folding pathway since it displays nativelike structural epitopes. Anti-I MAb's did
not block folding, as determined by the presence of the native trimer band on the SDS gel
(lane 6). Since the binding of these antibodies did not interfere with productive folding, the
nonnative structural epitopes recognized by the anti-I MAb's was located on either off-
pathway aggregates or on a domain of productive intermediates that was not sterically
prevented from folding.
Examination of the nondenaturing gel (Fig. 4.8b) showed the absence of the native
trimer band for the sample refolded with anti-I (lane 6). This was not due to anti-I blocking
the folding reaction because native trimer was detected on the SDS gel (lane 6, Fig. 4.8a).
Apparently, anti-I bound to a productive folding intermediate and was incorporated into the
native trimer. This indicated that the aggregation intermediates contained structural epitopes
in common with productive folding intermediate. The region on which the nonnative
epitope is located was nonessential for folding, and data suggested that the N-terminus was
the target for binding.
To confirm that the antibodies were binding to productive folding intermediates, an
immunoprecipitation experiment (Fig. 4.9) was performed on tailspike chains after in vitro
tailspike refolding in the presence of MAb's (anti-I and anti-N). MAb binding was initiated
by diluting the denatured tailspike protein with MAb's in excess (20gg tailspike/mL, 0.8M
urea, 40mM phosphate buffer, pH 7.6, at 100C for 10 min). The solution was transferred
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Figure 4.8: In vitro refolding and aggregation in the presence of tailspike MAb's
(anti-I and anti-N) to determine whether MAb binding blocks productive folding.
Refolding was performed as described in Fig. 4.7. Samples were
electrophoresed through SDS and nondenaturing gels, and bands were
visualized by silver staining. Native tailspike (lanes 1 and 8); sample #1 of
aggregating tailspike without MAb's (lane 2), with anti-I MAb's (lane 3), or with
anti-N MAb's (lane 4). Sample #2 after refolding period without MAb's (lane 5),
with anti-I MAb's (lane 6), or with anti-N MAb's (lane 7). Controls of anti-I
MAb's (lane 9) and anti-N MAb's (lane 10).
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Figure 4.9: Protocol for the immunoprecipitation of tailspike chains after in vitro tailspike
refolding in the presence of MAb's (anti-I and anti-N) to determine whether MAb's bind to
productive folding intermediates. MAb binding was initiated by diluting the denatured
tailspike protein with MAb's in excess (20gpg tailspike/mL, 0.8M urea, 40mM phosphate
buffer, pH 7.6, at 100C for 10min), and the solution was transferred to refolding
conditions (200C, 30min). The solution was incubated with Protein-G beads at 40C for
1.5hr while rocking gently. A sample was taken, and the remaining solution was
centrifuged with a brief microcentrifuge pulse. The supernatant was saved (sup. #1), and
the pellet was resuspended with SDS sample buffer. A sample (designated sup. #2 or
"pellet") was taken after another brief microcentrifuge pulse to remove the beads.
Samples were electrophoresed through SDS and nondenaturing gels.
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to refolding conditions (200C), and samples were taken after refolding for 30 min. Equal
volumes of refolding solution and Protein-G beads at 40C were combined and incubated
for 1.5 hr while rocking gently. Samples were taken, combined with SDS or
nondenaturing sample buffer, and stored on ice. The remaining solution was centrifuged
with a brief microcentrifuge pulse, and the supernatant was sampled. The pellet was
resuspended in SDS sample buffer to free the species bound to the MAb-bead complex,
and a sample was taken after another brief spin to remove the beads. Samples were
electrophoresed through SDS and nondenaturing gels, and bands were visualized by silver
staining.
Imnunoprecipitation of the tailspike-MAb complex confirmed that the antibodies
were recognizing productive folding intermediates (Fig. 4.10). Compared to the control
lane of refolding tailspike without the presence of monoclonal antibodies (lane 2), the
presence of anti-I MAb's did not affect the yield of native protein, as seen on the SDS gel
(lane 3). Anti-N MAb's blocked the formation of native trimer, as determined by the
absence of the trimer band in lane 4. In the immunoprecipitation of refolding tailspike in
the presence of anti-N MAb's, nonnative tailspike chains were found in the supernatant
(lane 6) and the pellet (lane 8) in equal amounts. These fractions represent aggregation
intermediates that are not recognized by anti-N MAb's in the supernatant and the productive
folding intermediates in the pellet. Likewise, both the supernatant (lane 5) and pellet (lane
7) fractions of tailspike refolding with anti-I MAb's contained native and monomeric
chains. However, a greater fraction of native tailspike is in the pellet, which is about
equivalent to the amount of folded protein for this sample. The immunoprecipitation of
native trimer which formed in the presence of anti-I MAb' s suggests that these antibodies
were incorporated into the native trimer. The nonnative epitope that anti-I MAb's
recognized was found on productive folding intermediate as well as aggregates.
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Figure 4.10: Immunoprecipitation of tailspike chains after in vitro tailspike refolding in
the presence of MAb's (anti-I and anti-N) to determine whether MAb's bind to
productive folding intermediates. Refolding and immunoprecipitation were performed
as described in Fig. 4.9. Samples were electrophoresed through SDS and
nondenaturing gels, and bands were visualized by silver staining. Native tailspike
(lane 1). Refolded tailspike without MAb's (lane 2), with anti-I MAb's (lane 3), or with
anti-N MAb's (lane 4). Immunoprecipitation supernatant for refolded tailspike solution
with anti-I MAb's (lane 5) or with anti-N MAb's (lane 6). Immunoprecipitation pellet for
refolded tailspike solution with anti-I MAb's (lane 7) or with anti-N MAb's (lane 8).
Controls of anti-I MAb's (lane 9) and anti-N MAb's (lane 10). Note that the
immunoprecipitation pellet samples of lanes 7 and 8 were not loaded onto the
nondenaturing gel because they were resuspended in sample buffer containing SDS.
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C. Discussion
The multimeric intermediates on the aggregation pathway contained nonnative structural
epitopes in common with the folding intermediates from which they formed. These
epitopes were not found on denatured polypeptide chains nor on the fully folded native
tailspike. The existence of a structural epitope of aggregation intermediates in common
with productive folding intermediates suggests that the partially folded intermediates are the
precursors to the multimeric aggregation intermediates.
The model describing the anti-tailspike antibodies binding to structural epitopes of
productive folding and aggregation intermediates in shown in Fig. 4.11. Anti-nonnative
tailspike MAb's recognize early productive folding intermediates before the junction
between the folding and aggregation pathways. These nonnative epitopes are also present
and exposed on the aggregation intermediates. Since anti-I MAb's do not recognize the
native trimer, either the nonnative epitope is not present on the folded protein or the site is
buried. During tailspike refolding, anti-I MAb's can become incorporated into the native
trimer, which suggests that the epitope is located in a region that is relatively flexible. Anti-
native tailspike MAb's recognize a nativelike structural epitope on a folding intermediate
apparently after the junction with the aggregation pathway but before the protrimer folding
intermediate. Binding of antibodies to the nativelike epitope prevents the formation of the
protrimer intermediate or native tailspike trimer due to steric interference.
i. Domains nonessential for folding
The binding of certain antibodies to productive folding intermediates without interference
with the folding reaction was unexpected. The ability of the polypeptide chain to fold with
an antibody bound to it has identified regions on the polypeptide chain that are nonessential
for folding. Further studies have pinpointed the nonnative epitope to the N-terminus of the
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Figure 4.11: Model describing the anti-tailspike antibodies binding to structural epitopes of
productive folding and aggregation intermediates. Anti-nonnative tailspike MAb's (anti-I)
recognize aggregation intermediates and early productive folding intermediates before the
junction between the folding and aggregation pathways. During tailspike refolding, anti-I
MAb's can become incorporated into the native trimer by binding to the productive folding
intermediates. Anti-native tailspike MAb's (anti-N) recognize a nativelike structural epitope
on a folding intermediate after the junction with the aggregation pathway but before the
protrimer folding intermediate. Binding of antibodies to the nativelike epitope prevents the
formation of the protrimer intermediate or native tailspike trimer.
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tailspike chain. Apparently, the N-terminal domain is not required for native trimerization,
and the domain is flexible enough to accommodate the antibody complex.
Most of the MAb's against native tailspike do not react with temperature sensitive
folding mutants Gly244Arg and/or Gly323Asp. These mutations are located on the dorsal
fin region of the main (-spiral, suggesting that some of the anti-N MAb's bind to the 3-
spiral. Since anti-native tailspike MAb's blocked productive folding, the nativelike epitope
is a critical step in folding. This suggests that formation of the (-spiral precursor is an
essential folding event. Perhaps binding of the anti-N MAb's to the interface of 3-spiral
precursor sterically hinders native trimerization.
ii. Structural implications
The nonnative structural epitopes found on both the productive folding intermediates and
the multimeric aggregation intermediates may represent either domains that either are
actively involved in intermolecular association or are not. Aggregation epitopes may
represent sites of intermolecular helix-helix docking (Brems et al., 1986), cross-0--sheet
formation (Lansbury, 1992), hydrophobic patches (Ptitsyn et al., 1990), or other structural
motifs that may be analogous to intramolecular interaction within the native conformation
(Bennett et al., 1994). Nonnative epitopes not involved in the aggregation reaction are
more likely to be displayed on the surface of the folding and aggregation intermediates
rather than being buried at the subunit interfaces. Since the anti-I monoclonals reacted with
the tailspike chains by nondenaturing Western blotting, the nonnative epitopes on the N-
terminus of the tailspike polypeptide chain probably do not represent aggregation sites that
are intimately involved in interchain association.
The structural analysis of the aggregation and folding intermediates suggests that
the (-helix structure is involved in aggregation. Unimolecular misfolding of the (3-helix
may occur by the formation of misaligned (-sheets within a single polypeptide chain. The
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resulting misfolded intermediate could have hydrophobic patches susceptible to
aggregation. Temperature-sensitive mutations may interfere with the correct alignment of
subunits and slow the rate of sequential coiling of the P-helix. This would enhance
aggregation kinetically by increasing the half life of the critical folding intermediate
(BeiBinger et al., 1995). The formation of aggregation intermediates may also involve
interdigitated 3-helix contacts with nativelike strand alignment. A network of cross-3-sheet
linkages would create a very stable aggregated inclusion body complex. General
approaches to influencing the balance between productive folding and aggregation can be
formulated based on the polymerization mechanism and structural data.
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CHAPTER 5: POLYMERIZATION MECHANISM OF AGGREGATION
The self association of partially folded polypeptide chains to form multimeric complexes
occurs during in vitro aggregation, inclusion body formation, and amyloidosis (Marston,
1986; Benson & Wallace, 1989). Although the mechanism of polypeptide chain
aggregation is not well characterized, the ability to influence the kinetic competition
between productive folding and aggregation is a requirement for improving the recovery of
active protein expressed in a heterologous host cell (Mitraki & King, 1989). The objectives
of folding strategies include increasing the yield of soluble native protein in vivo for direct
recovery of active product, enhancing inclusion body formation for ease of initial
purification from cellular proteins, or increasing the efficiency of in vitro refolding.
Although general folding strategies have been developed (DeBernardez-Clark & Georgiou,
1991), currently each novel protein requires unique folding optimization on a case by case
basis. An understanding of the polymerization mechanism of aggregation may lead to the
rational design of folding strategies.
Unlike crystallization and self-assembly processes, aggregation involves the
association of thermolabile folding intermediates rather than the stable native protein
(Mitraki & King, 1989; King et al., 1996). The aggregation reaction is strongly dependent
on protein concentration and temperature due to collision frequencies and hydrophobic
interactions that drive the association of partially folded species (Zettlmeissl et al., 1979).
The aggregation process is in kinetic competition with the productive folding pathway, and
the aggregate is not necessarily in thermodynamic equilibrium with the monomers, as in
crystallization. Aggregation is not equivalent to "insolubility" since it is not reversible upon
dilution (Caspar, 1980; Baker & Agard, 1994).
In certain polymerization processes, such as crystallization and amyloid fibril
formation, the initial nucleation complex forms slowly, but rapid polymerization can occur
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once the aggregate reaches a certain critical size. Biological systems that display
nucleation-growth kinetics include the polymerization of sickle cell hemoglobin (Ferrone et
al., 1980), amyloid fibril formation (Jarrett & Lansbury, 1992), actin polymerization
(Tobacman & Kom, 1983), bacterial flagella assembly (Asakura et al., 1964), and collagen
refolding (Harrington & Karr, 1970). The nucleus for polymerization is the smallest
aggregate that has a propensity to increase in size rather than dissociate. Since the
nucleation step is rate limiting, seeding the reaction with a homologous fibril produces
immediate aggregation of a supersaturated solution (Jarrett et al., 1993).
The folding and aggregation of P22 tailspike polypeptide chains has been studied
extensively both in vivo and in vitro (Goldenberg et al., 1983; Haase-Pettingell & King,
1988; Mitraki et al., 1993). The time-course of the formation of folding intermediates,
native trimer, and aggregation intermediates can be followed both in vivo and in vitro and
quantified (Danner & Seckler, 1993; Haase-Pettingell & King, 1988; Speed et al., 1995).
In vitro studies have determined the final stage of refolding to be a unimolecular reaction
with a rate constant of k=1.6x10- 3s-1 at 100 C and k=7x10- 3s-1 at 250C at a protein
concentration of 20pg/ml (Fuchs et al., 1991). In vivo temperature shift-down
experiments determined that the protrimer forms by a first order reaction with kl=0.30min-
1 and then transforms to the native conformation by another first order reaction with
k2--0.19min-1 at 240C (Goldenberg et al., 1983). A detailed kinetic analysis of the
multimerization mechanism of aggregation is also required for a complete analysis of the
protein folding problem.
A. Materials and methods
i. In vitro aggregation
P22 tailspike protein was produced and purified as described in the Materials and Methods
section of Chapter 3 (King & Yu, 1986). For the refolding experiments, denaturation of
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native P22 tailspike protein was done in 5M urea at pH 3 for >45 min. In vitro refolding
was initiated by a 20-fold rapid dilution with phosphate buffer containing 0.58M urea,
1mM EDTA, 1mM 3-mercaptoethanol, pH 7.6. The refolding and aggregation conditions
were 100 gg/mL tailspike protein in 0.8M urea, 40mM sodium phosphate buffer, pH 7.6,
at temperatures ranging from 100C to 250C.
ii. Classical light scattering
Classical light scattering of refolding and aggregating tailspike protein was measured with a
Hitachi F4500 spectrofluorometer. A baseline of background scattering at 500nm was
established by recording for 200s the light scattering of 40mM sodium phosphate buffer
with 0.58M urea (ImM EDTA, 1 mM P-ME, pH 7.6). The in vitro refolding and
aggregation reaction was initiated by diluting 100 pl denatured tailspike protein into the
dilution buffer with continuous stirring. The refolding conditions were 100 glg/mL
tailspike protein in 0.8M urea, 40mM sodium phosphate buffer, pH 7.6, at 200C. The
light scattering at 500 nm was recorded for over 5hr.
iii. Gel electrophoresis
As described in Chapter 3, nondenaturing polyacrylamide gel electrophoresis (PAGE) was
performed using a discontinuous buffer system (Andrews, 1986; Speed et al., 1995). For
in vitro refolding and aggregation reactions, 23gL of denatured tailspike polypeptide chains
was diluted 20x with 40mM sodium phosphate buffer containing 0.58M urea (1mM
EDTA, 1 mM 3-ME, pH 7.6) to final refolding conditions of 100 gg/mL tailspike protein
in 0.8M urea, 40mM sodium phosphate buffer, pH 7.6. This reaction was performed at
temperatures of 100C, 150C, 200C, and 250C using the same batch of denatured tailspike.
Aliquots of samples were taken at specified times, added to cold 3x sample buffer in an ice-
water bath and then immediately frozen in liquid nitrogen. Samples were thawed on ice
and immediately loaded in duplicate onto a nondenaturing gel at 40C. Forty pL of each
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sample was loaded onto gels that were to be Coomassie stained, and 20pL was loaded onto
gels that would be silver stained. The samples were electrophoresed using 9% acrylamide
nondenaturing gels and run at constant current (10mA/gel) for 4 hours at 40C. Bands were
visualized by silver staining (Sather & King, 1994) and Coomassie staining. Densitometry
was performed on the gels that were Coomassie stained using a Molecular Dynamics
densitometer and recording the intensity of transmittance. Quantitation of the bands was
done using the Molecular Dynamics software.
For the two-dimensional gel electrophoresis experiments, refolding was performed
at 100 gg/mL in 0.8M urea, 40mM sodium phosphate buffer, pH 7.6. To test the
reversibility of aggregation, the refolding was performed at 40C, and a sample was taken
10min after dilution and combined with cold 3x sample buffer. The sample was
electrophoresed using a nondenaturing gel (8-9% acrylamide) as described previously. The
lane of multimers on the gel was cut and incubated overnight between glass plates at 40C.
The following day, it was soaked in nondenaturing sample buffer containing 1mM DTT for
5 min at 40C. The gel strip was then placed horizontally across the top of a 1.5mm thick
gel and electrophoresed in a second dimension (8% acrylamide gel) at 40C. Protein bands
were visualized by silver staining.
A similar protocol was used to test the polymerization mechanism of aggregation.
The refolding reaction was performed at 100 gg/mL in 0.8M urea, 40mM sodium
phosphate buffer, pH 7.6, at 200C, and a sample was taken 0.3min after dilution.
Nondenaturing gel electrophoresis was performed as described above. The lane of
multimers on the gel was cut and incubated overnight between glass plates at room
temperature to promote aggregation within the gel. The gel strip was then electrophoresed
in the second dimension as described.
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iv. Computer simulations
The kinetic profiles of the early multimeric intermediates were simulated using Matlab
software. Sets of ordinary differential equations describing the aggregation reaction were
solved by second and third order Runge-Kutta formulas. Both sequential and multimeric
polymerization mechanisms were tested as well as variants on these models, as described in
Fig. 5.6. The Matlab programs were written to curve fit the aggregation kinetics data
measured by CLS and gel densitometry (Appendix C).
B. Results
Studies have been performed in characterizing the aggregated inclusion body state both in
vivo (Bowden et al., 1991; Przybycien et al., 1994; Oberg et al., 1994) and in vitro
(Zettlmeissl et al., 1979). However, there is an absence of data on the process by which
folding intermediates polymerize to form large aggregated complexes. In the present
studies, the mechanism by which the early soluble multimers polymerize along the
aggregation pathway was investigated. This was the point in the refolding pathway that
could influence the kinetic competition between productive folding and aggregation and a
stage in which the aggregation intermediates were still soluble.
To characterize the early steps in the aggregation process, nondenaturing gel
electrophoresis was used to isolate the multimeric aggregation intermediate during in vitro
aggregation. Aggregation intermediates of P22 tailspike polypeptide chains have been
isolated and characterized by this method, as described in Chapter 3 (Speed et al., 1995).
In addition, classical light scattering was also used to monitor the kinetics of aggregation.
Quantitative analysis of the aggregation kinetics was performed to determined the
polymerization mechanism.
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i. Classical light scattering
Classical light scattering (CLS) was used to monitor continuously in vitro aggregation of
P22 tailspike in a noninvasive manner. The light scattered at 500nm during the initial
multimerization steps of aggregation was measured. The refolding conditions were
100g/mL, 20'C, 0.8M urea in 40mM phosphate buffer, pH 7.6. Previous work at higher
initial protein concentrations (>150tg/mL) and with guanidine hydrochloride as a
denaturant promoted rapid aggregation. The slower aggregation conditions were chosen to
analyze quantitatively the initial multimerization steps.
The light scattering during the aggregation reaction was measured for over 5hrs
(Fig. 5.1). The increase in light scattering intensity was linear throughout the
measurement. The majority of the polypeptide chains under these conditions formed
aggregates rather than the native trimer, and the yield of productive refolding was only
10%, as determined by gel electrophoresis and quantitative densitometry. Since productive
refolding was minimal under the aggregation conditions chosen, the light scattering was
mainly due to the multimeric aggregates in solution.
The intensity of light scattered was proportional to NiMi2, where Ni is the number
(or concentration) of aggregate molecules of species i and Mi is the molecular weight of
species i. This dependence on particle size and concentration was valid for Rayleigh light
scattering, in which particle size was less than the wavelength (d<X). This assumption was
confirmed by checking that Iacl/X4. Relatively slow aggregation conditions were chosen
such that the length scale of the particles was less than the incident wavelength, and light
scattering was maintained in the Rayleigh regime. Under faster aggregation conditions, the
increase in the intensity of light scattering with time was sigmoidal as aggregation
proceeded. These conditions were not chosen for quantitative analysis because the large
aggregates that formed caused the light scattering to rapidly exit the Rayleigh regime.
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Figure 5.1: Classical light scattering of the in vitro aggregation of tailspike
polypeptide chains. Dilution out of denaturant was performed as described in the
Materials & Methods section, and refolding conditions were 100 pg/mL tailspike, in
0.8M urea, 40mM sodium phosphate buffer, pH 7.6, at 200C. The aggregation
reaction was monitored at 500nm using a Hitachi spectrofluorometer. Matlab
programs were used to solve the differential equations of polymerization for
multimeric (solid line) and sequential (dashed line) mechanisms. The intensity of light
scattered was also fit by linear regression with I=477+199-Time, R=0.9998.
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If aggregation intermediates were a homogeneous population of multimers of
identical size, these multimers could self-associate via a cluster-cluster polymerization
mechanism, causing a linear increase in light scattered over the course of an aggregation
reaction (Appendix B 1). If aggregation requires a sequential addition of monomeric
subunits to a growing aggregation, the aggregation reaction becomes stunted after all the
monomers became dimers. Assuming a heterogeneous distribution of monomers in
equilibrium with multimers, the light scattering due to aggregation would exhibit a
sigmoidal-kinetic behavior (Appendix B2). The nucleation-growth model also predicts a
sigmoidal curve with a lag phase in which the early steps in aggregation have a slower
characteristic rate constant than later stages in the polymerization reaction. Qualitative
analysis of the CLS data suggests that aggregation occurred by multimeric cluster-cluster
polymerization.
Quantitative analysis of the CLS data was performed using Matlab software to
simulate the aggregation reaction. The Matlab programs that were written solved sets of
differential equations in modeling the polymerization reaction are shown in Appendix C.
One polymerization model that was tested involved a sequential addition of monomeric
subunits to the growing aggregate. The differential equations describing sequential
polymerization were the following equations, translated into Matlab syntax:
dNl = - 2kN2 - kN, N i
dt i=2
i = kNINi-, - kNIN i  for i > 1
dt
A second aggregation model that was tested was the cluster-cluster or multimeric
polymerization, and the equations describing this mechanism were the following:
ýNi =i/2l 2 -nmerNi- jkNjNi-j -k idt ,j=l =
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Certain assumptions were made to simplify the problem of testing the aggregation models.
Under the refolding conditions that were used, aggregation was strongly favored and was
approximated as an irreversible reaction. To avoid generating a large matrix of rate
constants for each possible combination of multimers, all association rate constants were
assumed to be approximately equal. The aggregation reaction was simulated by tracking a
finite number of multimers, up to a defined size (20-mers) which was empirically
determined as sufficient for the given aggregation conditions.
As predicted in the previous qualitative analysis, the kinetic profile of the intensity
of light scattered was consistent with multimeric polymerization. The multimeric
polymerization model genererated a linear increase in light scattering as the aggregation
reaction proceeded. In contrast, the sequential model predicted a plateau in the scattering,
and the aggregation reaction effectively stopped once the monomeric intermediates became
depleted.
ii. Gel electrophoresis
Although light scattering techniques allow a continuous noninvasive monitoring of the
aggregation reaction, certain assumptions are generally required to analyze the signal
measured for a heterogeneous mixture of multimeric species. A physical isolation of
monomer, dimer, trimer, tetramer, and higher ordered multimeric species provides a direct
measurement of the amounts of each multimer in the polymerization reaction without
assumptions about the homogeneity or geometry of the aggregates.
Nondenaturing polyacrylamide gel electrophoresis (PAGE) was used to isolate and
characterize the early multimers on the aggregation pathway, as described in Chapter 3
(Speed et al., 1995). The in vitro aggregation conditions were the same as described for
the CLS experiment (100 pgg/mL tailspike protein, in 0.8M urea, 40mM sodium phosphate
buffer, pH 7.6), and a range of refolding temperatures was tested. Previous controls
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described in Chapter 3 indicated that the aggregation reaction was sufficiently quenched by
dilution with cold 3x sample buffer and temporary storage on ice. However, for these
experiments, the sample at each timepoint was frozen in liquid nitrogen immediately after
combining with cold sample buffer. All of the samples were thawed on ice just before
loading onto the nondenaturing gel. Gels were run in duplicate, and bands were visualized
by Coomassie and silver staining. Controls indicated no difference in the multimeric
distribution for samples frozen in liquid nitrogen and previous results of Chapter 3.
Electrophoresis of samples taken during the course of an in vitro refolding study
showed the change in the distribution of aggregates as the aggregation reaction proceeded
(Fig. 5.2). As the aggregation reaction progressed, the distribution of aggregation
intermediates shifted to higher ordered multimers at the top of the gel. At low
temperatures, native trimerization was inhibited, as seen in the aggregation samples at
100C. Below 150C, previous in vitro refolding studies showed that the conversion of
protrimer intermediate to the native trimer was the rate limiting step for folding (Goldenberg
& King, 1982). At higher temperatures, both folding and aggregation rates increased. Of
the 4 conditions tested, refolding at 200C produced the highest yield of native tailspike
trimer. Increasing the temperature above 200C resulted in a greater increase in the
aggregation rate versus productive folding.
Although the denatured state of the tailspike was unfolded monomeric polypeptide
chains, the earliest time point (0.5 min after dilution) showed a distribution of multimeric
aggregation intermediates. The initial hydrophobic collapse and formation of folding
intermediates with secondary structure occurred on the order of msec (Kim & Baldwin,
1990). If the earliest folding intermediates were highly susceptible to aggregation, then
aggregation intermediates could form within a few seconds. In addition, some aggregation
could occur during the initial dilution and freezing the sample due to shear and during the
loading the samples onto the gel at 40C.
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Figure 5.2: In vitro refolding and aggregation kinetics of P22 tailspike polypeptide
chains. Native tailspike protein was denatured in 5M urea, pH 3, and refolding was
initiated by 20-fold dilution to 100ug/mL protein, in 0.8M urea, 40mM sodium
phosphate buffer (pH 7.6) at 10C, 15C, 20C, and 25C. Samples were combined with
cold 3x sample buffer, immediately frozen using liquid nitrogen, and thawed on ice at
the time of gel loading. The samples were electrophoresed through a 9% acrylamide
nondenaturing gel for 4hr at 4C. The amount of sample loaded was 2.7ug protein for
the aggregation timepoints and 0.07ug, 0.20ug, 0.40ug, and 0.13ug for the native
tailspike controls, respectively (left to right). The protein bands were visualized by
Coomassie staining.
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Examination of the distributions of aggregation intermediates revealed that the
polymerization reaction continued after the monomeric folding intermediates had been
depleted (Fig. 5.2). Apparently aggregation could proceed without the presence of
monomers by the association of multimers of various sizes via a "cluster-cluster"
mechanism (Hernker & Frank, 1990), or multimeric polymerization. The aggregation
reaction was not restricted to a sequential mechanism of monomeric subunits adding to the
growing aggregate, or "particle-cluster" aggregation.
To examine the kinetics of aggregation, the concentration of each aggregation
intermediate and native trimer during the course of refolding and aggregation was measured
by quantitative densitometry of the Coomassie stained bands. The staining of each
multimer was assumed to be proportional to the number of polypeptide chains within the
complex. Calculation of the concentration of the aggregation intermediates in each band
was based on the staining intensity of the 4 control lanes of native tailspike trimer. These
controls produced a very linear correlation between the intensity of the Coomassie stain and
the amount of tailspike polypeptide chains.
Figure 5.3 shows the kinetic profiles of the aggregation intermediates and native
trimer for in vitro refolding and aggregation at 100C, 150C, 200C, and 250C (100 gg/mL
tailspike protein at 200C and 0.8M urea in sodium phosphate buffer, pH 7.6). The
symbols represent data points determined by quantitative densitometry, and the solid lines
represent computer simulations of the aggregation reaction using Matlab software. Several
models were tested, including sequential polymerization and multimeric polymerization, as
defined in Fig 5.6. At the lower temperatures, both aggregation and refolding were
significantly slowed down. During the course of refolding at 200C and 250C, the
concentration of each multimer peaked and then gradually fell as higher aggregates formed.
The aggregation reaction continued until most of the polypeptide chains were too large to
enter the gel.
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Figure 5.3: Computer simulations of the kinetics of tailspike aggregation as a function of
temperature. In vitro refolding and aggregation reactions were performed under the
conditions of 100ug/mL protein in 0.8M urea, 40mM sodium phosphate buffer, pH 7.6 at
temperatures of 10C, 15C, 20C, and 25C. Samples were electrophoresed through
nondenaturing gels, and bands were visualized by Coomassie staining. Quantitative
densitometry was performed using a Molecular Dynamics densitometer, and data points are
indicated by the symbols: o, monomer; V, dimer; A, trimer aggregate; 0, tetramer; 0,
pentamer; ,, native trimer. Solid lines indicate computer simulation profiles computed with
Matlab software to solve the differential equations using the multimeric polymerization model.
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Note the small differences in scaling of the 4 graphs in Fig. 5.3 for clarity of
viewing the data points. For refolding at all 4 temperatures tested, approximately 50% of
the polypeptide chains did not enter the gel for the initial timepoint taken 0.3min after
dilution. The loss of polypeptide chains to the aggregated state was significant under the
aggregation conditions chosen for these experiments, and generally refolding yields were
less than 10%.
To analyze the kinetic data obtained by quantitative densitometry, computer
simulations were run using Matlab software. The differential equations describing the
polymerization reaction were similar to those used for the quantitative analysis of the CLS
data. However, since native trimer formation could be quantified by gel electrophoresis,
productive folding terms were included in the analysis (Appendix C).
The results of the computer simulations for the gel densitometry data also confirmed
that aggregation occurred by multimeric polymerization rather than the sequential
mechanism. In sequential polymerization, the depletion of the pool of monomers at an
early stage in the aggregation reaction prevented further multimerization from occurring.
The kinetic profiles of the multimers reached a plateau as the concentration of monomers
fell exponentially. For multimeric polymerization, the kinetic profiles of multimers
matched the densitometry data (Fig. 5.3). This result was consistent with the CLS data and
with the observation that aggregation continued after the pool of monomers had been
depleted within the sensitivity of silver staining.
iii. Mechanism of aggregation determined by 2D-PAGE
To distinguish the sequential polymerization mechanism from multimeric polymerization
directly, two-dimensional nondenaturing gel electrophoresis was performed. The refolding
conditions were 100g/mL tailspike in 0.8M urea, 40mM phosphate buffer, pH 7.6, at
200C. A sample was taken 0.3min after dilution, combined with cold 3x sample buffer,
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and electrophoresed through a 9% acrylamide nondenaturing gel at 40C. The lane of
multimers on the gel was cut and incubated overnight between glass plates at room
temperature to promote aggregation of the multimers in the gel. The following day, the
lane of multimers was run in a second dimension on a nondenaturing gel, and the bands
were visualized by silver staining.
The 2-D gel showed a diagonal pattern of bands and a series of higher ordered
multimers above these species. If sequential polymerization was required for aggregation,
then only the monomers would self-associate. The 2-D gel showed that the monomers
associated to form higher aggregates, dimers formed tetramers, and trimer aggregates
formed hexamers (Fig. 5.4). Each multimer did not equilibrate with multimers of various
sizes but only formed higher ordered aggregates by self association. Since all of the
aggregation intermediates were competent for further aggregation, this was direct
experimental evidence that aggregation occurred by multimeric polymerization.
A similar 2D-PAGE experiment was performed to determine the reversibility of
aggregation. The refolding conditions were chosen to generate a large population of dimer
aggregation intermediates (100gjg/mL tailspike in 0.8M urea, 40mM phosphate buffer, pH
7.6, at 40C). A sample was taken 10min after dilution, combined with cold 3x sample
buffer, and electrophoresed through a 9% acrylamide nondenaturing gel at 40C. The lane
of folding and aggregation intermediates on the gel was cut and incubated overnight at 40C.
The low temperature presumably would favor the reverse reaction, or dissociation of
multimeric intermediates. Overnight incubation was necessary since both the forward and
reverse reactions were slowed down. As described previously, the gel strip was then
placed horizontally across a nondenaturing gel and electrophoresed in a second dimension.
The pattern on the 2-D gel was a diagonal series of well-defined dots corresponding
to a sequential set of folding and aggregation intermediate (Fig. 5.5). There was no
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Figure 5.4: 2D-Nondenaturing gel electrophoresis of aggregation intermediates
formed during in vitro refolding. The refolding conditions were 100ug/mL tailspike,
in 0.8Murea, 40mM sodium phosphate buffer, pH 7.6 at 20C for 0.3min. The
sample was immediately electrophoresed through a nondenaturing gel (9%
acrylamide) at 4C. After electrophoresis, the lane of aggregation intermediates was
incubated between glass plates overnight at room temperature to promote
aggregation within the gel. The following day, the multimers were run in a second
dimension on a nondenaturing gel (9% acrylamide). The control lanes are samples
of purified native tailspike and refolding samples incubated overnight at 20C and 4C.
To depict the alignment of the 2-D pattern, the horizontal gel strip is a duplicate lane
of refolding sample that was electrophoresed in the first dimension.
Native Aggregates20C 4C I -1
Y

Figure 5.5: 2D-Nondenaturing gel electrophoresis of aggregation intermediates
formed during in vitro refolding. The refolding conditions were 100ug/mL tailspike,
in 0.8Murea, 40mM sodium phosphate buffer, pH 7.6 at 4C for 10min. The sample
was immediately electrophoresed through a nondenaturing gel (9% acrylamide) at
4C. After electrophoresis, the lane of aggregation intermediates was incubated
between glass plates overnight on ice to test the reversibility of aggregation. The
following day, the multimers were run in a second dimension on a nondenaturing gel
(9% acrylamide). The control lanes are samples of purified native tailspike and
refolding samples incubated overnight at 4C and 20C. To depict the alignment of
the 2-D pattern, the horizontal gel strip is a duplicate lane of refolding sample that
was electrophoresed in the first dimension.
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evidence that the multimers were in equilibrium with each other nor that the reaction was
reversible. As seen previously, each aggregation intermediate did not equilibrate with
multimers of various sizes; the dimer did not appear to dissociate into monomers, and the
trimer aggregate did not equilibrate with monomers or dimers. If aggregation was
reversible or the multimers were in thermodynamic equilibrium, the dissociation reaction
was too slow to detect.
C. Discussion
In analyzing the polymerization mechanism of aggregation, research in the field of colloidal
chemistry provides a basis to characterize the multimerization of folding intermediates
(Sonntag & Strenge, 1987; DeYoung, Fink, & Dill, 1993). Traditional polymerization
models describe various aspects of the kinetics and thermodynamics of multimerization.
Thermodynamic models have the inherent assumption that the association reaction is
reversible and that the multimeric intermediates are in thermodynamic equilibrium with each
other. These models are not applicable in the irreversible formation of large insoluble
aggregates but may be relevant for the initial multimerization steps (Chen et al., 1995). The
biophysical forces involved in aggregation are often difficult to quantify without having
detailed structural information of the folding intermediates that are susceptible to
aggregation.
i. Polymerization mechanism
A fundamental question in the polymerization of folding intermediates is the physical
mechanism of aggregation. Two possible models to describe the multimerization process
include, 1) sequential particle-cluster polymerization, in which monomeric units add
individually to a growing chain, or 2) multimeric cluster-cluster polymerization, in which
multimers of any size associate rather than sequential addition of monomeric units to a
growing aggregate (Fig. 5.6). Most nucleation-growth processes occur by sequential
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Figure 5.6: Models to depict the polymerization mechanism of aggregation.
SEQUENTIAL POLYMERIZATION:11S 4%1 i r l ddii -F
equenta a ton 
o monomers
K Kn
.9 -
MULTIMERIC POLYMERIZATION:
Growth of aggregate by association of multimers rather than a sequential addition of
monomers
n1
K_ K
m
KpP
146
Kd  K
ed n-
polymerization in which an unfavorable nucleation of monomers to form the critical
aggregate size is followed by a rapid growth in the aggregate. However, condensation is a
multimeric polymerization process with kinetics similar to the nucleation-growth model.
Once initial multimeric complexes form, these structures offer potential sites for the
addition of monomers or other small multimers, resulting in an apparent acceleration in the
rate of association.
The data indicate that aggregation occurs by multimeric polymerization, in which
two multimers of any size can associate to form a larger aggregate and does not require a
sequential addition of monomeric subunits. The aggregation mechanism of multimeric
polymerization was independently confirmed by several methods. First, analysis of both
classical light scattering and gel densitometry data were consistent with the multimeric
polymerization model and not the sequential mechanism. In addition, examination of the
distribution of multimeric intermediates isolated by nondenaturing gel electrophoresis over
the course of aggregation revealed that the aggregation reaction could continue after the
population of monomers had been depleted. Also, data obtained by 2D-PAGE proved that
two dimers can combine to form a tetramer and trimer aggregates can associate to form
hexamers. The cluster-cluster polymerization mechanism of aggregation is an important
determinant in the kinetics of inclusion body formation.
ii. Aggregation offolding intermediates
On the 2-D nondenaturing gel, all of the aggregation intermediates were competent for
further multimerization. However, the native trimer did not aggregate. The native tailspike
trimer is a thermostable species which is resistant to aggregation. Aggregation occurred by
the association of thermolabile folding and aggregation intermediates and not the native
state (King et al., 1996).
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The monomers that were isolated in the first dimension of the gel formed
aggregation intermediates but not native trimer in the second dimension. The monomeric
folding intermediates trapped in the gel may not have formed native trimer because the
incubation conditions were not being conducive for folding. Another possibility is that the
monomer isolated by PAGE was actually the first aggregation intermediate not competent
for productive folding. Previous studies have indicated that an off-pathway species, I*, is
in equilibrium with a monomeric productive folding intermediate (Mitraki et al., 1993). A
monomeric aggregation intermediate (I*) may have an incorrect intramolecular |3-helix
conformation with misalignment of the f3-sheet contacts.
Compared to aggregation in solution, the aggregation reaction occurring within the
gel appeared to be slower than in standard solution conditions. The network of acrylamide
fibers caused limited diffusivity of macromolecules within the gel matrix, and this effect
could have reduced the polymerization rate. This phenomenon may aid in the isolation of
aggregation intermediates that are normally transient in solution but are kinetically trapped
when electrophoresed through a nondenaturing gel in the cold.
iii. Irreversibility of aggregation
The apparent lack of reversibility in aggregation indicated that the aggregation intermediates
were not in rapid equilibrium with each other. Aggregation was essentially an irreversible
event in which kinetics of polymerization influenced the extent of aggregation. The kinetic
competition between productive folding and aggregation controls this balance rather than
the thermodynamic stability of the native state or thermodynamic equilibrium amongst off-
pathway aggregation intermediates.
Although aggregation was essentially irreversible and dimer aggregates were not in
equilibrium with the productive monomers, the question of whether two dimers can
combine to form a tetramer aggregate is still relevant. The mechanism of aggregation
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influences the folding pathway and affects the yield of native protein. Aggregation via
multimeric polymerization depletes the supply of productive monomers slower than
sequential polymerization. The ability of small aggregates to combine to form larger ones
reduces the concentration of aggregates that may associate with the remaining productive
folding intermediates. In addition, if one is purifying protein from the aggregated inclusion
body state, then the mechanism of aggregation influences the size and kinetics of inclusion
body formation.
Although multimeric polymerization allows various combinations of multimeric
precursors to associate, this does not imply a lack of specificity. Inclusion bodies have
been found to be relatively pure and not contaminated with cellular proteins (Marston,
1986). Numerous temperature-sensitive folding mutants of the tailspike protein cause
aggregation to occur by a single amino acid change, indicating specificity of aggregation.
In addition, mixed aggregation studies also indicate that two different proteins are not
susceptible to forming heterogeneous coaggregates during in vitro refolding, as discussed
in Chapter 6.
The polymerization mechanism of aggregation has implications on the methodology
of in vitro protein refolding. Aggregation via a multimeric polymerization mechanism
influences reactor design for the refolding process. To keep the concentration of partially
folded polypeptide chains low and reduce intermolecular collisions, typically a batch reactor
is more appropriate than a plug flow reactor (Denbigh, 1951), or immobilization of
refolding polypeptide chains onto a solid support can further improve refolding yields
(DeBernardez-Clark & Georgiou, 1991). Since the native protein generally does not
aggregate, a series of step-wise dilutions of the denatured protein into the refolding solution
can be performed in a fed-batch reactor, keeping the concentration of folding intermediates
below the threshold of the aggregation regime (Rudolph & Fischer, 1987).
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CHAPTER 6: SPECIFIC AGGREGATION OF PARTIALLY FOLDED
POLYPEPTIDE CHAINS
The misfolding and aggregation of polypeptide chains into inclusion bodies in prokaryotes
is a serious problem in the biotechnology industry and in biomedical research (Marston,
1986; DeBernardez-Clark & Georgiou, 1991; Wetzel, 1994). The formation of amyloid
deposits in various human diseases may be a closely related phenomenon (Benson &
Wallace, 1989; Thomas et al., 1995). During in vitro refolding of proteins, the aggregation
reaction that competes with productive refolding reflects a similar off-pathway association
reaction of folding intermediates (Mitraki & King, 1989). Such aggregation reactions have
often been regarded as nonspecific coagulation of incompletely folded polypeptide chains to
form an insoluble, disordered precipitate (Zettlmeissl et al., 1979). However, various
observations suggest that aggregation of partially folded chains proceeds through specific
interactions. In fact, for many pharmaceutically important proteins, such as insulin and
human growth hormone, isolation of the inclusion bodies is the most efficient initial step in
the purification process, followed by refolding in vitro (Cleland, 1993).
Numerous studies have identified specific aggregation sites involved in the
association of folding intermediates for various proteins. For bovine growth hormone,
peptide fragments of a discrete region of the polypeptide chain influence in vitro
aggregation (Brems et al., 1988; Lehrman et al., 1991). Studies of the aggregation of
phosphoglycerate kinase during refolding identified specific intermolecular associations that
occurred between defined domains of partially folded intermediates (Mitraki et al., 1987). .
Single amino acid substitutions of the temperature sensitive folding class inhibit the
aggregation of P22 tailspike folding intermediates in vivo and in vitro (Mitraki et al., 1991;
Mitraki et al., 1993), and likewise several temperature-sensitive folding mutations of
interleukin-j increase inclusion body formation (Wetzel et al., 1991). In both cases, the
change in overall hydrophobicity due to point mutations is too insignificant to account for
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the pronounced difference in extent of aggregation. These mutations may indicate specific
aggregation sites or hydrophobic patches that are involved in the association reaction.
The mechanism by which certain additives interact with partially folded
intermediates seems to be protein-specific. The cosolvent polyethylene glycol (PEG) of
molecular weight 1000 to 8000Da inhibits carbonic anhydrase II aggregation by binding to
the hydrophobic site on the first folding intermediate (Cleland & Wang, 1990a; Cleland &
Randolph, 1992). PEG binding to that site prevents dimerization by inducing changes in
the surface characteristics of the folding intermediate. The binding of PEG to aggregation
sites of CAB is a specific interaction which does not occur for many other proteins.
Similarly, the ability of some molecular chaperones to rescue certain polypeptide chains but
not others may represent a related in vivo specificity in the recognition of precursors in the
aggregation pathway (Tian et al., 1995).
Investigations of refolding reactions in which mixtures of polypeptide chains are
aggregating yield conflicting reports on the specificity of aggregation. Aggregation
experiments of turkey and hen lysozyme and BSA suggested that aggregation occurred by a
nonspecific association of an early folding intermediate, as measured by the effect on the
final yield of lysozyme enzymatic activity (Goldberg et al., 1991). However,
tryptophanase renaturation in the presence of BSA or crude cell extract indicated specificity
in aggregation, as determined by the recovery of enzymatic activity of tryptophanase
(London et al., 1974). Studies on the effect of urea on apomyoglobin aggregation
indicated that aggregation can either proceed via nonspecific association of "denatured"
polypeptide chains or by the association of partially folded intermediates with specificity,
depending on the refolding conditions (De Young, Dill, & Fink, 1993). In the aggregation
of j3-amyloid peptide (Jarrett et al., 1993), prion protein (Kocisko et al., 1995),
transthyretin (Saraiva et al., 1984), and islet amyloid polypeptide (Charg et al., 1995), the
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formation of amyloid fibrils was protein specific and was not seeded by pre-formed
aggregates of similar amyloidogenic proteins.
It has been difficult to determine for populations of large insoluble aggregates
whether each particle is composed predominantly of one particular protein species or of
heterogeneous species. For a mixture of aggregating polypeptide chains, the subunits of
each aggregate particle in the solid precipitated state may be composed predominantly of
one particular protein or a mixture of different proteins. This difficulty in determining the
specificity of aggregation has been circumvented by characterizing the early soluble
multimeric intermediates prior to the aggregate growing too large to remain in solution
(Speed et al., 1995). These species have been identified for the P22 tailspike and coat
proteins whose folding and aggregation pathways have been characterized both in vivo and
in vitro (Speed et al., 1995; Teschke & King, 1995). Using nondenaturing gel
electrophoresis to isolate the soluble aggregates, the constituent polypeptide chains of each
multimer complex could then be identified by Western blotting with specific antibodies.
P22 tailspike and coat proteins
The folding and aggregation intermediates of the tailspike protein of phage P22 have been
extensively studied both in vitro and in vivo (Goldenberg & King, 1981; Mitraki et al.,
1993; Haase-Pettingell & King, 1988). The P22 tailspike endorhamnosidase is a
thermostable trimer which is resistant to SDS and protease, whereas the folding
intermediates are sensitive. The main body of each of the 72kDa monomeric subunits
within the native trimer has a [-helix structure, in which the [-sheet contacts are between
each successive rung of the helix (Steinbacher et al., 1994). During refolding, a
monomeric folding intermediate can either undergo productive folding or associate
incorrectly to form multimeric intermediates, which lead to the formation of large insoluble
aggregates, as outlined in Chapter 2 (Fig. 6.1a). This folding intermediate is thermolabile,
and therefore the partitioning between productive and aggregation pathways is sensitive to
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Figure 6.1: a) In vitro refolding and aggregation pathway for P22 tailspike protein.
Unfolded polypeptide chains (U), partially folded intermediate (I), protrimer intermediate
(Ipt), protrimer species (pt), and the native trimer (N). Along the aggregation pathway are
the off-pathway intermediate (I*) and multimeric aggregation intermediates which form large
insoluble aggregates. b) In vitro refolding, assembly, and aggregation pathway P22 coat
protein. Unfolded polypeptide chains (U), partially folded intermediates (I1 and I), and
folded monomer (N). The folding intermediates are susceptible to off-pathway
polymerization reactions forming kinetically-trapped stable multimers or multimeric
aggregation intermediates leading to large insoluble aggregates.
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AND AGGREGATION
temperature (Mitraki et al., 1993; King et al., 1996). Monoclonal antibodies have been
isolated against the tailspike which discriminate between partially folded intermediates and
the native state (Friguet et al., 1990).
The P22 coat protein is required for the assembly of the phage P22 heads, and the
folding, aggregation, and assembly of coat protein has been studied both in vivo and in
vitro (Teschke & King, 1993; Teschke & King, 1995). During in vitro refolding of the
P22 coat protein, unfolded polypeptide chains rapidly form a kinetic intermediate followed
by a second partially folded intermediate (Fig. 6.1b). The 55kDa folded monomer is then
competent for assembly into the viral capsid structure composed of 420 subunits arranged
in an icosohedral geometry. At higher temperatures both in vivo and in vitro, folding
intermediates associate off-pathway to an aggregated inclusion body state (Teschke &
King, 1993; Teschke & King, 1995). The coat protein has a second misfolded state in
which the chains get kinetically trapped as stable dimers and trimers which are unable to
polymerize into closed shells (Teschke & King, 1995). Minor changes in the balance
between productive folding and assembly versus aggregation or multimerization can have
significant effects on the kinetics and distribution of folding and aggregation intermediates.
A. Materials and methods
i. Materials
P22 tailspike protein was produced and purified as described in Chapter 3 (King & Yu,
1986; Fuchs et al., 1991). All tailspike protein used for these experiments was from the
same preparation of protein stored as an ammonium sulfate precipitate, which was dialyzed
against Tris buffer. The P22 coat protein was produced and purified as described by
Teschke & King, 1993. For the Western blot, the polyclonal antibodies against the P22
coat protein were produced and purified, and the antibodies were biotinylated to react with
avidin in the Western blot (CM Teschke, 1993). The tailspike monoclonal antibodies were
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derived using native tailspike as the antigen and screening by ELISA for reactivity against
native tailspike and thermally denatured tailspike polypeptide chains (Friguet et al., 1990).
ii. In vitro refolding and aggregation
For mixed refolding reactions, the denaturation and aggregation conditions for the P22
tailspike protein were identical to those of the P22 coat protein. Denaturation conditions
were 5M urea, 40mM sodium phosphate buffer (pH 3) for >lhr at room temperature. P22
tailspike and coat chains were refolded at 100lg/mL, 250C or 300C, 0.6M urea in 40mM
sodium phosphate buffer (pH 7.6). Samples were taken 1 min and 5 min after dilution and
combined with 3x sample buffer (0.015M Tris, 0.12M glycine, 3mM DTT, 30% glycerol,
bromophenol blue) in an ice-water bath. Native purified tailspike served as a control. To
obtain native coat monomer, denatured coat protein was renatured under productive
refolding conditions of 50pg/mL, 40C, 0.0625M urea in 40mM sodium phosphate buffer
(pH 7.6) for 1hr.
For the samples shown in Fig. 6.2, the coat protein was denatured in 6.75M urea,
pH 7.6, for >lhr at room temperature, and refolding was performed at 100lpg/mL, 300C,
0.4M urea in 40mM sodium phosphate buffer, pH 7.6, for 0.3 min. P22 tailspike
denaturation was similar to the protocol described above, and refolding was performed at
100gg/mL protein, 200C, and 0.8M urea in 40mM sodium phosphate buffer, pH 7.6, for
15min. Bands were visualized by silver staining, as described by Sather & King (1994).
iii. Nondenaturing gel electrophoresis
Nondenaturing gel electrophoresis with a discontinuous buffer system was performed as
described (Andrews, 1986; Speed et al., 1995). For the mixed refolding experiment, 30jgL
of each refolding and aggregating sample was loaded in triplicate onto 9% acrylamide
nondenaturing gels and electrophoresed at a constant current (10mA/gel) for 4hrs at 40C.
The gels were cut into 3 sections for 2 Western blots using either anti-tailspike or anti-coat
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antibodies, and the remaining section was silver stained as described (Sather & King,
1994).
iv. Western blotting
The procedure for Western blotting involved transferring the protein from the gels to an
Immobilon-P PVDF membrane in a tris-glycine buffer (20% methanol, 0.1% SDS) with a
constant current of 100mA overnight. The membrane was then soaked in a tris buffered
saline solution containing 10% powdered milk as a blocking agent (TBS-PM), followed by
incubation in a solution of primary antibodies for 1.5 hrs. The coat antibodies were biotin-
labeled polyclonal rabbit antibodies, and the tailspike antibodies were a mixture of mouse
monoclonal antibodies (0.4gg/mL) against the native and nonnative forms of the tailspike
(Friguet et al., 1990). The membrane was washed 3xl0min with TBS with 5% powdered
milk and Tween 20 (TBS-PM-20). Then, the membrane was incubated for 2 hrs with the
secondary antibody labeled with horseradish peroxidase. The secondary antibody was a
peroxidase-labeled goat anti-mouse IgG for the tailspike protein (Amersham, 1:5000
dilution into TBS-PM) and biotinylated peroxidase enzyme complexed with avidin for the
coat protein (ABC Vectastain kit). The membrane was washed again with TBS-PM-20,
and the anti-peroxidase solutions of the Amersham enhanced chemiluminescence kit were
applied to the membrane. X-ray film was placed on the membrane for exposure times
ranging from 5sec to 20min. An X-OMAT machine was used to develop the film.
B. Results
To examine the interaction between aggregation intermediates of P22 tailspike and coat
polypeptide chains, renaturation conditions were chosen such that aggregation was
competing with productive refolding. Before performing mixed aggregation reactions of
the P22 coat and tailspike proteins, the aggregation intermediates of these two proteins
were characterized individually.
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i. Characterization offolding and aggregation intermediates
The purified native tailspike protein used for these experiments represented a predominant
single band on a nondenaturing gel, as shown in Figure 6.2a. For the refolding
experiments, a sample of native tailspike protein was denatured in 5M urea, pH 3, for
>45min at room temperature. Refolding was initiated by 20x dilution to final refolding
conditions of 100lpg/mL protein, 0.8M urea in 40mM sodium phosphate buffer, pH 7.6, at
200C. Samples were withdrawn after refolding for 15min and mixed with chilled sampled
buffer on ice. The amount of sample loaded in each lane was 1.3jig protein, and the
samples were electrophoresed through a 9% acrylamide nondenaturing gel for 4hr at 40C.
The protein bands were visualized by silver staining.
Under these refolding conditions, both productive folding intermediates
(Goldenberg & King, 1982) and aggregation intermediates (Speed et al., 1995) of the
tailspike polypeptide chain were resolved by nondenaturing gel electrophoresis, as can be
seen in Figure 6.2b. A fraction of the denatured chains refolded to the native trimer, which
migrated slightly slower than the dimer aggregate. The protrimer folding intermediate
migrated to a position just above the trimer aggregate, forming an apparent trailing edge
(Goldenberg et al., 1983). The sequential set of multimers represented aggregation
intermediates previously identified on the pathway to the aggregated inclusion body state,
as discussed in Chapter 2. The monomer, dimer, trimer, tetramer and pentamer species
were resolved in the gel shown in Figure 6.2. These aggregation intermediates were
sensitive to SDS, thermolabile, and protease sensitive, clearly distinguishing them from the
native trimer (Speed et al., 1995).
For the P22 coat refolding experiments, purified coat protein, in the form of
polymerized procapsid shells, was denatured in urea. In vitro refolding was initiated by
dilution to 50gig/mL, 0.0625M urea, in 40mM sodium phosphate buffer, pH 7.6, at 40C.
After lhr of refolding, the sample was electrophoresed through a nondenaturing gel, as
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Figure 6.2: Nondenaturing gel electrophoresis used to isolate multimers formed
during in vitro refolding and aggregation, a) Purified native P22 tailspike protein
(0.3ug) b) P22 tailspike refolding at l00ug/mL protein, 20C, and 0.8M urea in
40mM sodium phosphate buffer, pH 7.6, for 15min. Denaturation conditions were
5M urea, pH 3, for >45min at room temperature. Refolding was performed by 20x
dilution as described in the Materials & Methods section. The amount of sample
loaded was 1.3ug protein, and samples were electrophoresed through a 9%
acrylamide nondenaturing gel for 4hr at 4C. Bands were visualized by silver
staining. c) P22 coat polypeptide chains refolded at 50ug/mL, 0.0625M urea in
40mM sodium phosphate buffer, pH 7.6, at 4C for 1hr (0.3ug loaded). d) P22
coat polypeptide chains aggregating at 100ug/mL, 0.4M urea in 40mM sodium
phosphate buffer, pH 7.6, at 30C for 0.3min (2ug loaded). Denaturation conditions
for the coat protein were 6.75M urea, pH 7.6, for >1 hr at room temperature.
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described previously. The single band in the refolding reaction represented the monomeric
native coat protein (Fig. 6.2c).
To study the off-pathway multimeric intermediates of coat chains, the protein
concentration and temperature of refolding were increased, and the residual urea
concentration was decreased. In vitro aggregation was initiated by dilution to 100gg/mL,
0.4M urea, in 40mM sodium phosphate buffer, pH 7.6, at 300C. A sample was
withdrawn at 0.3min and analyzed by nondenaturing gel electrophoresis. Similar to the
previous results, the predominant band in the refolding reaction was a monomer of coat
protein with greater electrophoretic mobility than the coat multimers or the tailspike
monomer (Fig. 6.2d). A set of coat multimers with lower electrophoretic mobility was
evident above the monomer band. In the in vitro refolding of coat protein, stable trapped
multimers were formed (Teschke & King 1995) in addition to the transient multimeric
species that were intermediates along the aggregation pathway. Both species were
probably represented in the multimers resolved.
Given the ability to separate aggregation intermediates for both P22 tailspike and
coat proteins, it was possible to test whether they aggregated with each other in refolding
mixtures.
ii. Mixed aggregation studies
For the mixed aggregation reactions, tailspike aggregation controls, and coat aggregation
controls, the coat and tailspike protein were denatured separately under identical conditions,
using 5M urea in 40mM sodium phosphate buffer, pH 3.0, at room temperature for >lhr.
The mixed in vitro refolding reactions were performed under conditions in which
aggregation intermediates were populated for both polypeptide chains, with each protein at
a concentration of 100lg/mL, in 0.6M urea, 40mM sodium phosphate buffer, pH 7.6, at
250C and 300C. Samples were taken at imin and 5min and placed in an ice-water bath.
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The controls were coat protein renatured at 40C for lhr in 40mM sodium phosphate buffer
containing 0.0625M urea, pH 7.6 and purified native tailspike (3jlg loaded).
Since the tailspike and coat polypeptide chains have very different lengths,
sequences, and conformations, mixed multimers would be expected to have different
electrophoretic mobilities from the coat/coat and tailspike/tailspike multimers. Therefore,
the gel patterns of the mixed aggregating reactions were examined for species with altered
mobility, using Western blotting with antibodies directed against the chains (Figure 6.3).
A mixture of monoclonals, recognizing both native and nonnative epitopes, was used to
identify complexes containing tailspike chains (Friguet et al., 1990).
Figure 6.4 and 6.5 shows the distributions of tailspike and coat aggregation
intermediates, as visualized by Western blotting using anti-coat polyclonal antibodies and
anti-tailspike monoclonal antibodies (Friguet et al., 1990). The native tailspike in lane 1
migrated as a single band recognized by the anti-tailspike antibodies (Fig. 6.4). No
significant antigenic reactivity was observed between the anti-tailspike antibodies and the
refolded coat protein (Nc) as can be seen in lanes 6 and 11 (Fig. 6.4).
Multimeric aggregation intermediates in the refolding reactions of the tailspike alone
(At) can be seen in lanes 2, 7, 12, and 16 (Fig. 6.4). In the refolding reactions at 250C and
300C, native tailspike was not yet present at 1 minute but began to accumulate by 5
minutes. Intermediates present in the refolding mixtures (At+c) were resolved in lanes 3,
8, 13, and 17. The tailspike aggregates displayed no shift in electrophoretic mobility for
the mixed aggregation samples (At+c) compared to the tailspike intermediates aggregating
alone (At). Thus it is unlikely that the tailspike chains in the mixture were complexed with
coat polypeptide chains. The coat alone species (Ac) cannot be observed in this panel since
they were not recognized by anti-tailspike antibodies.
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Figure 6.3: Protocol for mixed refolding experiment with P22 coat and tailspike proteins.
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Figure 6.4: Western blot of in vitro aggregation samples electrophoresed
through a nondenaturing gel and probed by tailspike monoclonal
antibodies. The samples in each lane are the following: Nt, native tailspike;
At, tailspike polypeptide chains aggregating at 100ug/mL, 20C, 0.6M urea in
40mM sodium phosphate buffer, pH 7.6; At+c, tailspike and coat protein
aggregating under the same conditions; Ac+Nt, coat protein aggregating at
100ug/mL, 20C, 0.6M urea in 40mM sodium phosphate buffer, pH 7.6 in the
presence of native tailspike at 100ug/mL; and Ac, coat protein aggregating
under the same conditions; Nc, coat protein refolding for 1hr at 50ug/mL, 4C,
0.0625M urea in 40mM sodium phosphate buffer, pH 7.6.
1 min, 25C 5 min, 25C 1 min, 30C 5 min, 30C
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Figure 6.5: Western blot of in vitro aggregation samples electrophoresed
through a nondenaturing gel and probed by coat polyclonal antibodies. The
samples in each lane are the following: Nt, native tailspike; At, tailspike
polypeptide chains aggregating at 100ug/mL, 20C, 0.6M urea in 40mM
sodium phosphate buffer, pH 7.6; At+c, tailspike and coat protein aggregating
under the same conditions; Ac+Nt, coat protein aggregating at 100ug/mL,
20C, 0.6M urea in 40mM sodium phosphate buffer, pH 7.6 in the presence of
native tailspike at 100ug/mL; and Ac, coat protein aggregating under the
same conditions; Nc, coat protein refolding for 1 hr at 50ug/mL, 4C,
0.0625M urea in 40mM sodium phosphate buffer, pH 7.6.
1 min, 25C 5 min, 25C 1 min, 30C 5 min, 30C
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Figure 6.5 shows the same samples but probed with anti-coat antibody. Lanes 6
and 11 show the predominant band of native coat monomer (Nc) detected by the antibody.
Lanes 1, 2, 7, 12, and 16 show the absence of cross reaction between the anti-coat
antibody and tailspike, for both native protein (Nt) and folding and aggregation
intermediates (At). Lanes 3-5, 8-10, 13-15, and 17-19 show the coat refolding
intermediates, both alone (Ac) and in the presence of equimolar tailspike polypeptide chains
(At+c and Ac+Nt). Similar patterns of multimeric intermediates were detected by the anti-
coat antibody whether the coat chains were aggregating alone or in the presence of the
tailspike. Thus the coat intermediates in the mixtures did not appear to be complexed with
tailspike chains.
In order to compare the electrophoretic mobility of the multimers containing
tailspike polypeptide chains versus coat chains, the lanes of the mixed aggregation samples
(At+c) from Fig. 6.4 and 6.5 were digitally copied and aligned (Fig. 6.6). In comparing
the mixed refolding lanes probed by either anti-tailspike antibodies (Abt) or anti-coat
antibodies (Abc), there was no heterogeneous coaggregate of coat and tailspike polypeptide
chains (Fig. 6.6). Since the monomeric coat protein electrophoresed faster than the
tailspike monomer, a heterogeneous dimer of coat and tailspike would probably have a
mobility between that of the tailspike monomer and the pure tailspike dimer (unless the
shape of the heterogeneous aggregate caused an anomalous mobility). No new band
appeared in the mixed aggregation lanes between the tailspike monomer and tailspike
dimer.
A heterogeneous aggregate should be visible by Western blotting with both anti-
tailspike and anti-coat antibodies, assuming that the epitopes are exposed. This assumption
is reasonable considering that the electrotransfer procedure was performed in a denaturing
solution. For the mixed aggregation lanes, no band matched in electrophoretic mobility
when probed by either the tailspike or coat antibodies. In fact, the electrophoretic mobility
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of the aggregation intermediates seemed to alternate between the coat and tailspike
multimers along the ladders. These results suggested that no heterogeneous coaggregate of
tailspike and coat polypeptide chains formed.
iii. Effects of polypeptide chain concentration
Although coaggregation of the coat and tailspike proteins was not occurring, there were
some changes in the kinetics of folding and aggregation of tailspike and coat chains. The
presence of each aggregating polypeptide chain increased the overall rates of both refolding
and self-association. As a result, in the mixed aggregation samples (At+c), less protein
entered the gel because some of the higher order aggregates were caught in the stacking gel.
In increasing both folding and aggregation rates, the relative balance between these two
competing reactions was also affected. In fact, the presence of coat chains actually
increased the yield of refolded native tailspike protein at 250C (lanes 7-8). For the coat
chains, the presence of tailspike polypeptide chains resulted in increased coat aggregation.
If this were due to coaggregation, then the yield of native tailspike protein would have
decreased. However, at 300C, less tailspike refolded correctly, presumably because the
coat protein increased the tailspike aggregation rate more than the refolding rate at the
higher temperature (lanes 16-17, Fig. 6.4).
For tailspike polypeptide chains aggregating alone, kinetics studies have shown that
the broad monomer band representing a series of monomeric folding and aggregation
conformers becomes narrow as the refolding and aggregation reactions proceed, as
discussed in Chapter 3. Comparing the tailspike aggregation intermediates formed with or
without the presence of coat protein, the tailspike monomer intermediate band in the mixed
aggregation solution (At+c) was not as broad as in the lane of tailspike aggregating alone
(At), such as in lanes 2 and 3 (Fig. 6.4).
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Figure 6.6: Western blot of mixed aggregation reactions of tailspike and coat
protein electrophoresed through a nondenaturing gel and probed by either
tailspike monoclonal antibodies (Ab t) or coat polyclonal antibodies (Ab c).
The lanes were digitally copied from the nondenaturing gels of Fig 6.4 and Fig
6.5 and aligned for visual comparison of electrophoretic mobility. The sample
loaded into each lane was At+c, tailspike and coat polypeptide chains
aggregating at 100ug/mL, 20C, 0.6M urea in 40mM sodium phosphate buffer,
pH 7.6.
At+c at 25C At+c at 30C
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When refolded in the presence of tailspike, the smallest coat multimers displayed an
electrophoretic mobility shift (e.g. lanes 8-9, Fig. 6.5). The P22 coat chains undergo
another off-pathway association reaction forming kinetically-trapped multimeric
intermediates which do not generate higher ordered aggregates, unlike most aggregation
intermediates (Teschke & King, 1995). The particular kinetically-trapped multimer that
was populated in the sample of coat aggregating alone had an electrophoretic mobility
similar to that of the native tailspike trimer (lanes 9 and 18, Fig. 6.5). The decrease in this
intermediate in the mixed aggregation sample was probably due to the increase in coat
aggregation kinetics. The presence of tailspike polypeptide chains in the refolding solution
resulted in less coat protein forming the kinetically-trapped multimers and more coat protein
aggregating by self-association rather than by coaggregation with tailspike.
One explanation of the effect of polypeptide chain concentration is that the chains
were sensitive to macromolecular crowding, and the presence of additional chains forced
the polypeptide chains to occupy a smaller volume, driving folding and aggregation. To
test the macromolecular crowding model, denatured coat chains were refolded in the
presence of native tailspike protein. As seen in Fig. 6.5, native tailspike did not affect the
refolding and aggregation of the coat protein (Ac+Nt vs. Ac). Either macromolecular
crowding was not a significant factor in driving the folding and aggregation reactions, or
the addition of native tailspike was not an effective test of this phenomenon. Partially
folded polypeptide chains order water molecules around themselves differently than their
native state (Dill, 1990), and free tailspike chains may have more macromolecular crowding
potential than compact rod-shaped native tailspike at a three-fold lower molar concentration.
An alternative possibility is that the kinetic effects of doubling the chain concentration in the
refolding mixtures are due to transient interactions between molten globule intermediates
populated in the first milliseconds of the refolding reaction. Native tailspike protein was
not incorporated into the aggregating coat protein, which confirmed that aggregation
occurred by the association of folding intermediates and not native protein.
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C. Discussion
More than 1,800 species of endogenous proteins are synthesized and folded in E.coli cells
growing exponentially (Neidhardt, 1987). Although recombinant proteins often
accumulate to high levels in the inclusion body state, the fraction of ribosomes synthesizing
the recombinant chains is always much less than those synthesizing endogenous protein
chains. The recovery of inclusion bodies containing recombinant chains of more than 75%
purity implies selective association of recombinant folding intermediates relative to
association with endogenous chains (Marston, 1986). The relative purity of inclusion
bodies may be due to the kinetics of formation of certain folding intermediates susceptible
to association, the lack of cellular factors and chaperones to fold foreign protein, or the
existence of specific interactions among the associating folding intermediates.
The refolding experiments involving the P22 tailspike and coat polypeptide chains
examined the ability of each polypeptide chain within a refolding mixture to self-associate
independently rather than form heterogeneous complexes (Fig. 6.7). If aggregation
occurred via nonspecific association of hydrophobic patches on folding intermediates, two
different polypeptide chains would coaggregate through multiple contacts. With specificity
in the association process, heterogeneous coaggregates could form through interactions
involving certain structural moieties interacting in a defined manner, such as helix-helix
docking (Brems et al., 1986; Chen et al., 1995). In the most restrictive case of specificity,
each partially folded polypeptide chain only undergoes self-association.
The mixed aggregation experiments showed that tailspike folding intermediates did
not coaggregate with the coat intermediates. The folding intermediates for each protein
preferred to self-associate, suggesting specificity in aggregation. The ladders of
aggregation intermediates that formed in the mixed refolding samples were remarkably
similar to the controls rather than a smear of various combinations of heterogeneous
coaggregates. The largest effect was on the relative balance of the refolding, aggregation,
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Figure 6.7: Models for aggregation specificity
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and assembly kinetics. The presence of the other proteins in the refolding solution
increased the kinetics of folding and aggregation for each protein.
Another indication of the specificity of aggregation is the effect of point mutations
on the association of folding intermediates. The mechanism by which mutations often act
is by altering the kinetic competition between productive folding and aggregation rather
than affecting the thermodynamic stability of the native protein (Mitraki et al., 1991). The
mutations may alter the kinetics by changing the stability of either the critical folding
intermediates at the junction between folding and aggregation or the first multimeric
intermediate on the aggregation pathway (Mitraki et al., 1993; Wetzel, 1994).
i. Mechanism of aggregation
During in vitro refolding, initial dilution out of denaturant causes an immediate
hydrophobic collapse of the polypeptide chain (Kim & Baldwin, 1990). According to the
molten globule hypothesis, the chain then undergoes a conformational rearrangement to
form a globular intermediate with native-like secondary structure and fluctuating tertiary
structure (Ptitsyn et al., 1990; Kuwajima et al., 1985). During the series of structural
rearrangements, the folding intermediates may have exposed hydrophobic patches on their
surface which make the polypeptide chains susceptible to self-association. In fact, at the
earliest times after dilution, multimeric aggregates are already present. These rapidly
formed species may represent aggregates of the initial collapsed state or molten globule
state. However, the absence of coaggregates in the mixed reactions argues for specificity
even in this initial reaction.
Although no heterogeneous coaggregates were observed for the P22 coat and
tailspike proteins, the result does not rule out the possibility of coaggregation of proteins in
general. The proteins in the mixed aggregation experiment may only form coaggregates if
they self-associate by similar mechanisms, such as helix-helix docking versus cross-3-
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sheet formation. If the tailspike polypeptide chains associate by a 1-sheet mechanism and
the coat by helix docking, then coaggregation of the tailspike and coat proteins may not
occur. Since the mechanism of aggregation is unknown for most proteins, it is difficult to
properly match the aggregation modes for the proteins in the study.
Although the mechanism of aggregation of coat polypeptide chains is unknown, the
tailspike chains probably associate by 1-sheet interactions. This hypothesis is based on the
high degree of 1-sheet structure within the tailspike and the proposed mechanism of the
temperature-sensitive folding mutations disrupting the formation of the 13-helix motif,
resulting in an intermolecular cross-p3-sheet structure or misalignment of the 13-helix
interfaces. Therefore, one would not expect the tailspike to coaggregate with bovine
growth hormone, which aggregates by a helix-helix docking mechanism (Brems et al.,
1988). Perhaps a more appropriate test of aggregation specificity would be to determine
whether the tailspike coaggregates with 13-amyloid peptide, which forms fibrils having a
cross 1-sheet structure.
ii. Oligomeric proteins
Unlike globular monomeric proteins, oligomeric proteins must self-assemble within cells to
form an active multisubunit complex while avoiding aggregation. The P22 tailspike protein
is a trimer in its native state, and the monomeric coat protein is designed to assemble into
viral procapsid complexes of approximately 420 subunits. In vivo and in vitro studies of
the assembly of oligomeric proteins determined that these proteins have a higher affinity for
themselves than for other proteins (Jaenicke & Rudolph, 1986). However, all proteins,
whether monomeric or oligomeric, in theory have evolved to avoid aggregation with
themselves or any other proteins encountered in vivo. In testing coaggregation properties,
the conditions are presumably beyond the normal range of the cellular environment
allowing either self-aggregation or mixed-associations to occur. Perhaps proteins that
naturally encounter each other in the cell have evolved to avoid coaggregating, including the
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P22 tailspike and coat proteins. Additional experiments could determine the specificity of
in vivo aggregation by testing if these two proteins form separate inclusion bodies.
iii. Kinetic factors
The kinetics of forming the critical folding intermediates susceptible to aggregation must be
relatively similar for the proteins to form heterogeneous coaggregates. If one protein folds
or aggregates much faster than the other, then it effectively excludes the other from being
incorporated into a coaggregate complex. The key factor that determines the likelihood of
coaggregation is the half-life of the critical folding intermediates that are susceptible to
aggregation. Formation of the partially folded species susceptible to aggregation occurs at
a rate of approximately 3x10-3 s- 1 for P22 coat chains (Teschke & King, 1995) and 4x10 -3
s- 1 for tailspike chains (Danner & Seckler, 1993). In general, this parameter is difficult to
control and to match for two proteins within a mixed aggregation experiment. Perhaps
differences in the mechanism and kinetics of aggregation for proteins examined in previous
studies are the cause of the discrepancies in aggregation specificity reported in the literature.
This kinetic factor is only pertinent for in vitro coaggregation, where all the
polypeptide chains begin refolding simultaneously upon dilution out of denaturant. For in
vivo folding, protein folding is a continuous process which begins as nascent polypeptide
chains come off the ribosome, and these chains may presumably aggregate with any
partially folded intermediates they encounter in the cell.
In addition, if more than one folding intermediate on a given pathway has the ability
to aggregate, then the propensity for coaggregation may change as refolding proceeds. The
first intermediate that forms after an initial hydrophobic collapse may be very susceptible to
coaggregation if it contains very little defined secondary structure. These early folding
intermediates would have the degree of freedom to form energetically favorable
intermolecular bonds rather than the correct native intramolecular interactions. As refolding
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continues, later folding intermediates with native-like secondary structure would probably
be less likely to coaggregate nonspecifically. In addition, the yield of correctly refolded
protein may significantly drop if refolding occurs in the presence of another protein that
more readily aggregates and seeds the coaggregation reaction with pre-formed aggregation
intermediates. Therefore, the ability for a protein to coaggregate may be a multiphasic
phenomenon that depends on the structure of the intermediates and ability to form
heterogeneous nucleation sites on initial multimeric intermediates.
iv. Specificity of macromolecular interactions
Determining whether a given protein forms a heterogeneous coaggregate with another
protein tests the global specificity of aggregation. These mixed aggregation experiments
determine the overall promiscuity and not the local specificity of protein aggregation. The
degree to which the amino acids and secondary structure involved in the intermolecular
contacts are conserved in the aggregates is a measure of the local specificity. It is possible
for a protein to self-associate via heterogeneous local interactions. Likewise, two proteins
may coaggregate without global specificity and form conserved contacts with local
specificity. To examine local specificity of aggregation, detailed structural information is
required, such as solid-state NMR (Sun et al., 1995). The local structure involved in
aggregation do not necessarily have to be nonnative but may occur by a misalignment of
nativelike structures or intermolecular domain swapping, analogous to the native
intramolecular interactions (Bennett et al., 1994).
Within both prokaryotic and eukaryotic cells, molecular chaperonins assist
polypeptide chain folding reactions. The GroEL/Hsp60 class of chaperonins recognize
folding intermediates destined for aggregation and assist the intermediate past the junction
to the next stage in the productive pathway. Both coat and tailspike folding intermediates
are recognized by the GroEL chaperonin, though only the coat chains can be productively
chaperoned (Gordon et al., 1994; Brunschier et al., 1993). Such thermolabile folding
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intermediates are likely to be a general class of substrates of the heat shock chaperonins
(King et al., 1996). Although the chaperonins can rescue many species of proteins, a
significant number of proteins are not recognized. The same features which allow folding
intermediates to discriminate between each other may also be the features that permit
chaperonins to distinguish between classes of folding intermediates.
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CHAPTER 7: SUMMARY AND CONCLUSIONS
This research work has identified a set of multimeric intermediates on the pathway to the
aggregated inclusion body state. The ability to isolate and characterize multimeric
intermediates indicates that the polymerization reaction occurs by a defined pathway. These
aggregation intermediates displayed nonnative biophysical properties and structural
epitopes in common with early productive folding intermediates from which they formed.
i. Mechanism of aggregation
The mechanism of aggregation was proven to occur by a multimeric cluster-cluster
polymerization mechanism. This condensation-like mechanism of polymerization is critical
in determining the kinetics of inclusion body formation. To recover the majority of
polypeptide chains in the aggregated inclusion body state from the cells, the aggregation
reaction must not become limited by the amount of available monomeric polypeptide
chains, which would become depleted rapidly with a sequential polymerization mechanism.
In addition, during in vitro or in vivo folding, the ability of aggregation intermediates to
self-associate lowers the effective molar concentration of aggregates. The lower
concentration of aggregates reduces the rate at which these aggregates associate with other
productive folding intermediates, thereby increasing the yield of native protein.
The lack of a rapid equilibrium amongst the aggregation intermediates suggests that
aggregation is essentially irreversible. The irreversibility of aggregation reiterates the point
that the junctional folding intermediate is the critical intermediate where one the relative
balance between productive folding and aggregation can be influenced. The stability of the
native tailspike protein is not an important factor in aggregation since the thermolabile
folding intermediates aggregate rather than the native protein (King et al., 1996).
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Intermolecular association of partially folded intermediates occurs with specificity,
as shown in the mixed refolding experiments discussed in Chapter 6. If aggregation were a
nonspecific coagulation process, the only means of control would be to lower the refolding
temperature or growth temperature (Schein & Noteborn, 1988) or dilute to a concentration
of monomeric subunits below the critical aggregation concentration (Jarrett et al., 1993).
Because folding and aggregation have inherent specificity, the implication is that the
balance between productive folding and aggregation can be controlled strategically. Direct
intervention to affect the rate of folding and/or aggregation can be done by changing the
environment in which the polypeptide chains fold. This can be accomplished by the
methods discussed in Chapter 2 (Section F), including site directed mutagenesis, cosolvent
addition, utilization of molecular chaperones, or foldases. These cofactors can inhibit
aggregation by binding to potential aggregation sites, increasing the rate of productive
folding, or affecting the stability of critical folding and aggregation intermediates.
Another implication of the specificity of aggregation is that refolding can be
performed with the crude cell lysate without much problem with coaggregation (London et
al., 1974). The presence of the folding intermediates of other cellular proteins does not
necessarily result in heterogeneous coaggregation. The total protein concentration is not as
critical a factor as the concentration of the particular folding intermediates susceptible to
self-association.
ii. Structural implications on folding and aggregation
The P22 tailspike protein serves as a useful model for understanding protein folding,
inclusion body formation, and in vitro aggregation. The 3-helix structure of the tailspike is
a newly discovered folding motif that is relevant for various cell membrane enzymes (Raetz
& Roderick,1995), pollen allergens (Yoder et al., 1993), and possibly amyloidosis (Kelly
& Lansbury, 1994). The structural data on the aggregation intermediates discussed in
Chapter 4 suggest that the [-helix plays a critical role in aggregation of tailspike
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polypeptide chains. It is reasonable to assume that for structurally related f-sheet proteins,
such as P-amyloid, the local secondary structure of the aggregates may resemble the 3-
helix.
Mapping the nativelike and nonnative epitopes of the folding and aggregation
intermediates has revealed structural and mechanistic information. The ability of the anti-
native and anti-nonnative tailspike antibodies to recognize the protrimer folding intermediate
indicates that the protrimer contains the nativelike f-helix body and the partially folded
nonnative N-terminus. This suggests that folding of the tailspike trimer begins at the C-
terminus. The wrapping of the 3 polypeptide chains to form an intermolecular f-sheet at
the C-terminus could align the chains for sequential zipping of the P-helix contact. The
cysteine residues at the C-terminus may be involved in intermolecular chain alignment in
trimerization (Sather & King, 1994; Robinson & King, manuscript in preparation).
Folding from the C-terminus to N-terminus is consistent with truncated tailspike chains
lacking the N-terminal region (residues 108-666) being thermostable trimers and the amber
fragments lacking the C-terminus remaining as monomeric polypeptide chains (Danner et
al., 1993; Friguet et al., 1990).
The nonnative epitopes recognized by the anti-intermediate tailspike antibodies were
displayed by both the productive folding and aggregation intermediates. In reviewing the
aggregate structural data of Chapter 4, the implication is that the productive folding
intermediates and off-pathway aggregates contain domains that structurally resemble the P-
helix motif. It is possible that a monomeric intrachain 3-helix forms along the productive
folding pathway, whereas interchain 3-helices link the subunits of the aggregation
intermediates. The promiscuous formation of interchain 3-helix contacts could form a
network of tailspike polypeptide chains (Fig. 7.1).
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Figure 7.1: Formation of tailspike aggregation intermediates containing the
|-helix motif.
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Structural models of aggregation involving the misfolding of the |-helix are
depicted in Fig. 7.2. A unimolecular misalignment of [-sheet contacts within a single
polypeptide chain could create hydrophobic patches, causing the folding intermediates to be
susceptible to aggregation. Temperature-sensitive mutations may slow down the correct
alignment and zipping up of the (-helix and affect aggregation kinetically by increasing the
half life of the critical folding intermediate (Bei8inger et al., 1995; King et al., 1996). With
unimolecular misfolding as the rate limiting step, the first order kinetics were consistent
with the weak concentration dependence of misfolding under the refolding conditions tested
by Seckler (Danner & Seckler, 1993). Another model is that an interdigitated 3-helix
forms with nativelike strand alignment. This cross-3-sheet structure would be extremely
stable and consistent with the documented properties of inclusion bodies (Marston, 1986).
The formation of a dense network of interdigitated nativelike (3-helices would create stable
aggregated inclusion bodies that were resistant to SDS and protease, while the early
multimeric precursors would be sensitive, similar to the folding intermediates (Speed et al.,
1995). In addition, the model is consistent with multimeric polymerization and specificity
in the aggregation reaction.
One can hypothesize the local structure of an interchain P-helix using the
monomeric subunit within the native tailspike trimer as a model. Although aggregation
occurs by the association of folding intermediates rather than the native trimer, the local
secondary structure within the monomeric folding intermediate may resemble the native (3-
helix structure. To form an interdigitated (-helix containing nativelike interchain contacts,
the (3-helix aggregate may form a helix having double the pitch or double the radius of the
native structure (Fig. 7.3). These models would conserve the nativelike strand alignment
in the (3-helix structure. The helix having a doubled pitch would probably have steric
hindrances and display nativelike epitopes on the main body of the (-helix, which are not
found on the aggregation intermediates (Chapter 4). However, the intermolecular helix
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Figure 7.2: Models of the structural mechanism of aggregation involving the 1-helix motif.
UNIMOLECULAR MISFOLDING
I*=misfolded monomer
(intrachain a-sheet)
Ipt=monomeric P-helix
INTERCHAIN [-HELIX
I2=interchain P-helix
Ipt=monomeric n-helix
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Figure 7.3: Model to depict the putitive structure of an interstrand 13-helix in tailspike
aggregation intermediates.
•Nativelike monomer
-Double pitch
•Double radius
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with a doubled radius would display nonnative epitopes in the O3-helix domain. This model
explains the paradox of aggregated inclusion bodies containing local nativelike secondary
structure yet displaying nonnative epitopes (Oberg et al., 1994; Chapter 4). A tailspike
molecule with a doubled radius would create a large central intramolecular cavity that could
contain water molecules, similar to the intermolecular cavity of the native trimer
(Steinbacher et al., 1994) and consistent with the high void volume of inclusion bodies
(Taylor et al., 1986). This model also accounts for the formation of stable interdigited
complexes, leading to the formation of a large aggregated network.
iii. General refolding strategies
General approaches to influencing the balance between productive folding and aggregation
can be formulated based on the polymerization mechanism and structural data.
Understanding the driving force of aggregation and the role of hydrophobicity and
electrostatics can lead to the rational design of refolding strategies. Novel refolding
strategies discussed in Chapter 2 (Section F) have dramatically improved refolding yields.
However, most cases still require optimizing the refolding scheme for each new protein
individually.
Typically, detailed structural information on the folding and aggregation
intermediates is unknown for a given protein of interest. In the biotechnology industry, the
downstream processing of therapeutic proteins must be determined early in development,
and often there is insufficient time to determine the optimal refolding strategy. However,
some basic criteria can characterize the biophysical properties of the aggregation
intermediates and inclusion body state for effective design of a refolding strategy.
For example, if the native protein contains a set of disulfide bonds, the polypeptide
chains expressed in E. coli may be in the aggregated inclusion body state because of an
inability to form disulfides in the reducing environment of the cytoplasm. Possible
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solutions to this problem include expressing the protein as a fusion protein containing a
signal peptide directing the chains to the periplasmic space or catalyzing the oxidation of
cysteine with the addition of trace metal ions during refolding (DeBemardez-Clark &
Georgiou, 1991). If the protein contains a large number of disulfide bonds or requires
glycosylation for activity, then the protein should be expressed in mammalian cells [e.g.
tissue plasminogen activator, (Cleland, 1993); erythropoietin, (Lin et al., 1985)]. On the
other hand, for proteins that do not contain any disulfide bonds in the native state but form
incorrect disulfides within the aggregated inclusion bodies, refolding in the presence of
metal chelators or reducing agents can improve refolding yields.
Other strategies are required for proteins that are susceptible to aggregation via
hydrophobic or electrostatic interactions. Typical strategies to avoid association of
hydrophobic folding intermediates include lowering the growth temperature or refolding
temperature (Schein & Noteborn, 1988), diluting to lower protein concentrations during
refolding (Jarrett et al., 1993), adding cosolvents, detergents, or sugars to the refolding
buffer (Schein, 1990; DeBernardez-Clark & Georgiou, 1991), or setting the pH of the
refolding buffer away from the isoelectric point of the protein (DeBemardez-Clark &
Georgiou, 1991). For protein that aggregates via electrostatic interactions, refolding is
performed in high ionic strength buffer, or even incubating the inclusion bodies directly in
high ionic strength buffer or ion exchange resin may dissociate the aggregates and generate
active native protein (Hoess et al., 1988).
The key to generalizing the principles of protein refolding is to identify the class of
polymerization mechanism and aggregation driving force for each new protein. General
classes of molecular interactions involved in aggregation include hydrophobic interactions,
intermolecular disulfide bond formation, and electrostatic interactions. Effective refolding
strategies alter the driving force controlling the relative rates of folding and aggregation at
the junction between productive folding and aggregation. The ability to influence the
189
kinetic competition between productive folding and aggregation is a common goal for the
biotechnology and medical communities.
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APPENDIX A: TEMPERATURE SENSITIVE FOLDING MUTATIONS IN
P22 TAILSPIKE (Adapted from King et al., 1990)
ALLELE
tsU34
tsU159
tsU131, tsU134
tsU9
tsU 116
tsU55
tsU166
tsU86
tsU5, tsU162
tsU56, tsU57
tsH300
tsU2
tsH304
tsH303
tsU 11
tsU160
tsU24
tsRAF, tsRE, tsi
tsU19
tsN42
tsU1, tsU18
tsU3
tsU7
tsH302
tsN48
ts9.1
tsmU8
tsH301
tsU53
tsU14
tsU170
tsU38
tsU85
tsU75
tsU143
A AMINO ACTD LOCAL SEOUENCE
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R
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163
163
175
177
180
196
199
224
227
230
235
238
244
250
250
250
258
H 270
285
299
307
309
311
323
333
334
344
368
382
405
434
435
471
492
493
Lys->Glu
Lys-+Val
Gly--Ala
Gly->Arg
Ile-+Asn
Glu-+Lys
Thr-ýLys
Leu->Ser
Ser---Phe
Asp-WVal
Thr-Ile
Asp--Ser
Gly-+Arg
Pro--Ser
Pro-+Leu
Pro--Leu
Ie-->Leu
Val--Gly
Arg->Lys
Ser--Asn
Thr--Ala
Glu--Val
Leu--His
Gly-+Asp
Ser->Asn
Ala-->Val
Glu->Lys
Thr-Ale
Arg->Ser
Glu->Lys
Arg--Cys
Gly-+Glu
Val--Ala
Ile--Leu
Ser-+Phe
Asp Phe Gly Gly Lys Val Leu Thr Ile
Asp Phe Gly Gly Lys Val Leu Thr Ile
Ala Lys Phe Ile Gly Asp Gly Asn Leu
Phe Ile Gly Asp Gly Asn Leu Ile Phe
Asp Gly Asn Leu Ile Phe Thr Lys Leu
Gly Val Pe Met Glu Ser Thr Thr Thr
Met Glu Ser Thr Thr Thr Pro Trp Val
Val Val Ala Thr Leu Lys Gln Ser Lys
Thr Leu Lys Gin Ser Lys Thr Asp Gly
Glu Ser Lys Thr Asp Gly Tyr Glu Pro
Gly Tyr Gln Pro Thr Val Ser Asp Tyr
Pro Thr Val Ser Asp Tyr Val Lys Phe
Val Lys Phe Pro Gly Ile Glu Thr Leu
Glu Thr Leu Leu Pro Pro Asn Ala Lys
Glu Thr Leu Leu Pro Asn Ala Lys
Glu Thr Leu Leu Pro Asn Ala Lys
Lys Gly Gln Asn Ile Thr Ser Thr Leu
Glu Cys Ile Cly Val Glu Val His Arg
Gly Phe Leu Phe Arg Gly Cys His Phe
Ala Asn Asn Pro Ser Gly Gly Lys Asp
Asp Gly Ile Ile Thr Phe Glu Asn Leu
Ile Ile Thr Phe Glu Asn Leu Ser Gly
Thr Phe Glu Asn Leu Ser Gly Asp Trp
Asn Tyr Val Ile Gly Gly Arg Thr Ser
Gly Ser Val Ser Ser Ala Gin Phe Leu
Ser Val Ser Ser Ala Gin Phe Leu Arg
Asn Gly Gly Phe Glu Arg Asp Gly Gly
Thr Trp Gin Gly Thr Val Gly Ser Thr
Asn Leu Gin Phe Arg Asp Ser Val Val
Asp Met Asn Pro Glu Leu Asp Arg Pro
Asn Leu Leu Val Arg Gly Ala Leu Gly
Leu Leu Val Arg Gly Ala Leu Gly Val
Thr His Glu Ser Val Phe Thr Asn Ile
Asn Gin Ile Tyr Ile Ser kGly Ala Cys
Gin He Tyr Ie Ser Gly Ala Cys Arg
APPENDIX B: CLASSICAL LIGHT SCATTERING DATA ANALYSIS
In analyzing the classical light scattering data measured during aggregation, the following
calculations derive the relationship between the extent of aggregation and the intensity of
light scattered.
i. Multimeric polymerization model
Assume homogeneous population of multimers
Define: N = concentration of multimers in solution
M = molecular weight of homogeneous population of multimers
No = concentration of monomers in solution at time 0
Mo = molecular weight of monomers
Rayleigh light scattering: I a NM 2
Conservation of mass: N = NoMOM
dI = d(cNM2) = d{cN NoM° = cN 02M 2
N N2
Aggregation kinetics: rate = kN2 = (2 dt
Slope: dI- = - cN = 2ckNo2M 2 = constantdt N2 dt
Therefore, assuming that there is a homogeneous population of aggregates, the multimeric
polymerization model predicts a linear increase in intensity of light scattered over the course
of an aggregation reaction.
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ii. Sequential polymerization model
Assume monomers in equilibrium with a uniform population of growing aggregates
Assume a constant number or concentration of aggregates (i.e. difficult nucleation step)
Define: N 1 = concentration of monomers in solution
M1 = molecular weight of monomers
Rayleigh light scattering:
Conservation of mass:
I x N1M 12 + NM2 = NM2
N 1M 1 + NM = NOMo
rate = kN1N = dN
N1 = Nexp(-kdtN)
N, = Noexp(-ktN)
(d = 2cNMdt dt = 2cN (kN1N ) MN N
(dI) = 2ckN1/ 2N1,M = 2ckN12Noe-ktN M
211/2oI  =10o -2cN-1/2NoM 
-ktN t
to
I N" 2
( 1/2 cNoM , (ktN r
I N1/2 - 1
= 2ckN1/2No 1
e- ktN 11/2Slope: cNMI (e-ktNN 1/2
dt )
Inflection point: d2IJdt-NI1 2cN-ktN M 1
-NI1/2 + 2cN1/2N Mje-ktN + cN1/2 oN1 = 0
Inflection point: t=-1 (N1/2 1/2 - cN°M 1  InkN 2cNOM 1
2cNOM 1
N1/2--/2 _ cN M,S o - c • 1
Therefore, assuming that a population of monomers is in equilibrium with a uniform
population of multimers, the sequential polymerization model produces a sigmoidal curve
for the kinetics of aggregation monitored by light scattering.
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N dM
M, dt
1/kN
APPENDIX C: MATLAB PROGRAMS TO MODEL AGGREGATION
QUANTITATIVE ANALYSIS OF CLASSICAL LIGHT SCATTERING DATA
i. Differential equations for multimeric polymerization
function Ndot=CLSmulti(t,N)
% program to model aggregation using multimeric polymerization model
% Definition of variables:
% "AGGREG" = aggregation rate constant
% "NMER"= number of multimers to be tracked in simulation (=20)
% "t" = time after dilution
% "N(i)" = concentration of multimer of size i
% "s" = sum of the differentials for all polymerization reactions for a particular multimer%
global AGGREG NMER;
for i= 1:NMER-1
s=0;
% formation of multimers from smaller intermediates
for j=1:i/2
s=s+AGGREG*N(j)*N(i-j);
end;
% polymerization of multimers to form larger aggregates
for j=1:NMER-1
if i==j
s=s-2*AGGREG*N(i)A2;
else
s=s-AGGREG*N(j)*N(i);
end;
end;
Ndot(i)=s;
end;
% designate largest multimer (NMER) for all large aggregates
Ndot(NMER)=--0;
for i=NMER/2:NMER- 1
for j=NMER-i:i
Ndot(NMER)=Ndot(NMER)+AGGREG*N(j)*N(i);
end;
end;
end;
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ii. Differential equations for sequential polymerization
function Ndot=CLSseq(t,N)
% program to model aggregation using sequential polymerization model
% Definition of variables:
% "AGGREG" = aggregation rate constant
% "NMER"= number of multimers to be tracked in simulation (=20)
% "t" = time after dilution
% "N(i)" = concentration of multimer of size i
global AGGREG NMER;
% formation of multimers from smaller intermediates
for i=2:NMER-1
Ndot(i)=AGGREG*N(1)*(N(i-1)-N(i));
end;
Ndot(NMER)=AGGREG*N(1)*N(NMER-1);
% polymerization of multimers depleting monomers
Ndot(1)=0;
for j=1:NMER-1
Ndot(l)=Ndot(1)-AGGREG*N(1)*N(j);
end;
Ndot(1)=Ndot(1)-AGGREG*N(1)*N(1);
end;
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iii. Differential equations for multimeric polymerization and productive folding
function Ndot=diffies(t,N)
% program to model native trimer formation & multimeric aggregation
% Definition of variables:
% "AGGREG" = aggregation rate constant
% "kN" = rate constant for native trimer formation
% "kPT"= rate constant for protrimer formation
% "NMER"= number of multimers to be tracked in simulation
% "t" = time after dilution
% "N(i)" = concentration of multimer of size i
% "s" = sum of the differentials for all polymerization reactions for a particular multimer%
global AGGREG kN kPT NMER;
for i=1:NMER-1
s=--O;
% formation of multimers from smaller intermediates
for j=1:i/2
s=s+AGGREG*N(j)*N(i-j);
end;
% polymerization of multimers to form larger aggregates
for j=1:NMER-1
if i==j
s=s-2*AGGREG*N(i)A2;
else
s=s-AGGREG*N(j)*N(i);
end;
end;
Ndot(i)=s;
end;
% designate largest multimer (NMER) for all large aggregates
Ndot(NMER)=--O;
for i=NMER/2:NMER-1
for j=NMER-i:i
Ndot(NMER)=Ndot(NMER)+AGGREG*N(j)*N(i);
end;
end;
% formation of Protrimer=N(NMER+1) and Native=N(NMER+2);
Ndot(1)=Ndot(1)-N(1)*3*kPT;
Ndot(NMER+1)=kPT*N(1)-kN*N(NMER+1);
Ndot(NMER+2)=kN*N(NMER+1);
end;
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iv. Differential equations for sequential polymerization and productive folding
function [Ndot]=seq(t,N)
global RATECONST NMER;
% program to model seq multimerization
.%
% Definition of variables:
% "AGGREG" = aggregation rate constant
% "kN" = rate constant for native trimer formation
% "kPT"= rate constant for protrimer formation
% "NMER"= number of multimers to be tracked in simulation
% "t" = time after dilution
% "N(i)" = concentration of multimer of size i
global AGGREG NMER;
% formation of multimers from smaller intermediates
for i=2:NMER-1
Ndot(i)=AGGREG*N(1)*(N(i-1)-N(i));
end;
Ndot(NMER)=AGGREG*N(1)*N(NMER- 1);
% polymerization of multimers depleting monomers
Ndot(1)=O;
for j=1:NMER-1
Ndot(1)=Ndot(1)-AGGREG*N(1)*N(j);
end;
Ndot(1)=Ndot(1)-AGGREG*N(1)*N(1);
% formation of Protrimer=N(NMER+1) and Native=N(NMER+2);
Ndot(1)=Ndot(1)-N(1)*3*kPT;
Ndot(NMER+1)=kPT*N(1)-kN*N(NMER+1);
Ndot(NMER+2)=kN*N(NMER+1);
end;
end;
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